The role of Zap70 in naïve T cell homeostasis by Schim Van Der Loeff, ICD
  
 
 
The role of Zap70 in naïve T cell 
homeostasis 
 
 
Ina Corinne Dorothea Schim van der Loeff 
 
 
UCL 
 
 
 
 
A thesis presented for the degree of Doctor of Philosophy, 2013 
 1 
Declaration 
I, Ina Schim van der Loeff confirm that the work presented in this thesis is my 
own. Where information has been derived from other sources, I confirm that this 
has been indicated in the thesis. 
 
 
 
Ina Schim van der Loeff 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
Publications arising from this thesis 
Sinclair, C.*, Saini, M.*, Schim van der Loeff, I., Sakaguchi, S., and Seddon, B.P. 
(2011). The long-term survival potential of mature T lymphocytes is 
programmed during development in the thymus. Sci Signal 4, ra77. 
*Contributed equally (see Appendix). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Acknowledgements 
To start, I would like to thank my supervisor Dr Benedict Seddon for giving me 
the opportunity to work on this project. This paragraph will not do justice to his 
support, advice and clarity of vision during discussions about experiments, data 
and the writing of thesis. I would also like to thank the members of my thesis 
committee Dr Andreas Wack, Dr Victor Tybulewicz and Dr Pavel Tolar for their 
advice and comments throughout my PhD. I would also like to thank the UCL 
MB PhD programme for allowing me to take time out of my medical training to 
pursue full-time scientific research. 
Throughout my PhD I also benefited from working alongside Dr Charles Sinclair 
who taught me numerous experimental techniques and whose almost 
encyclopaedic knowledge of immunology I frequently consulted during my PhD. 
I would also like to thank Sim Tung and Dr Iren Bains for being great neighbours, 
as well as Dr Thea Hogan, Dr Jie Yang, Dr Ana Silva Daniel Marshall and 
Louise Webb who I have happily shared lab space with for the last 3 years.  
Thanks also go to Victoria, Olivia, Pippa, Charlie and Louise from the various 
immunology divisions but especially to Elizabeth Natkanski for her friendship 
during many shared lunch and coffee breaks, and drinks in the NIMR bar. 
Finally, I would like to thank my parents and 3 sisters, Lily, Sanne and Wendela 
for their love and support, and my mum, for proofreading this thesis. And to Dr 
Luke La Hausse de Lalouvière for your love, encouragement and insight, for 
proofreading this thesis and for always challenging all my ideas – scientific and 
otherwise.  
 4 
Abstract 
TCR signalling is crucial to both T cell development and naive T cell 
homeostasis. Naïve T cell survival in the periphery is thought to depend on both 
cytokine signalling and constitutive TCR signalling. The nature of this TCR 
dependent survival signal remains controversial. The tyrosine kinase, Zap70, is 
essential for TCR signalling. The aim of this project is to investigate the role of 
Zap70 in the transduction of survival signals in naïve T cells. Using mice that 
conditionally express Zap70 by means of a tetracycline-inducible system, we 
found that Zap70 is absolutely required for the maintenance of naïve T cells in 
the periphery. Loss of Zap70 resulted in a dramatic and rapid reduction in 
mature naive CD8 T cells in the blood and peripheral organs consistent with a 
naïve T cell survival defect. This survival defect could not be accounted for by 
cell-intrinsic differences in IL-7Rα or Bcl-2 expression. Analysis of T cell survival 
in vitro revealed no differences in responses to IL-7 between F5 T cells with or 
without Zap70. Survival in vitro was found to be enhanced by the presence of 
CD11c+ enriched splenocytes but not T or B cells. Survival of F5 T cells in 
these cultures was dependent on Zap70 expression and also required intact 
MEK signalling. In addition, we also tested the ability of previously described 
Zap70 mutants, Zap70SKG and Zap70YYAA, to transduce homeostatic TCR 
survival signals in vivo. Both mutants were unable to support the development, 
survival or antigen-induced expansion of F5 T cells. Additionally, we found 
evidence that Zap70YYAA had a dominant negative effect on T cell development 
and reconstitution in F5 TetZap70 mice. In conclusion, we find that Zap70 is 
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essential for transmission of signals required for naive T cell survival and 
requires both full expression and functionality of Zap70. 
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Chapter 1 Introduction 
1.1 The immune system 
Integrated and overlapping cell-mediated and molecular responses protect 
hosts from infection by pathogens and make up the immune system. To mount 
a successful immune response an organism must become aware that infection 
by a pathogen has taken place. This recognition is followed by the control or 
elimination of the pathogen by effector immune cells and molecules. Finally, the 
cellular and humoral responses to a pathogen need to be integrated and 
regulated to avoid damage to the host. The first response to infection is 
provided by the innate immune system, which is present in some form in all 
animals and plants – even bacteria have antiviral mechanisms to prevent 
infection by bacteriophages (reviewed in Labrie et al., 2010). The adaptive 
immune response develops after the innate immune response is unable to 
contain an infection and depends on the antigen-specific recognition of 
pathogens by lymphocytes. Adaptive immune cells also have the unique 
capacity to persist after an initial infection as memory cells, which mediate long-
term antigen-specific protection against re-infection. Although adaptive 
immunity was thought to have arisen in jawed vertebrates recent studies show 
that many invertebrate immune systems possess characteristics similar to that 
of adaptive immunity, including antigen-specificity and immunological memory. 
This suggests that the innate and adaptive immune responses are closely 
linked and might have co-evolved (reviewed in Boehm, 2011).  
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1.1.1 Innate immunity 
The innate immune system provides the first line of largely non-antigen-specific 
defence against infection by a pathogen. This is mediated in the first instance 
by epithelial surfaces, which provide a mechanical barrier as well as chemical 
and microbiological barriers to infecting viruses, bacteria, fungi and parasites. 
These barriers include the skin, gut, respiratory tract and eyes, nose and oral 
cavity. The tight junctions joining epithelial cells in these organs, and the 
mucous and tear production in the lungs and oral cavity seal the host off from its 
external environment and prevent adherence of pathogens to epithelial surfaces. 
Furthermore, most epithelial surfaces are colonised with non-pathogenic 
commensal bacteria, which compete with pathogenic bacteria for nutrients and 
attachment to epithelial cells. Epithelial cells and phagocytes also produce an 
array of anti-microbial enzymes and peptides that either kill pathogens or limit 
their growth. The anti-microbial enzymes lysozyme and phospholipase A2 
damage bacterial cell walls and are secreted into tears and saliva but are also 
produced by the gut epithelium. Epithelial cells and innate immune cells like 
neutrophils and mast cells also secrete antimicrobial peptides including α- and 
β-defensins, cathelicidins and lectins (reviewed in Gallo and Hooper, 2012). 
Defensins and cathelicidins bind to pathogen membranes through electrostatic 
interactions ultimately disrupting the membrane and leading to pathogen lysis 
(reviewed in Gallo and Hooper, 2012). C-type lectins depend on peptidoglycan 
recognition to kill pathogens although whether this killing is the direct result of 
cell wall disruption or an enzymatic attack remains unclear (reviewed in Gallo 
and Hooper, 2012). 
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Following breach of the epithelial surface pathogens next encounter the 
complement system, which cooperates with innate immune cells to mark 
pathogens for phagocytosis or cell lysis (Gros et al., 2008). Complement 
activation can be mediated by antibodies, C-reactive protein (CRP) and 
complement component 1 subcomponent q (C1q) (classical pathway), lectins 
(lectin pathway) or by the spontaneous hydrolysis of C3 to C3b known as tick-
over (alternative pathway). Complement activation results in the initiation of a 
proteolytic cascade that generates complement fragments, which mediate the 
lysis, agglutination and opsonisation of pathogens and also induce a local 
inflammatory response. Epithelial damage by pathogens alone can induce local 
inflammation characterised by the release of prostaglandins and leukotrienes 
from endothelial cells and innate immune cells like polymorphonuclear 
leukocytes, macrophages and mast cells (reviewed in Funk, 2001). Acute 
inflammation is also characterised by vasodilation and increased vascular 
permeability promoting the transmigration and recruitment of innate and later 
adaptive immune cells. Innate immune cells express a number of invariant 
receptors that recognise specific pathogen-associated molecular patterns and 
can induce signalling via myeloid differentiation primary response gene 88 
(MyD88), interleukin-1 receptor-associated kinase (IRAK), the adaptor TNF 
receptor-associated factor 6 (TRAF6) and the MAPK kinase (MEK) kinase 
(MAPKKK) transforming growth factor β (TGFβ) activated kinase 1 (Tak1) 
ultimately activating Jun oncogene (AP1) and the inhibitor of κB (IκB) kinase 
(IKK) complex (reviewed in Akira and Takeda, 2004). Phosphorylation and 
degradation of IκB and activation of nuclear factor κB (NFκB) signalling by 
pattern recognition receptors stimulate the transcription and expression of pro-
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inflammatory genes like tumour necrosis factor α (TNFα), IL-1β, IL-6, IL-12p40, 
interferon-(IFN)-inducible genes and co-stimulatory molecules like cluster of 
differentiation (CD) 40, CD80 and CD86 (reviewed in Akira and Takeda, 2004). 
Innate immune cell pattern recognition receptors recognise a broad range of 
common pathogen motifs including fungal zymosan (complement receptor 3) 
(CR3), mannose or fucose on pathogen-infected cells (mannose receptor), 
bacterial peptidoglycan (Toll-like receptor 2, TLR2), lipopolysaccharide (LPS) 
(TLR4) and bacterial unmethylated cytosine-phosphate-guanine (CpG) 
dinucleotides (TLR9) (reviewed in Akira et al., 2001 and in Gordon, 2002). In 
addition to these pattern recognition receptors, scavenger receptors on 
macrophages, lectin receptors on macrophages and dendritic cells (DCs), and 
complement receptors on macrophages and neutrophils, promote the 
phagocytosis of both pathogens and senescent, apoptotic, and necrotic cells, 
which then allows antigen presenting cells (APCs) like macrophages and DCs 
to process and present potential antigens to T and B lymphocytes (reviewed in 
Gordon, 2002). Innate immune cells thus mediate the detection and clearance 
of broad groups of pathogens and can recruit and activate adaptive immune 
cells, which can mount highly antigen-specific cell-mediated and humoral 
responses. 
1.1.2 Adaptive immunity 
The adaptive immune response depends on the recognition of specific antigens 
from bacteria, viruses or parasites by specialised antigen receptors on B and T 
lymphocytes and becomes important when the innate immune response fails to 
completely eliminate an infection. Recirculating B and T lymphocytes first 
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encounter antigen on activated APCs in specialised lymphoid tissues, which in 
addition to co-stimulatory signals (reviewed in Lenschow et al., 1996 and in 
Acuto and Michel, 2003) induce antigen-specific lymphocytes to proliferate and 
differentiate into effector and memory T and B cells. Both B and T cells are of 
lymphoid origin and develop in the bone marrow (BM) and thymus, respectively. 
B cells mediate the humoral response to pathogens by differentiating into 
antibody-producing plasma cells while effector T cells can differentiate into 
cytotoxic T cells in response to CD8 and T cell receptor (TCR) interactions with 
antigenic peptide in the context of major histocompatibility complex I (pMHCI), 
or various types of helper T cell in response in response to CD4 and TCR 
interactions with pMHCII. Fundamental to the specific recognition of pathogens 
by T and B lymphocytes is the expression of polyclonal antigen-specific 
receptors which can recognise a variety of antigens. B cells express membrane-
bound immunoglobulin on their surface, known as the B cell receptor (BCR), 
and immunoglobulins of the same antigen specificity as the BCR are secreted 
by differentiated plasma cells. These secreted antibodies agglutinate, neutralise 
and opsonise pathogens as well as activate complement. Interaction between 
the immunoglobulin fragment crystallisable (Fc) region and the Fc receptor on 
phagocytes is essential for phagocytosis, degranulation and the initiation of 
cytokine transcription and expression (reviewed in Daëron, 1997). Unlike B cells, 
T cells only express a membrane-bound antigen receptor, the TCR, which only 
recognises oligomer peptide fragments of foreign peptides in the context of 
MHCI or II molecules.  
The generation of TCRs and immunoglobulins with a wide range of antigen-
specificities is mediated primarily by somatic recombination in both T and B 
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cells. The V regions of both immunoglobulins and the TCR are encoded by 
separate gene segments, V, D and J, which are rearranged and brought 
together during somatic recombination to generate a complete V-region exon 
made up of different combinations of V, D and J segments (Fugmann et al., 
2000). V(D)J recombination is mediated by the V(D)J recombinase complex, 
consisting of recombination activation gene (Rag) 1 and Rag2 as well as DNA 
ligase and DNA repair enzymes. The V(D)J recombinase is involved in the 
alignment and cleavage of sites of recombination, which are flanked by 
recombination signal sequences (RSSs) (Oettinger et al., 1990; Schatz et al., 
1989). Rag1 and Rag2 might also be important for coupling the cleavage and 
non-homologous end joining stages of V(D)J recombination (reviewed in 
Fugmann et al., 2000). Additional variability arises at the joints between gene 
segments as a result of the variable insertion of palindromic- and non-template-
encoded-nucleotides (reviewed in Fugmann et al., 2000). The importance of 
Rag-proteins and thus an adaptive immune system is clear from the severe 
primary immunodeficiencies in humans if either of the Rag genes are mutated 
(Sobacchi et al., 2006) and from Rag-deficient mice which lack any T or B cells 
and are severely immunocompromised (Mombaerts et al., 1992; Shinkai et al., 
1992). 
Antigen receptor signalling, in addition to being essential for the activation of T 
and B cells by their cognate antigen, also plays an important role in the 
regulation of lymphocyte development and maintenance. B lymphocytes have 
been shown to require tonic signalling through their BCR in addition to soluble 
signalling from B cell activating factor (BAFF) for their survival (reviewed in 
Rickert et al., 2011 and in Mackay et al., 2010). Similarly, T cell homeostasis 
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depends on tonic TCR signalling as well as cytokine signalling, in particular 
from interleukin-(IL)-7 (Seddon and Zamoyska, 2003). The regulation of T cell 
homeostasis by TCR and IL-7 signals is essential for the maintenance of a 
normal T cell repertoire that can respond and expand during an infection, as 
well as generate and maintain memory cells that can respond to re-infection 
with the same pathogen (Jameson, 2005). 
1.2 Signalling pathways involved in T cell homeostasis 
Homeostasis is defined as the maintenance of an equilibrium despite changes 
in the environment. In the case of the T cell compartment, both the development 
of new T cells in the thymus and the survival, proliferation and differentiation of 
peripheral naïve and memory T cells is under tight homeostatic control. This 
means that the size and composition of the T cell pool remain fairly stable 
throughout life (reviewed in Almeida et al., 2005 and in Freitas and Rocha, 
2000). Both Interleukin 7 receptor α (IL-7Rα) signalling and non-antigenic 
signalling through the TCR have been shown to be important for the regulation 
this homeostasis (Seddon and Zamoyska, 2003). 
1.2.1 IL-7Rα signalling 
IL-7Rα signalling (summarised in Figure 1.1) is initiated by cross-linking of the 
extracellular domains of the IL-7Rα chain and the common γ (γc) chain by IL-7, 
a 25kDa glycoprotein first identified as growth factor that could stimulate the 
proliferation of B cell progenitors in vitro (Namen et al., 1988). IL-7 is mainly 
produced by non-haematopoetic stromal cells in the thymus (Namen et al., 
1988; Wiles et al., 1992), spleen, kidney, liver (Namen et al., 1988) and skin 
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(Heufler et al., 1993) and the amount of available IL-7 is thought to be largely 
regulated by IL-7 consumption (reviewed in Mazzucchelli et al., 2007 and in Fry 
and Mackall, 2005). The cross-linking of the extracellular domains of the IL-7Rα 
chain and the γc chain of the IL-7R brings together Janus kinase 1 (Jak1) and 
Jak3, which are constitutively associated with the cytoplasmic tails of the IL-7Rα 
and the γc chain of IL-7R, respectively (Russell et al., 1994). Heterodimerisation 
brings the Jak1 and Jak3 in close proximity allowing phosphorylation of Jak1 
and the IL-7Rα chain by Jak3, which creates a docking site for the Src 
homology domain 2 (SH2) domain of signal transducer and activator of 
transcription (STAT) 1, 3 and 5 (reviewed in Jiang et al., 2005). Jak3 appears to 
be the major transducer of γc chain signals since Jak3-/- mice (Nosaka et al., 
1995; Park et al., 2004b; Suzuki et al., 2000) resemble γc-/- mice (Cao et al., 
1995) exhibiting similar defects in T and B cell development and signalling as 
well as reduced B cell leukaemia/lymphoma 2 (Bcl-2) expression and IL-7-
induced Bcl-2 synthesis (Suzuki et al., 2000). A subsequent study showed that 
in addition to reduced Bcl-2, Jak3-deficient thymocytes and T cells also had 
elevated Bcl-2-associated X protein (Bax) abundance (Wen et al., 2001). Jak1-/- 
mice also have severely impaired T and B cell development, with reduced 
thymocyte numbers but not an absolute block of T cell development, similar to 
IL-7-/- mice (Freeden-Jeffry et al., 1995).  
Following the phosphorylation of Jak1 and IL-7Rα chain by Jak3, Jak1 and Jak3 
phosphorylate the STATs recruited to IL-7Rα, which induces their dimerisation 
and translocation to the nucleus where they can activate specific gene 
transcription. In T cells, IL-7 predominantly induces the phosphorylation of two 
isoforms of STAT5, STAT5a and STAT5b, which can form homo- or 
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heterodimers (Foxwell et al., 1995; Rosenthal et al., 1997; Yu et al., 1998). As 
well as their tyrosine phosphorylation, IL-7 also stimulates the DNA binding 
activity of STAT5a/b (Foxwell et al., 1995). STAT5a and b are at least partially 
redundant in lymphocytes since deficiency of either STAT5a (Nakajima et al., 
1997) or STAT5b (Imada et al., 1998) has little effect on T and B cell 
development. Mice lacking both Stat5a and Stat5b do show defects in both T 
and B cell development (Yao et al., 2006). In fact, similar to Jak3-deficiency, 
STAT5a/b-deficiency leads to a severe reduction in thymocyte numbers without 
a complete block of T cell development, as well a reduction in the proportion of 
B cells and peripheral CD8 T cells, in particular (Yao et al., 2006) reflecting the 
importance of STAT5 in the transduction of γc chain and Jak3 signals. 
Interestingly, unlike other STATs, STAT5 has mostly been implicated in the 
transduction of pro-survival signals by regulating the expression of Bcl-2 family 
members and caspases (reviewed in Debierre-Grockiego, 2004). In fact, STAT5 
has been implicated in the regulation of IL-7-induced Bcl2 transcription (Jiang et 
al., 2004) and expression of Bcl2 was also impaired in the STAT5a/b-double-
deficient mouse (Yao et al., 2006). Furthermore, Jak1, Jak3 and STAT5 activity 
are all implicated in IL-7-induced growth and proliferation signals (Foxwell et al., 
1995) and STAT5 has been shown to induce CyclinD1 transcription in vitro 
(Matsumura et al., 1999) and maintain CyclinD2 expression in vivo (Yao et al., 
2006). IL-7 has also been implicated in the regulation of c-myc expression 
(Crawley et al., 1996; Seckinger et al., 1994), another important regulator of cell 
growth and proliferation (reviewed in Dang, 2012). 
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Finally, it has been shown that IL-7 can induce the phosphorylation of the 
regulatory subunit of phosphatidylinositol 3-kinase (PI3K) (p85) in human 
thymocytes (Dadi et al., 1994) although the downstream targets of this signal 
remain poorly characterised (reviewed in Jiang et al., 2005). The p85α subunit 
has been shown to interact with a tyrosine residue on IL-7Rα, Y449, in mouse B 
cells (Venkitaraman and Cowling, 1994) and the same residue of IL-7Rα is also 
thought to be important for the phosphorylation of STAT5 (Jiang et al., 2004). In 
T cell acute lymphoblastic leukaemia (T-ALL) cells, PI3K was shown to be 
indispensable for IL-7-induced upregulation of Bcl-2, downregulation of the cell 
cycle inhibitor cyclin-dependent kinase inhibitor 1B (p27kip1) and expression of 
glucose transporter 1 (GLUT1) (Barata et al., 2004). Both STAT5 and protein 
kinase B (Akt/PKB) are also implicated in the regulation of glucose metabolism 
by IL-7 in T cells in vitro  (Wofford et al., 2008). T cell development and 
proliferation, however, are normal in mice lacking the p85α subunit of PI3K 
(Fruman et al., 1999) calling into question the exact role of PI3K in IL-7 
signalling in vivo. 
1.2.2 Regulation of IL-7Rα expression 
While IL-7 transcription is thought to occur at a constant constitutive rate, IL-
7Rα transcription and expression is strictly controlled during development and 
modulated by various external stimuli on mature T cells (reviewed in 
Mazzucchelli and Durum, 2007). It is expressed on the most immature CD4- 
CD8- double negative (DN) thymocytes, downregulated on CD4+ CD8+ double 
positive (DP) thymocytes after which it is re-expressed on CD4+ and CD8+ 
single positive (SP) thymocytes and IL-7 responsiveness measured by STAT5 
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phosphorylation correlates well with IL-7Rα expression on each of these 
thymocyte populations (Van De Wiele et al., 2004). IL-7 signalling in DN 
thymocytes is important for their protection from apoptosis (Khaled et al., 2002) 
and has also been implicated in the rearrangement of the Tcrg gene  (Candeias 
et al., 1997b). Naïve CD4 and CD8 T cells in the periphery express 
heterogeneous levels of IL-7Rα but are all able to upregulate their surface IL-
7Rα after overnight culture without IL-7 (Park et al., 2004a), suggesting that 
naïve T cells receive signals that induce IL-7Rα downregulation in vivo. In fact, 
one such factor is IL-7 itself, which has been shown to induce the 
downregulation of IL-7Rα on naïve T cells and suppress Il7ra transcription (Park 
et al., 2004a). Interestingly, forced expression of IL-7Rα leads to a reduction in 
the size of the naïve T cell pool (Park et al., 2004a). These data are consistent 
with an altruistic model of IL-7Rα signalling whereby IL-7-induced 
downregulation of IL-7Rα expression prevents cells that have already received 
sufficient IL-7 survival signals to consume further IL-7 (Park et al., 2004a). 
Finally, while most effector CD8 T cells dramatically downregulate IL-7Rα 
expression, a proportion of virus-specific effector CD8 T cells retain high IL-7Rα 
expression and are thought to be the precursors for long-term memory CD8 T 
cells (Huster et al., 2004; Kaech et al., 2003). Other studies, however, have 
failed to find a relationship between IL-7Rα re-expression and CD8 memory 
formation (Lacombe et al., 2005). 
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1.2.3 TCR signalling 
The TCR complex consists of a heterodimer of membrane-bound, TCRα and β 
(Kappes et al., 1983), associated with CD3δε and CD3γε heterodimers and a 
CD3ζ homodimer. Deficiency in any of the CD3 subunits leads to impaired TCR 
signalling and T cell development (Dave et al., 1998; Haks et al., 1998; Liu et al., 
1993; Malissen et al., 1995) reflecting the importance of TCR signalling for T 
cell homeostasis. The TCR complex recognises antigenic peptides in the 
context of MHCI in the case of CD8 T cells, and MHCII in the case of CD4 T 
cells. The CD4 and CD8 co-receptors interact specifically with the non-
polymorphic domains of MHCII (Doyle and Strominger, 1987) and MHCI 
(Norment et al., 1988), respectively. Phosphorylation of lymphocyte-specific 
protein tyrosine kinase (Lck), associated with the CD4 and CD8 co-receptors 
(Veillette et al., 1988), is one of the earliest events in TCR signalling 
(summarised in Figure 1.2) (reviewed in Brownlie and Zamoyska, 2013), and it 
has been proposed that the main function of the CD4 and CD8 co-receptors is 
to bring Lck in close proximity to its substrates, the CD3 immunotyrosine 
activation motifs (ITAMs) (Artyomov et al., 2010). The TCR complex, however, 
does not have any intrinsic kinase activity and so how pMHC interactions with 
TCR initiate the TCR signalling cascade remains unknown.  
One model proposes that TCR binding of pMHC causes the TCR to undergo a 
conformational change to initiate signalling. In support of this model, the 
cytoplasmic domain of CD3ε is inserted in the plasma membrane in resting T 
cells, inaccessible to Lck and TCR ligation would need to induce dissociation of 
the CD3ε ITAM from the plasma membrane to render it accessible to Src family 
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kinases (Xu et al., 2008a).  What might cause dissociation of the CD3ε ITAM 
from the plasma membrane remains unclear. In a second model, pMHC binding 
to the TCR segregates the TCR complex in areas of the plasma membrane rich 
in Lck but devoid of CD45, protecting it from dephosphorylation by CD45 
(reviewed in van der Merwe and Dushek, 2010). Indeed, it was recently shown 
in an artificial receptor system that extracellular protein-protein interactions can 
generate binding energies that can induce segregation of membrane proteins 
without conformational change (James and Vale, 2012). Following the initiation 
of TCR signalling, Lck phosphorylates its targets, including the ITAMs of CD3γ, 
CD3δ, CD3ε, CD3ζ and ζ-associated protein of 70kDa (Zap70) which ultimately 
results in a conformational change in Zap70 (Brdicka et al., 2005) allowing it to 
phosphorylate its targets, linker of activated T cells (LAT) and SH2 domain 
containing leukocyte protein of 76kDa (Slp76) (Bubeck Wardenburg et al., 1996; 
Zhang et al., 1998a).  
1.2.3.1 The regulation of Lck activity by CD45 and Csk 
Src family kinase activity is regulated by the phosphorylation of an activating 
tyrosine in the catalytic domain and a C-terminal inhibitory tyrosine. It was 
recently shown that in resting T cells ~40% of total Lck is active and 
phosphorylated at Y394 and ~20-30% of total Lck is doubly phosphorylated at 
both the activating and inhibitory tyrosines, Y394 and Y505 (Nika et al., 2010). 
Interestingly, both Lck phosphorylated only at Y394 (pY394) and Lck doubly 
phosphorylated at Y394 and Y505 (pY394 pY505) showed very similar kinase 
activity in vitro (Nika et al., 2010) and were in the open, active conformation. It 
has also been shown that no additional activation of Lck is required for TCR 
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signalling (Nika et al., 2010). A subsequent study demonstrated that TCR 
triggering induces clustering of Lck in its active conformation but not in its 
closed inactive conformation (Rossy et al., 2013). The clusters of active Lck 
also excluded the phosphatase CD45 (Rossy et al., 2013). Thus, the local 
concentration of active Lck in an open conformation appears to be more 
important than the overall abundance of phosphorylated Lck in a cell (reviewed 
in Brownlie and Zamoyska, 2013). 
While the activating tyrosine of Src family kinases is autophosphorylated, the 
inhibitory tyrosine is phosphorylated by C-terminal Src kinase (Csk), a 
ubiquitous kinase whose only substrate is the inhibitory tyrosine of Src family 
kinases (reviewed in Veillette et al., 2002). Once phosphorylated, the C-terminal 
inhibitory tyrosine of Lck, Y505, can bind to the SH2 domain, blocking the 
substrate binding domain and locking the Src family kinase into an auto-
inhibited closed conformation (Xu et al., 2008b). Consistent with a negative 
regulatory role for Csk in TCR signalling, Csk-deficient thymocytes and mature 
T cells all show constitutive TCR signalling independent of TCR, Rag1 or MHC 
expression (Schmedt and Tarakhovsky, 2001; Schmedt et al., 1998). 
Furthermore, inhibition of analog-sensitive form Csk was sufficient to activate 
TCR signalling independent of TCR interactions with pMHC (Schoenborn et al., 
2011).  
The activating and inhibitory tyrosines of Src family kinases are also substrates 
for phosphatases including CD45, protein tyrosine phosphatase non-receptor 
type 6 (Shp1) and protein tyrosine phosphatase non-receptor type 22 (Ptpn22) 
(Rhee and Veillette, 2012). In Cd45-/- mice, T cell development and signalling is 
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severely impaired (Byth et al., 1996) and Lck and Fyn proto-oncogene (Fyn) are 
hyperphosphorylated at their inhibitory tyrosine residues (Stone et al., 1997). 
Expression of constitutively active Lck rescues T cell development in Cd45-/- 
mice suggesting CD45 mainly counteracts Csk by dephosphorylating Y505 and 
is thus a positive regulator of TCR signalling (Pingel et al., 1999; Seavitt et al., 
1999). The kinase activity of Lck, however, is paradoxically increased in CD45-
deficient thymocytes suggesting that CD45 might have both a positive and a 
negative role in TCR signalling (D'Oro and Ashwell, 1999). More recent work 
has shown that low CD45 abundance is sufficient to dephosphorylate the 
inhibitory pY505 residue, whereas more CD45 is required to dephosphorylate 
the activating pY394 residue (McNeill et al., 2007). Subsequent studies have 
suggested that at low doses, CD45 has predominantly positive regulatory role in 
TCR signalling while at higher doses CD45 inhibits TCR signalling (McNeill et 
al., 2007; Zikherman et al., 2010).  
1.2.3.2 The initiation of Zap70 signalling in T cells 
Following TCR engagement with pMHC, Zap70, is recruited to the TCR 
signalling complex. This was shown to involve Ras homology gene family 
member H (RhoH), a haematopoietic GTPase-deficient member of the Rho 
GTPase family, whose noncanonical ITAMs bind Zap70 (Gu et al., 2006).  
Rhoh-/- mice show a block in T cell development leading to reduced peripheral T 
cells and reduced CD3ζ phosphorylation and Zap70 translocation following CD3 
stimulation (Gu et al., 2006). A small fraction of Zap70 is constitutively 
associated with the tyrosine-phosphorylated CD3ζ (van Oers et al., 1994). Lck-
mediated phosphorylation of CD3ζ following TCR triggering leads to further 
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recruitment of Zap70, which like its family member spleen tyrosine kinase (Syk), 
consists of a C-terminal kinase domain and two tandem N-terminal SH2 
domains (Chan et al., 1992) (Figure 1.3). Importantly, two tyrosine residues in 
the domain linking the SH2 domains and the kinase domain of Zap70, Y315 and 
Y319, need to be phosphorylated by Lck to relieve the auto-inhibitory 
conformation of inactive Zap70 (Brdicka et al., 2005) enhancing its kinase 
activity (Deindl et al., 2009). Binding of the doubly phosphorylated ITAMs of 
CD3ζ and CD3ε by the tandem Zap70 SH2 domains (Hatada et al., 1995; 
Wange et al., 1993), is thought to further stabilise the open and active 
conformation of Zap70 as well as localise Zap70 near the TCR and Lck 
(reviewed in Au-Yeung et al., 2009). Zap70 kinase activity requires 
phosphorylation Y492 and Y493 in the kinase domain of Zap70 by Lck or Zap70 
itself (reviewed in Au-Yeung et al., 2009), which allows Zap70 to phosphorylate 
its targets, LAT (Zhang et al., 1998a) and Slp76 (Bubeck Wardenburg et al., 
1996). 
The importance of the SH2 domains for the interaction between Zap70 and the 
CD3ζ ITAMs is very clear in SKG mice, which express a mutant Zap70 
containing a missense mutation in the C-terminal SH2 domain (Sakaguchi et al., 
2003). Reduced recruitment of Zap70SKG to the TCR complex and CD3ζ chains 
in these mice results in impaired calcium (Ca2+) mobilisation and impaired 
phosphorylation of LAT and phospholipase C γ (PLCγ) following TCR 
stimulation in vitro (Sakaguchi et al., 2003). Unlike in Zap70-/- mice (Negishi et 
al., 1995), T cell development is not completely blocked in SKG mice although 
the reduced TCR signalling does lead to impaired positive and negative 
selection (Sakaguchi et al., 2003). The weaker TCR signalling mediated by 
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Zap70SKG is thought to lead to the selection of T cells with higher affinity for self-
peptide in the context of MHC (spMHC). Potentially autoreactive T cells are thus 
selected, which might have been eliminated during negative selection in 
wildtype (WT) mice (Sakaguchi et al., 2003). This shift in the T cell repertoire 
leads to the spontaneous development of arthritis in SKG mice unless they are 
housed in a clean environment (Sakaguchi et al., 2003; Yoshitomi et al., 2005). 
Interestingly, while the number and in vitro suppressive activity of CD4 
regulatory T cell (Treg) from SKG mice is normal (Hsu et al., 2009), they appear 
less able to prevent arthritis if co-transferred with SKG CD4 T cells into 
immunodeficient BALB/c mice (Sakaguchi et al., 2006). Importantly, in addition 
to mediating attenuated TCR signalling, Zap70SKG abundance is also 
significantly reduced compared to Zap70WT, which is likely to contribute to the 
signalling and T cell development defects seen in SKG mice (Hsu et al., 2009). 
1.2.3.3 The roles of Y292, Y315 and Y319 during Zap70 signalling 
Three tyrosine residues in the interdomain B linking the two SH2 domains of 
Zap70 and its kinase domain are both known sites of phosphorylation and have 
been implicated in interactions with Zap70 targets such as E3 ubiquitin-protein 
ligase Cbl (c-Cbl), Vav1 proto-oncogene 1 (Vav1), Lck, Crk proto-oncogene 
(p38) and PLCγ (reviewed in Au-Yeung et al., 2009). Y292 appears to 
negatively regulate Zap70 function since T cells from knock-in mice expressing 
Y292 mutated to phenylalanine (Y292F) showed hyperphosphorylation of LAT 
and SLP-76 (Magnan et al., 2001), both Zap70 substrates. 
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Y315 and Y319 are phosphorylated after TCR engagement (Chan et al., 1995) 
and are both thought to be positive regulators of Zap70 function (reviewed in 
Au-Yeung et al., 2009) in addition to being important for destabilising the auto-
inhibited conformation of Zap70 once phosphorylated (Brdicka et al., 2005). 
Phosphorylated Y315 is thought to be a binding site for the SH2 domain of Vav1 
(Wu et al., 1997) and the adaptor protein p38 (Gelkop et al., 2005), which might 
link TCR stimulation to reorganisation of the actin cytoskeleton (reviewed in Au-
Yeung et al., 2009). Finally, Y315 has also been implicated in the activation of 
PLCγ and mutation of Y315 to phenylalanine (F) (Y315F) mutation lead to a 
small reduction in PLCγ phosphorylation as well as small reductions in 
downstream extracellular regulated kinase (Erk) phosphorylation and Ca2+ 
mobilisation (Magnan et al., 2001). Y319, meanwhile, binds the SH2 domain of 
Lck (Pelosi et al., 1999) and PLCγ (Williams et al., 1999). the Y319F mutation 
results in reduced Ca2+ mobilisation, Ras proto-oncogene (Ras) activation and 
CD69 expression as well as impaired phosphorylation of PLCγ and LAT 
(Williams et al., 1999). 
T cell development and TCR signalling in mice expressing Zap70 with both 
Y315 and Y319 residues of Zap70 mutated to alanine (A) (YYAA hereon) were 
recently analysed (Hsu et al., 2009). Similar to the SKG mutation, the YYAA 
mutation leads to a hypomorphic allele of Zap70. Like in SKG mice, both 
positive and negative selection is impaired in YYAA mice leading to a shift in the 
T cell repertoire towards more autoreactive T cells (Hsu et al., 2009). 
Interestingly, despite showing defects in TCR signalling as assessed by Erk 
phosphorylation, Ca2+ mobilisation and CD5 and CD69 expression during T cell 
development, YYAA mice do not develop arthritis following innate immune cell 
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activation (Hsu et al., 2009). Despite SKG T cells having a much more severe 
defect in TCR signalling than YYAA T cells, T cell numbers in SKG and YYAA 
mice are similar (Hsu et al., 2009) contradicting the view that the absolute 
numbers of T cells correlate with Zap70 signalling strength (Siggs et al., 2007). 
In fact, evidence from the YYAA mice suggests that as well as quantitative 
differences in TCR signalling between Zap70 alleles, the specific functions 
impacted by the different Zap70 mutations lead to differential effects on T cell 
development and function (Hsu et al., 2009). Consistent with this, the YYAA 
mice showed a specific defect in Treg development and suppressive activity in 
vitro which did not affect the SKG mice (Hsu et al., 2009). Again, when 
considering the effect of Zap70YYAA on TCR signalling it is important to take into 
account that the abundance of Zap70 is reduced in YYAA compared to WT 
mice, especially in peripheral T cells (Hsu et al., 2009).  
1.2.3.4 Downstream targets of Zap70 
After TCR engagement, active Zap70 phosphorylates LAT (Zhang et al., 1998a) 
and Slp76 (Bubeck Wardenburg et al., 1996). LAT is also phosphorylated by 
Lck (Jiang and Cheng, 2007) and IL-2 inducible T cell kinase (Itk) (Perez-Villar 
et al., 2002). The tyrosine phosphorylation of LAT requires its constitutive 
association with lipid rafts (Zhang et al., 1998b). Slp76, meanwhile, is 
constitutively associated with growth-factor-receptor-bound-protein-2-(Grb2)-
related adaptor downstream of Shc (Gads) and the Slp76-Gads complex is 
recruited to phosphorylated LAT within lipid rafts following TCR engagement 
(Liu et al., 1999). LAT and Slp76 lack any intrinsic enzymatic activity but contain 
protein-binding domains and play a crucial role in the transduction of TCR 
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signals by recruiting signalling and additional adaptor proteins into multiprotein 
signalling complexes, which couple TCR engagement of pMHC to downstream 
signalling pathways (reviewed in Koretzky et al., 2006 and in Balagopalan et al., 
2010). Phosphorylated LAT has been shown to associate with Vav1, PLCγ, 
Slp76, c-Cbl, the p85 subunit of PI3K and various Grb2 family members 
including Gads, Grb2 and son of sevenless 1 (Sos1) (reviewed in Balagopalan 
et al., 2010). Phosphorylated Slp76 interacts with Vav1, non-catalytic region of 
tyrosine kinase adaptor protein (Nck), the p85 subunit of PI3K and Itk (reviewed 
in Koretzky et al., 2006). The proline-rich domain of Slp76 is important for 
interactions with Gads (Liu et al., 1999), PLCγ (Yablonski et al., 2001) and Lck 
(Sanzenbacher et al., 1999) while the SH2 domain is important for binding 
adhesion and degranulation-promoting adaptor protein (Adap) and 
haematopoietic progenitor kinase 1 (Hpk1) (reviewed in Koretzky et al., 2006).  
The study of LAT-deficient and Slp76-deficient T cell lines has revealed the 
importance of the recruitment of these adaptors and their substrates to the TCR 
signalling complex for the activation of a number downstream signalling 
pathways (reviewed in Balagopalan et al., 2010 and in Koretzky et al., 2006). 
LAT-deficient T cells showed reduced TCR-induced Ca2+ mobilisation and 
suboptimal phosphorylation of Vav1, PLCγ and Slp76, both of which were 
rescued by LAT reconstitution (Zhang et al., 1999). In the same T cell line 
(Zhang et al., 1999), LAT was also shown to be important Erk activation and for 
CD69 upregulation, which are both downstream of Ras signalling (D'Ambrosio 
et al., 1994 and reviewed in Rincon, 2001). Finally, LAT is also required for 
TCR- and nuclear-factor-of-activated-T-cells-(NFAT)-mediated gene 
transcription (Zhang et al., 1999). Slp76-deficiency also lead to defects in Erk 
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activation and Ca2+ mobilisation and TCR-induced NFAT activation was 
completely abrogated (Yablonski et al., 1998). Phosphorylation of Zap70, LAT 
and Itk, however, was normal in Slp76-deficient T cells (Yablonski et al., 1998). 
PLCγ is therefore an important downstream target of both LAT and Slp76. The 
recruitment of PLCγ to LAT is important for its tyrosine activation and to localise 
PLCγ near its substrate phosphatidylinositol 4,5-bisphosphate (PIP2) and does 
not require Slp76 (Yablonski et al., 1998). The phosphorylation of PLCγ, 
however is significantly impaired, in absence of Slp76 (Yablonski et al., 1998). 
PLCγ activation by Slp76 and LAT leads to the generation of inositol 
triphosphate (IP3) and diacylglycerol (DAG) and the activation of protein kinase 
C (PKCθ) as well as the mobilisation of intracellular Ca2+ (reviewed in 
Balagopalan et al., 2010 and in Koretzky et al., 2006). The rapid IP3-dependent 
increase in intracellular Ca2+ activates a number of downstream signalling 
proteins, including the phosphatase calcineurin which dephosphorylates the 
NFAT family of transcription factors (reviewed in Hogan et al., 2010 and in Oh-
hora, 2009), inducing them to translocate to the nucleus and initiate the 
transcription of NFAT-dependent genes (reviewed in Hogan et al., 2003). DAG, 
meanwhile, activates PKCθ in T cells, which in turn activates the AP1 
transcription factor complex (Baier-Bitterlich et al., 1996) and NFκB signalling 
(Sun et al., 2000). PLCγ and DAG have also been shown to regulate the activity 
of RasGRP and downstream Ras signalling in thymocytes (Dower et al., 2000).  
Ras and downstream mitogen-activated protein kinase (MAPK) signalling in T 
cells can also be activated by Sos1 (Buday et al., 1994), a well-know activator 
of Ras in multiple tissues which constitutively associates with Grb2 (Egan et al., 
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1993). Sos1 recruitment to LAT (Zhang et al., 1998a) and CD3ζ (Nel et al., 
1995) following TCR stimulation is thought to depend on Grb2 interacting with 
LAT. Consistent with this, mutation of the Grb2 binding residues of LAT, Y171 
and Y191, reduces the amount Sos1 that associated with LAT (Zhang et al., 
1998a). The recruitment of the Grb2-Sos1 complex to LAT and the plasma 
membrane colocalises Sos1 with its substrate Ras (reviewed in Mor and Philips, 
2006). Active Ras recruits Raf proto-oncogene 1 (Raf1) to the plasma 
membrane enhancing its enzymatic activity (reviewed in Morrison and Cutler, 
1997) allowing Raf1 to phosphorylate and activate MEK which in turn 
phosphorylates and activates Erk1 and Erk2 which ultimately leads to the 
induction of AP1 (reviewed in Mor and Philips, 2006).  
In addition to activating PLCγ, Slp76 also plays an important role in the TCR-
induced reorganisation of the cytoskeleton, which is essential for productive 
engagements with APCs, formation of the immunological synapse at the T cell-
APC interface and ultimately T cell activation (reviewed in Billadeau et al., 2007). 
Tyrosine phosphorylation of Slp76 has been shown to be required for the 
recruitment of Nck and WASP to the site of TCR engagement as well as Vav1 
and cell division cycle 42 (Cdc42), key activators of WASP (Zeng et al., 2003). 
Consistent with this, overexpression of Slp76 or Vav1 lead to increased TCR-
induced F-actin polymerisation while expression of a Slp76 mutant that fails to 
be tyrosine-phosphorylated results in reduced TCR-induced actin 
polymerisation (Bubeck Wardenburg et al., 1996). Furthermore, cells 
expressing mutant Slp76, Vav1 or Nck also fail to activate Cdc42/Rac-activated 
kinase 1 (Pak1), a downstream target of Cdc42 (Bubeck Wardenburg et al., 
1998). Slp76-, LAT- and Nck-deficient T cells show normal TCR-induced Pak1 
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activation and activation of Ras-related C3 botulinum substrate 1 (Rac1), a 
potential activator of Ras-related protein 1 (Rap1), only requires Zap70 and LAT, 
but not Slp76 calling into question the role of Slp76 in actin polymerisation 
downstream of TCR activation (Ku et al., 2001). 
Finally, LAT and Slp76 activate PI3K signalling and the p85 regulatory subunit 
of PI3K has been shown to bind directly to both LAT (reviewed in Balagopalan 
et al., 2010) and Slp76 (Shim et al., 2004). PI3K consists of 110kDa and an 
85kDa subunit and promotes the conversion of PIP2 to phosphatidylinositol 
3,4,5-bisphosphate (PIP3), which recruits pleckstrin homology (PH) domain 
containing proteins, like Akt and pyruvate dehydrogenase kinase 1 (Pdk1) 
(reviewed in Fruman and Bismuth, 2009). Akt activates mTOR signalling, which 
is essential for TCR-induced proliferation, but also phosphorylates forkhead box 
O (Foxo) proteins which are important regulators of T cell trafficking, 
proliferation, survival, tolerance and Treg induction (reviewed in Ouyang and Li, 
2011). 
1.2.3.5 Integrin signalling 
Integrin signalling, predominantly mediated by the β2 integrin lymphocyte 
function associated antigen 1 (LFA1), plays an important role in T cell migration 
and arrest on surfaces that express the LFA1 ligand intercellular adhesion 
molecule 1 (ICAM1). It is also essential during T cell contact with ICAM1-
expressing APCs leading to immunological synapse formation and T cell 
activation (reviewed in Hogg et al., 2011). At the immunological synapse, TCR-
pMHC complexes and LFA1-ICAM1 complexes are organised and spatially 
separated into a central supramolecular activation cluster (cSMAC), containing 
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the TCR complex, and a peripheral supramolecular activation cluster (pSMAC), 
containg LFA1 and the cytoskeletal protein talin (Monks et al., 1998). While 
initial contacts between T cells and APCs are transient, TCR signalling leads to 
a conformational change in LFA1, increasing its affinity for ICAM1 allowing 
stable T cell-APC interactions, which are important for T cell activation 
(reviewed in Billadeau et al., 2007). The signals that mediate the increase in 
LFA1 affinity downstream of TCR signalling have not been fully characterised 
but a number of signalling and adaptor proteins have been implicated (reviewed 
in Billadeau et al., 2007). These include Zap70 and LAT (Epler et al., 2000; 
Goda et al., 2004), PLCγ (Katagiri et al., 2004), Vav1 and Itk (reviewed in 
Billadeau et al., 2007). Slp76 is also thought to be essential for integrin 
activation, both downstream of integrin signalling itself and downstream of TCR 
stimulation (Baker et al., 2009). Importantly, the C-terminal SH2 domain of 
Slp76 binds Adap (reviewed in Koretzky et al., 2006) and this interaction is 
important for integrin induced outside-in signals (Baker et al., 2009).  
 
 
 
 
 
 
 
 47 
1.3 T cell development 
Unlike B cell development, which occurs almost entirely in the BM, T cell 
development occurs at least partly in a specialised, dedicated organ in the 
superior mediastinum, the thymus (Miller, 1961). Pluripotent T cell progenitors 
from BM migrate to the thymus where they proliferate and initiate commitment 
to the T cell lineage leading to the generation of a polyclonal T cell repertoire 
that recognises spMHC but not so strongly as to lead to T cell activation. αβ T 
cells, which develop alongside γδ T cells in the thymus, also commit to either 
CD4 or CD8 T cell lineage and acquire effector potential before leaving the 
thymus and entering the naïve T cell pool as recent thymic emigrants (RTEs). 
1.3.1 Double negative stages of T cell development  
Early T cell progenitors are characterised by high expression levels of stem cell 
antigen 1 (Sca-1), tyrosine protein kinase kit (c-kit) and CD44 but lack 
expression of IL-7Rα and the CD4 and CD8 co-receptors and are referred to as 
DN thymocytes (reviewed in Weerkamp et al., 2006). DN thymocytes are 
typically subdivided into four phenotypically distinct subsets based on their 
relative expression of CD44 and CD25, including a CD44+CD25- DN1, a 
CD44+CD25+ DN2, a CD44-CD25+ DN3 and a CD44-CD25- DN4 subset and 
these subsets also represent sequential stages of DN thymocyte development 
as follows: DN1  DN2  DN3  DN4 thymocytes (Godfrey et al., 1993). 
Intact TCR and IL-7Rα signalling are essential for progression beyond the DN 
stage of T cell development and induce TCR rearrangement and promote DN 
thymocyte survival, respectively. 
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The DN1 subset is a highly heterogeneous population and that only DN1 
thymocytes with high c-kit expression are actually early T-cell progenitors 
(reviewed in Ceredig and Rolink, 2002). DN2 thymocytes can also be 
subdivided into DN2a and DN2b based on their expression of c-kit (Ceredig and 
Rolink, 2002). DN2a and DN2b thymocytes also represent two distinct 
developmental stages and DN2b thymocytes express GFP downstream of the 
proximal Lck promotor and have lost DC development potential (Masuda et al., 
2007). Interestingly, the same study also showed that fully T-cell lineage 
committed DN2b thymocytes undergo several more rounds of proliferation 
before starting to somatically recombine their Tcrb or Tcrg and Tcrd loci 
(Masuda et al., 2007). DN3 thymocytes are commonly subdivided into DN3a 
and DN3b based on their size (Hoffman et al., 1996) and CD27 expression 
(Taghon et al., 2006) just before they undergo before and after β- or γδ-
selection, respectively. 
The differentiation of DN thymocytes involves the migration of DN thymocytes 
from the perimedullary cortex outward to the subcapsular zone through distinct 
microenvironments that provide specific differentiation, proliferation, survival 
and further migration signals (reviewed in Petrie and Zuniga-Pflucker, 2007). 
DN2 thymocytes first express Rag1 in the inner cortex (Wilson et al., 1994) 
when they start recombining their Tcrd and Tcrg loci (Capone et al., 1998; Livak 
et al., 1999). Despite expression of Rag, Tcrb recombination is not initiated until 
DN3 thymocytes migrate to the outer cortex and subcapsular zone (Petrie et al., 
1995) and this delay is thought to reflect the accessibility of the Tcrb locus 
(reviewed in Petrie and Zuniga-Pflucker, 2007). IL-7 has been proposed to 
regulate Tcrb accessibility (Crompton et al., 1997; Muegge et al., 1993) and is 
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also known to play a role in Tcrg recombination (Candeias et al., 1997b; Maki et 
al., 1996). Transgenic Bcl2 expression, however, successfully rescues αβ but 
not γδ T cell development in IL-7Rα-deficient mice (Akashi et al., 1997), 
suggesting IL-7 is dispensable for Tcrb recombination but mainly acts to 
promote the survival of DN thymocytes. Thymocytes that fail to successfully 
recombine their Tcrb loci die (Falk et al., 2001) whereas thymocytes that 
succesfully recombine their Tcrb loci express heterodimers of the recombined 
TCRβ chain and invariant pre-TCRα chain (Groettrup et al., 1993) (pre-TCR).  
Pre-TCR expression is required for the dramatic increase in proliferation that 
follows β-selection (Pénit et al., 1995; Vasseur et al., 2001) and pre-TCR 
signalling then triggers the recombination and expression of Tcra and silences 
the expression of pre-TCRα (Koyasu et al., 1997). Both Cd4 and Cd8 
transcription and co-receptor expression is also upregulated at this stage so 
that cells become CD4+ CD8+ DP thymocytes (Petrie et al., 1990). Src family 
kinases Lck and Fyn downstream of the pre-TCR are also partially redundant 
and only mice lacking both Fyn and Lck have a complete block in T cell 
development at the DN stage (Groves et al., 1996; van Oers et al., 1996). 
Zap70 and Syk downstream of Lck and Fyn are also partially redundant for pre-
TCR signalling since early thymocyte maturation appears to be normal in 
Zap70-deficient (Negishi et al., 1995) and Syk-deficient mice (Cheng et al., 
1997).  
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1.3.2 Positive and negative selection 
In contrast to DN thymocytes, CD4+ CD8+ DP thymocytes migrate from the 
subcapsular cortex inward back to the central medulla and thus the same 
microenvironments that induced outward migration of DN thymocytes, induce 
the inward migration of DP thymocytes (reviewed in Petrie and Zuniga-Pflucker, 
2007). The inward migration of DP thymocytes is accompanied by a number of 
changes including the termination of thymocyte proliferation (Egerton et al., 
1990). Thymocytes only start proliferating again when they reach the medulla 
as mature CD4 and CD8 SP to undergo selection of functional non-autoreactive 
T cells by positive and negative selection (reviewed in Starr et al., 2003). 
Thymocytes that do not recognise spMHC die by neglect, while cells that 
recognise spMHC too strongly, and are thus potentially autoreactive, undergo 
receptor editing, deviate to another lineage or die by apoptosis (reviewed in 
Starr et al., 2003). Migration of DP thymocytes prior to positive selection is 
random and not directed towards the medulla, possibly to allow for interactions 
with MHC-expressing thymic epithelial cells, whereas positively selecting DP 
thymocytes migrate rapidly in the direction of the medulla (Witt et al., 2005).  
The productive recombination of the Tcra alone is insufficient for the termination 
of recombination, allelic exclusion and further differentiation of αβ thymocytes 
(reviewed in Starr et al., 2003). Only interactions of TCRαβ heterodimers with 
spMHC leads to reduced Rag1 and Rag2 transcription and prevents further 
Tcra recombination (Borgulya et al., 1992; Brandle et al., 1992). Consistent with 
the important role of MHCI and MHCII for the maturation of thymocytes beyond 
the DP stage, β2-microglobulin-/- (β2m-/-) Aβ-/- thymocytes are blocked at the 
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CD4+ CD8+ DP stage (Grusby et al., 1993). In B cells, the succesful 
recombination and assembly of the BCR is sufficient to trigger allelic exclusion 
and differentiation (Nemazee, 2006). The checkpoint for MHC-recognition and 
MHC-restriction during T cell maturation fits with T cells only recognising 
antigenic peptides in the context of MHC. The positive selection of T cells that 
express a TCR with a low affinity for spMHC requires direct cell-to-cell contact 
with radio-resistant MHC+ cortical thymic epithelial cells (cTEC) in vitro 
(Anderson et al., 1994) and in vivo (Speiser et al., 1989). cTECs exclusively 
express a catalytic proteasome subunit β5t, instead of β5 or β5i which reduces 
the activity of the proteasome (Murata et al., 2007). The immunoproteasome 
processes antigenic peptides for presentation in the context of MHCI (reviewed 
in Murata et al., 2008). β5t-deficient mice have a specific defect in CD8 T cell 
development (Murata et al., 2007) and so the immunooproteasome in cTECs 
has been proposed to play a particularly important role in the generation of 
positive selection ligands for MHCI-restricted thymocytes. Cathepsin L, 
meanwhile, plays an important role in the processing and presentation of 
peptides in the context MHCII (Honey et al., 2002; Nakagawa et al., 1998). 
Firstly, it has an important role in the degradation of the invariant chain in 
cTECs, which binds the MHCII peptide binding groove to prevent inappropriate 
peptide binding (Nakagawa et al., 1998). Secondly, independently of its role in 
the processing of the invariant chain, cathepsin L is thought to be involved in 
the generation of peptide ligands for MHCII in cTECs (Honey et al., 2002). 
The establishment of tolerance to self in the thymus is the result of clonal 
deletion or lineage deviation of potentially autoreactive T cells during negative 
selection in the thymic medulla by thymic DCs and medullary thymic epithelial 
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cells (mTEC) (reviewed in Anderson et al., 2007). Whereas positive selection of 
T cells is largely mediated by rare low-affinity spMHC, recognition of spMHC 
with high affinity either induces negative selection by apoptosis, lineage 
deviation or receptor editing (reviewed in Palmer and Naeher, 2009). Strong 
TCR signalling mediated by CD3 antibodies clearly causes the death CD4+ 
CD8+ DP thymocytes in vitro (Smith et al., 1989) and the administration of 
antigenic peptide in vivo also induces clonal deletion of  TCR stimulated DP 
thymocytes (Murphy et al., 1990; Tarazona et al., 1998). Importantly, inhibition 
C-C-motif-chemokine-receptor-(CCR) 7-mediated migration of DP thymocytes 
from the cortex to the medulla leads to the development of autoreactive T cells 
suggesting that the medulla plays an important role in the negative selection of 
autoreactive thymocytes (Kurobe et al., 2006). Consistent with this, a subset of 
mTECs express autoimmune regulator (Aire), a transcription factor involved in 
the expression of tissue-restricted antigens (TRAs) in mTECs and Aire-
deficiency leads reduced TRA expression and autoimmunity in mice (Anderson 
et al., 2002). Recently, thymocytes about to undergo clonal deletion in TCR 
transgenic mice were shown to associate with cortical CD11c+ DCs which play 
an important role in their negative selection (McCaughtry et al., 2008). 
Finally, the downstream targets of weak and strong TCR signaling leading to 
thymocyte survival and death during positive and negative selection, 
respectively (Alam et al., 1996) are thought to diverge at the level of Erk and c-
jun N-terminal kinase (Jnk). Deletion of the B1 subunit of calcineurin in 
thymocytes in vivo leads to inefficient Erk signalling whereas TCR-induced Jnk 
phosphorylation was normal (Neilson et al., 2004). Intriguingly, B1-deficiency 
completely abolishes positive selection but is dispensable for negative selection 
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(Neilson et al., 2004). TCR-induced Jnk and p38 activation, in contrast, is 
specifically impaired in Grb2+/- mice which show normal TCR-induced ERK 
activation but impaired negative selection (Gong et al., 2001). Furthermore, Erk 
has been shown to have a lower activation thresholds than Jnk and p38 in 
thymocytes (Gong et al., 2001). A more recent study characterised the selection 
potential of a range of ovalbumin-(Ova)-variants in foetal thymic organ cultures 
of OT-I TCR transgenic thymocytes and correlated the selection potential and 
TCR affinity of the ligands with downstream TCR signalling (Daniels et al., 
2006). This study revealed that even very small differences in ligand affinity, as 
assessed by tetramer binding, can lead to differences in proximal TCR 
signalling events such as CD3ζ and Zap70 phosphorylation (Daniels et al., 
2006). Furthermore, ligands that induced negative selection induced a greater 
concentration of phosphorylated Zap70 at the plasma membrane, enhanced 
phosphorylation of LAT, recruitment of Grb2-Sos1 to LAT ultimately leading to 
Ras and Erk signalling at the plasma membrane (Daniels et al., 2006). Positive 
selectors, on the other hand, did not recruit Grb2-Sos1 and activated Ras and 
then Erk at the Golgi resulting in slower and overall reduced phosphorylation of 
Erk (Daniels et al., 2006). This is consistent with previous work that suggested 
that activation of Erk at the plasma membrane is fast and transient, while 
activation at the Golgi is slower and more sustained (Chiu et al., 2002 and 
reviewed in Mor and Philips, 2006). Clearly, TCR signals of different strength 
can induce divergent downstream signalling pathways but exactly how these 
pathways induce thymocyte death or survival downstream of the TCR remains 
unclear. 
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1.3.3 CD8/CD4 lineage decision  
Currently there are two models that describe commitment to the CD4 or CD8 T 
cell lineage based on MHCI- and MHCII-restricted thymocytes receiving 
different signals following spMHC and TCR engagement. Since CD4 has a 
higher binding affinity for Lck than CD8 (Wiest et al., 1993), stronger TCR 
signalling mediated by CD4 in MHCII-restricted thymocytes was initially 
proposed to lead to commitment to the CD4 lineage mediated, while weaker 
signalling in MHCI-restricted thymocytes would promote CD8 lineage 
commitment. Consistent with a quantitative instructive model of lineage 
commitment, increasing Lck activity promotes MHCI-restricted thymocytes to 
differentiate into CD4 T cells while, reducing Lck activity promotes MHCII-
restricted thymocytes to commit to the CD4 T cell lineage (Hernández-Hoyos et 
al., 2000). Furthermore, transgenic expression of a hybrid co-receptor with a 
CD8 extracellular domain and a CD4 cytoplasmic domain leads to the 
development of MHCI-restricted CD4 T cells (Itano et al., 1996; Seong et al., 
1992). MHCI-restricted thymocytes were not redirected, however, when 
expression of the hybrid CD8.4 co-receptor was regulated by endogenous 
CD8α transcriptional control elements (Bosselut et al., 2001; Erman et al., 
2006) suggesting that quantitative differences alone do not instruct CD4/CD8 
lineage fate.  
In an alternative instructive model the length rather than the strength of TCR 
signalling is proposed to determine CD4/CD8 lineage commitment. Intermediate 
CD4+CD8lo thymocytes which are thought to have undergone positive selection 
but have not yet commited to the CD4 or CD8 T cell lineage can give rise to 
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CD8 SP thymocytes (Brugnera et al., 2000). The termination of CD8 expression 
and interruption of TCR signalling in CD4+CD8lo DP thymocytes is proposed to 
promote commitment to the CD8 lineage in an IL-7-dependent manner 
(Brugnera et al., 2000) and is also consistent with the regulation of co-receptor 
expression being important for CD4/CD8 lineage commitment (Bosselut et al., 
2001; Erman et al., 2006). Furthermore, when CD4 expression is regulated by 
CD8α transcriptional control elements (CD4E8III) CD4 expression is prematurely 
terminated and this has been shown to promote CD8 T cell development in 
MHCI-deficient mice (Sarafova et al., 2005). Restricting Zap70 expression and 
thus TCR signalling to CD4+ CD8+ DP thymocytes, however, leads to a block in 
CD4 and CD8 T cell development rather than redirection of MHCII-restricted to 
the CD8 lineage, suggesting that TCR signalling is required beyond an initial 
positive selection signal in CD4 and CD8 T cell development (Liu et al., 2003). 
Recent work using mice that conditionally express Zap70 integrated aspects of 
the quantitative and kinetic signalling instructing models of CD4/CD8 lineage 
development (Saini et al., 2010). CD4 and CD8 T cells were shown to develop 
from phenotypically distinct subsets of DP thymocytes with different kinetics and 
CD8 T cell development was shown to require the temporal upregulation of 
Zap70 expression downstream of TCR-mediated positive selection signals 
(Saini et al., 2010). 
While the proximal signalling events that regulate lineage commitment remain 
controversial a number of transcription factors have been shown to be essential 
for the development of CD4 and CD8 T cells. Runt-related transcription factor 
(Runx) proteins play an important role during CD8 T cell development by 
silencing Cd4 transcription but while the overexpression of Runx3 does 
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increase the proportion of developing CD8 SP thymocytes, it does not 
completely block CD4 T cell development (Kohu et al., 2005). It was recently 
shown that, transgenic expression of Runx3 in Zap70-/- thymocytes was 
insufficient for CD8 T cell development but that IL-7 could induce Runx3 
expression and CD8 T cell development in absence of TCR signalling (Park et 
al., 2010). Interestingly, the ratio of developing CD4 and CD8 thymocytes in IL-
7- an IL-7Rα-deficient mice is not dramatically altered compared to WT mice, 
despite an overall reduction in T cell development, calling into question the 
proposed non-redundant instructive role for IL-7 signalling for CD8 lineage 
commitment (Freeden-Jeffry et al., 1995; Peschon et al., 1994). Finally, Runx 
proteins are also implicated in the repression T-helper-inducing POZ/Krueppel 
factor (Th-POK) expression (Collins et al., 2009), an important regulator of CD4 
lineage commitment (He et al., 2005; Sun et al., 2000). In addition to Th-POK, 
GATA-binding protein 3 (Gata3) has been shown to be an important regulator of 
CD4 T cell development and deletion of Gata3 in DP thymocytes completely 
abolishes CD4 T cell development but has no effect on CD8 thymocytes (Pai et 
al., 2003). A mutation in Th-POK, meanwhile, results in redirection of MHCII-
restricted thymocytes to the CD8 lineage (He et al., 2005). 
1.3.4 Development of γδ T cells, Treg and NK T cells 
While αβ thymocytes undergo positive and negative selection based on their 
affinity for spMHC, it is less clear whether prospective γδ T cells also undergo 
positive selection (reviewed in Hayday and Pennington, 2007). In contrast to the 
positive and negative selection of αβ thymocytes, any selection of γδ 
thymocytes is likely MHC-independent since β2m-/- Aβ-/- mice have normal 
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numbers of γδ T cells (Grusby et al., 1993). Pre-TCR signalling is also 
completely dispensable for γδ T cell development (Fehling et al., 1995). 
Interestingly, there does seem to be a role for TCR signalling in γδ T cell 
development since attenuated TCR signalling in Lck-deficient γδ TCR 
transgenic mice diverted γδ to the αβ lineage (Haks et al., 2005). Furthermore, 
a reduction of CD5 expression, a negative regulator of TCR signalling (Azzam 
et al., 2001; Tarakhovsky et al., 1995), has also been shown to increase γδ 
lineage commitment (Hayes et al., 2005). In addition, IL-7R signalling plays play 
an important role in γδ thymocyte development. IL-7Rαhi DN2 thymocytes give 
rise to more γδ than αβ cells, whereas IL-7Rαlo DN2 thymocytes give rise to 
more αβ than γδ cells (Kang et al., 2001). Finally, the transcription factor Sry-
box containing gene 13 (Sox13) was recently identified as γδ lineage specific 
gene and consistent with this, Sox13-deficiency results in impaired γδ T cell 
development without affecting αβ T cell development, while transgenic Sox13 
expression promotes γδ T cell development (Melichar et al., 2007). Despite a 
clear role for TCR signalling strength in γδ T cell development, it is less clear 
how γδ TCR ligand interactions instruct γδ T cell development in absence of a 
γδ TCR restricting element like MHC for αβ TCR (reviewed in Pang et al., 2012).  
Strong TCR signalling is also implicated in the development Treg and natural 
killer (NK) T cells allowing potentially autoreactive thymocytes to differentiate 
into alternative αβ T cell lineages (reviewed in Moran and Hogquist, 2012). CD4 
Treg play an important regulatory role in the immune response by suppressing 
the activation of other immune cells in response to self-peptide or antigen 
(Sakaguchi et al., 1995). The current model for Treg lineage differentiation in the 
thymus is that strong spMHC TCR signalling, over the threshold for positive 
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selection, induces the upregulation of CD25, increasing the sensitivity of the Treg 
precursor to IL-2, which plays an important role in the induction of the Treg 
marker forkhead box p (Foxp3) (Lio and Hsieh, 2008). The role of TCR 
signalling strength during Treg development and function was recently assessed 
using a TCR signalling reporter mouse (Moran et al., 2011). In this mouse, 
Nur77 expression, an immediate early gene upregulated following TCR 
stimulation, is reported by GFP (Nur77GFP) (Moran et al., 2011). The study 
showed that Treg perceive stronger TCR signals during development than 
conventional T cells and continue to do so in the periphery (Moran et al., 2011). 
NK T cells express a relatively invariant TCR chain, which recognises self-lipids 
in the context of the MHCI-related molecule CD1d, and they are also thought to 
perceive stronger TCR signals during their development and selection in the 
thymus (reviewed in Moran and Hogquist, 2012). The idea that NK T cells 
develop following strong, high affinity TCR signals was originally based on the 
activated phenotype of NK T cells, with high CD69 and CD44 expression, even 
in absence of intentional antigen-exposure (reviewed in Kronenberg, 2005). 
Interestingly, NK T survival and homeostasis in the periphery was shown to be 
largely CD1d-independent and thus, at least in the periphery, NK T cells are not 
thought to be autoreactive (McNab et al., 2005). Using the Nur77GFP TCR 
signalling reporter mice, it was recently shown that NKT precursors do indeed 
perceive strong TCR signals and so are conceivably selected following 
interactions with a high affinity ‘agonist’ ligand (Moran et al., 2011). Peripheral 
NK T cells, on the other hand, did not express more GFP than conventional 
CD4 T cells suggesting they, unlike Treg, do not continuously encounter high 
affinity ligands in the periphery (Moran et al., 2011). 
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1.3.5 Single positive thymocyte maturation and thymic egress 
After positive selection and CD4/CD8 lineage differentiation in the cortex and 
subsequently negative selection in the medulla, SP thymocytes achieve 
phenotypic and functional maturity in the central medulla before they leave the 
thymus at the cortico-medullary junction in a process called thymic egress 
(reviewed in Weinreich and Hogquist, 2008). After positive selection SP 
thymocytes downregulate heat stable antigen (HSA) (Bruce et al., 1981; Crispe 
and Bevan, 1987; Wilson et al., 1988) and CD69 expression, upregulate Qa 
lymphocyte antigen 2 region (Qa2) (Vernachio et al., 1989) and CD62-ligand (L) 
and also loose their susceptibility to apoptosis (Kishimoto and Sprent, 1997). 
Thymocytes leave the thymus via a strict ‘conveyor belt’ with more mature 
thymocytes emigrating before immature thymocytes (McCaughtry et al., 2007). 
Thymic egress occurs approximately 4-5 days after thymocytes become CD4 or 
CD8 SP as estimated by GFP-decay in mice with GFP expression under control 
of the Rag2 promotor (McCaughtry et al., 2007). Interestingly, in the same study 
(McCaughtry et al., 2007) it was also shown that CD8 SP take longer to mature 
and egress from the thymus than CD4 SP, consistent with data that CD8 
development is delayed compared to CD4 development (Saini et al., 2010).  
Thymic egress of the most mature thymocytes requires the Krueppel-like-factor-
2-(Klf2)-mediated upregulation of sphingosine-1-phosphate receptor 1 (S1P1) 
(Carlson et al., 2006; Matloubian et al., 2004), a receptor for sphingosine-1-
phosphate (S1P) produced by neural crest derived pericytes that surround the 
blood vessels at the cortico-medullary junction (Zachariah and Cyster, 2010). 
Consistent with an important role for S1P1 signalling in thymic egress, S1pr1-/- 
 60 
thymocytes fail to leave the thymus but interestingly, also failed to downregulate 
CD69 expression (Matloubian et al., 2004). Subsequently, CD69 has been 
shown to associate with S1P1 in vitro, facilitating its internalisation and 
degradation (Bankovich et al., 2010). Since CD69 expression is regulated by 
TCR signalling in thymocytes (Swat et al., 1993), the reciprocal inhibition of 
CD69 and S1P1 has been suggested to be a mechanism by which TCR 
signalling can regulate thymic export (Love and Bhandoola, 2011). Foxo1 has 
recently been shown to regulate both Il7ra and Klf2 transcription (Kerdiles et al., 
2009), which in turn regulates S1pr1 and Cd62l transcription (Carlson et al., 
2006). TCR signals via Pdk1 and Akt to Foxo1 might represent an additional 
way in which TCR signalling regulates thymic egress (reviewed in Love and 
Bhandoola, 2011). Consistent with thymic egress being regulated by TCR 
signalling via PI3K and Akt, activation of thymocytes by intrathymic antigenic 
challenge (Uldrich et al., 2006) or constitutive PI3K signalling in thymocytes 
(Barbee and Alberola-Ila, 2005) inhibit thymic emigration. 
1.4 Peripheral αβ T cell biology 
1.4.1 Recent thymic emigrants 
Following thymic egress, RTEs undergo functional as well as phenotypic 
maturation as they integrate into the mature naïve T cell pool (reviewed in Fink 
and Hendricks, 2011). Recently, mice expressing GFP under control of the 
Rag2 promotor have been used to study this population of naïve T cells 
(Boursalian et al., 2004). In these, GFP is first expressed late during DN 
development after which GFP expression drops in DP and SP thymocytes 
(Boursalian et al., 2004). Nevertheless, GFP-expressing cells are still detectable 
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in the periphery. GFPhi cells were shown to disappear 1 week post-thymectomy, 
while GFPlo cells only disappeared 1-2 weeks post-thymectomy and so 
represent a more mature subset of RTE (Boursalian et al., 2004). Interestingly, 
GFPhi CD4 and CD8 RTEs in these mice, appear to be phenotypically and 
functionally immature compared to more mature GFP- naïve T cells (Boursalian 
et al., 2004). RTEs express more HSA and CD3 than mature naïve T cells, 
whereas surface expression of Qa2, IL-7Rα and CD45RB is lower on RTEs 
(Boursalian et al., 2004).  
Both CD8 and CD4 RTEs also undergo functional maturation following thymic 
egress (Boursalian et al., 2004). CD8 RTEs give rise to fewer cytolytic CD8 T 
cells than mature naïve T cells in vitro (Boursalian et al., 2004) and generate 
fewer effector and memory cells than mature naïve T cells in vivo (Makaroff et 
al., 2009). Interestingly, secondary effectors generated by memory cells derived 
from RTEs or mature naïve T cells are functionally and phenotypically similar 
(Makaroff et al., 2009). CD4 RTE are also functionally immature and proliferate 
less than mature naïve T cells, produce less IL-2 and express less CD25, the 
high affinity receptor for IL-2 (Boursalian et al., 2004). Finally, CD4 RTEs also 
poorly differentiate into Th1, Th17 and Treg in vitro and are bias towards 
adopting Th2 lineage fate in vitro and in vivo, possibly as a result of reduced T-
bet, an important regulator of Th1 differentiation (Hendricks and Fink, 2011). 
The signals that induce RTE maturation are not fully characterised although a 
full DC compartment and access to SLOs are required (Houston et al., 2008). 
Interestingly, despite the importance of IL-7Rα and TCR signalling for T cell 
development and peripheral homeostasis IL-7 and spMHC signalls appear to be 
dispensable for the maturation of RTEs (reviewed in Fink and Hendricks, 2011). 
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1.4.2 Naïve CD4 and CD8 T cells 
Naïve T cells continuously recirculate from blood to lymph via SLOs including 
the spleen and lymph node (LN) (Gowans and Knight, 1964) where antigen is 
collected and presented to T cells by APCs (reviewed in Masopust and 
Schenkel, 2013). Recently, LN entry, retention and egress of CD4 and CD8 T 
cells was analysed in detail using a combination of intravital imaging and 
mathematical modelling (Mandl et al., 2012). This study revealed substantial 
differences between the recirculation of CD4 and CD8 T cells with CD4 T cells 
spending far less time in LN than CD8 T cells. CD8 T cells, on the other hand, 
leave LNs much more slowly than CD4 T cells and, unlike CD4 T cells, LN 
retention is not affected by MHC-deficiency (Mandl et al., 2012). 
In the blood, CD62L on T cells mediates the rolling on high endothelial venules 
(HEVs) in SLOs which allows T cell CCR7 to interact with C-C motif chemokine 
ligand  (CCL) 21 immobilised on HEVs (reviewed in Masopust and Schenkel, 
2013). Chemokine signalling activates LFA1 enabling it to bind to ICAM1, which 
ultimately results in T cell arrest within HEVs followed by migration into the T 
cell zone (reviewed in Hogg et al., 2011). T cells might subsequently enter LN 
downstream in the same chain of LNs via afferent lymph vessels (Braun et al., 
2011). In addition to activation of LFA1, CCL19 and CCL21 signalling to CCR7 
mediates T cell motility within the T cell zone, which is thought to facilitate T cell 
T scanning of APCs (Kaiser et al., 2005). Retention within the LN is also CCR7-
dependent (Kaiser et al., 2005). CCL19 induces CCR7 desensitisation (Kohout 
et al., 2004) leading to a gradual reduction in the strength of CCR7-dependent 
retention within the T cell zone. Similarly, S1P, ubiquitous in lymph and blood, 
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induces the transient downregulation of S1P1 allowing T cells to enter LN 
against the S1P gradient (Lo et al., 2005). Only once T cells are sensitive to 
S1P again, and insensitive to CCL19 do they leave the LN and enter an efferent 
lymph vessel to ultimately return to the blood via the thoracic duct (reviewed in 
Cyster et al., 2012 and in Masopust and Schenkel, 2013). 
Inflammation greatly increases the probability of naïve T cells encountering 
antigen by inducing an increase in the size of the arteriole that feeds the LN 
(Soderberg et al., 2005) but also by altering the expression of chemokine 
receptors in inflamed LNs (reviewed in Masopust and Schenkel, 2013). For 
instance, CD8 T cells in draining LN upregulate CCR5 allowing them to home to 
CD4 T cells interacting with antigen-specific DCs along local CCL3 and CCL4 
gradients (Castellino et al., 2006). Meanwhile, activated CD4 T cells upregulate 
CXCR3 allowing them to home to C-X-C motif chemokine ligand (CXCL) 9 and 
CXCL10 expressed in draining LNs (Groom et al., 2012). Finally, upon antigen 
recognition and subsequent T cell activation both CD69 and CCR7 are 
transiently upregulated, inhibiting surface S1P1 expression (Bankovich et al., 
2010; Shiow et al., 2006) and preventing SLO egress, which provides the 
antigen, co-stimulation and cytokine signals T cells need to become fully 
activated, to proliferate and differentiate into effector cells (reviewed in Mescher 
et al., 2006). 
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1.4.3 T cell activation and proliferation 
Optimal T cell activation, proliferation and acquisition of effector and memory 
function requires antigen stimulation (Zehn et al., 2012) as well as co-
stimulation (reviewed in Acuto and Michel, 2003) and cytokine signals. CD8 T 
cells, are additionally thought to require help from differentiated CD4 helper T 
cells to initiate effector responses or for memory generation, although the exact 
role of CD4 help during CD8 T cell differentiation remains controversial 
(reviewed in Mescher et al., 2006). T cells sample and interact with antigen-
presenting DCs in 3 distinct stages in vivo (Mempel et al., 2004). Following ~8h 
of multiple, brief T cell encounters with pulsed DCs, T cell motility dropped and 
more stable T cell DC conjugates were formed as T cells upregulated activation 
markers such as CD44, CD25 and CD69 and started secreting IL-2 and IFNγ 
(Mempel et al., 2004). The final stage T cell priming by DCs involved a return to 
short T cell DC interactions, which coincided with the onset of proliferation 
(Mempel et al., 2004).  
Interestingly, CD8 T cells were shown to require only 2h of exposure to antigen 
in vitro in order to proliferate and differentiate (Kaech and Ahmed, 2001; van 
Stipdonk et al., 2001), although longer exposure was required for subsequent 
proliferation in vivo (van Stipdonk et al., 2003). Subsequent studies have shown 
that memory cell differentiation (Kaech and Ahmed, 2001) and the onset and 
kinetics of CD8 T cell contraction (Badovinac et al., 2002) following antigen 
clearance are also programmed during the initial antigen exposure. More 
recently, it has been shown that the duration of antigen exposure in vivo might 
not affect CD8 T cell effector functionality but does determine the magnitude of 
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clonal expansion (Prlic et al., 2006). Shortening the duration of an infection also 
reduced the number of CD8 T cell memory cells forms but had no effect on the 
quality of the secondary response (Williams and Bevan, 2004). Finally, CD8 
expansion and differentiation into effector and memory cells is significantly 
enhanced by inflammatory signals (Shaulov and Murali-Krishna, 2008). In 
contrast to CD8 T cells, optimal CD4 T cell activation, proliferation and 
differentiation is thought to require continuous antigen and MHC exposure 
(reviewed in Zehn et al., 2012) as shown in a recent study using mice that 
express an inducible MHCII-restricted T cell epitope (Obst et al., 2005). 
Furthermore, CD4 memory formation is also impaired if the duration of an 
infection is shortened but the quality of the secondary response is not (Williams 
and Bevan, 2004). 
The majority of antigen-specific T cells that proliferate and differentiate into 
effector and memory cells have high affinity for antigenic pMHC yet weak TCR 
signalling can also induce T cell activation, proliferation and differentiation 
(reviewed in Zehn et al., 2009). In fact, the initial expansion and differentiation 
of OT-I TCR transgenic T cells was indistinguishable despite being stimulated 
with altered peptide ligands which bind the OT-I TCR with different affinities 
(Zehn et al., 2009). Higher affinity altered peptide ligands did promote more 
extensive and sustained proliferation, consistent with an accumulation of mainly 
high-affinity antigen-specific T cells during polyclonal immune responses (Zehn 
et al., 2009). Interestingly though, low and high affinity stimulated CD8 T cells 
were phenotypically and functionally similar expressing CD44, CD62L and 
granzyme B and IFNγ, although weakly stimulated CD8 T cells did express less 
CD25 and CCR7 (Zehn et al., 2009). Furthermore, weakly stimulated CD8 
 66 
effector and memory cells are functional (Zehn et al., 2009). The ability of the 
same altered peptide ligands to mediate positive or negative selection of OT-I 
thymocytes in vitro has also been studied (Daniels et al., 2006). The ligands 
that only induce positive selection of thymocytes all induced OT-I T cell 
expansion and differentiation in the periphery (Zehn et al., 2009) suggesting 
that OT-I T cell proliferation and negative selection occur at different thresholds 
(reviewed in Zehn et al., 2010).  
Finally, using sensitive imaging techniques it was recently shown that a single 
pMHCII complex is enough to elicit a measurable Ca2+ response in CD4+ T cells, 
although a full Ca2+ response and immunological synapse formation requires at 
least 10 pMHCII complexes (Irvine et al., 2002). Blocking CD4 impairs T cell 
Ca2+ responses but only if they are stimulated with fewer than 30 pMHCII 
complexes suggesting that CD4 enhances T cell sensitivity at low ligand density, 
in particular (Irvine et al., 2002). CD8 T cells can also detect single pMHCI 
complexes and need approximately 10 pMHCI complexes for a full Ca2+ 
response and immunological synapse formation (Purbhoo et al., 2010). 
Interestingly, 3 pMHCI were sufficient to enable CD8 T cell target cell killing 
suggesting that immunological synapse formation and full T cell activation might 
be dispensable for cytotoxicity (Purbhoo et al., 2004). In addition to antigen-
derived peptides, infected DCs also present spMHC to T cells and while a 
single cognate pMHC complex is insufficient for T cell activation, heterodimers 
of cognate and spMHC could activate T cells suggesting that in addition to their 
role in positive selection and T cell survival, spMHC contribute to T cell 
activation (reviewed in Stefanova et al., 2003). 
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1.4.4 Effector αβ T cells 
Following T cell activation and expansion, CD4 and CD8 T cells differentiate 
into effector cells. CD4 effector cells help B cells make antibody, sustain CD8 
responses, and modulate the magnitude and duration and immune response 
(reviewed in Zhu et al., 2010). Initially, two distinct populations of differentiated 
CD4 T cells were characterised based on their cytokine productions, namely T 
helper 1 (Th1) cells, which make IFNγ, IL-2 and some TNFα and Th2 cells, 
which are characterised by their IL-4, IL-5 and IL-13 production (Mosmann et al., 
1986). The in vitro differentiation of these CD4 effector subsets was also shown 
to depend on differential cytokine signalling with Th1 differentiation depending 
on IL-12 and IFNγ and Th2 differentiation requiring IL-4 as well as IL-2 
(reviewed in Zhu et al., 2010). Subsequently more CD4 effector subsets have 
been described including Th17 cells, which produce IL-17A, IL-17F and IL-22 
and can be differentiated in vitro in the presence of TGFβ and IL-6 (reviewed in 
Zhu et al., 2010). Furthermore, Treg develop in the thymus (see section 1.3.5) 
but can also be derived from naïve T cells in the periphery, which this is thought 
to require TGFβ and IL-2 (reviewed Josefowicz et al., 2012). In addition to 
cytokine and TCR signals, the differentiation of naïve CD4 T cells into effector 
cells also requires the expression of specific transcription factors and STAT 
proteins (reviewed Zhu et al., 2010). Th1 cells express T-bet and STAT4, Th2 
cells Gata3 and STAT5, Th17 cells RAR-related orphan receptor γT (RORγT) 
and STAT3 and iTreg Foxp3 and STAT5 and together these transcription 
factors collaborate within a complex network that positively and negatively 
regulates Th lineage commitment (reviewed in Zhu et al., 2010).  
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Activated CD8 T cells differentiate into cytotoxic T cells, which express 
granzyme B and perforin to kill antigen-expressing target cells and produce anti-
viral cytokines such as IFNγ and TNFα (reviewed in Parish and Kaech, 2009). 
IL-12 and IFNα/β are particularly important for their differentiation and 
expansion in vivo (Cousens et al., 1999; Thompson et al., 2006) but also play a 
role in the induction of IFNγ production (Nguyen et al., 2002). The transcription 
factors eomesodermin (Pearce et al., 2003) and T-bet (Sullivan et al., 2003) are 
both expressed in cytotoxic CD8 T cells and thought to be important for their full 
effector differentiation. Consistent with this, T-bet deficiency leads to impaired 
cytotoxicity and reduced IFNγ production (Sullivan et al., 2003). Naïve CD8 T 
cells appear to give rise to two phenotypically distinct subsets of effector cells 
based on their expression of IL-7Rα and the senescence marker killer cell 
lectin-like receptor subfamily G 1 (Klrg1) (reviewed in Zhang and Bevan, 2011). 
The majority of CD8 effector cells terminally differentiate and become short-
lived effector cells, expressing low IL-7Rα and high Klrg1. Some effector cells 
express high IL-7Rα and low Klrg1 and these cells are thought to specifically 
represent the precursors to memory CD8 T cells (Kaech et al., 2003). 
Interestingly, a single naïve CD8 T cell can give rise to both the short-lived 
effector cells and the memory precursors in vivo (Gerlach et al., 2010; 
Stemberger et al., 2007) and this is possibly the result of asymmetric T-bet 
distribution during cell division (Chang et al., 2011). There is also evidence, 
however, that CD8 effector cell heterogeneity is fixed before the first cell division 
takes place and that early IFNγ activation and strong pMHC signalling are 
linked to increased production of IL-2, IFNγ and TNFα as an effector CD8 T cell 
(Beuneu et al., 2010). Meanwhile, the anti-inflammatory cytokine IL-10 might 
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play a particularly important role in the differentiation of CD8 memory precursors 
and fewer IL-7Rαhi memory precursors are generated in IL-10-deficient mice in 
response to Listeria monocytogenes (Foulds et al., 2006). 
1.4.5 Memory T cells 
Following the resolution of an infection most CD4 and CD8 effector T cells die. 
The cells that survive this contraction phase become long-lived memory T cells 
which have enhanced functional capacity, can quickly proliferate and re-express 
effector genes when re-challenged (reviewed and in Parish et al., 2009 and in 
Pepper and Jenkins, 2011). Memory T cells can be divided into two subsets 
based on their expression of homing receptors CD62L and CCR7 and the 
resulting migration patterns (reviewed in Sallusto et al., 2004). Central memory 
cells (TCM) are CD62Lhi CCR7hi, produce IL-2 and recirculate to SLOs and BM 
whereas effector memory cells (TEM) are CD62Llo CCR7lo and recirculate to non-
lymphoid tissues (Sallusto et al., 1999). Furthermore, TEM cells retain some of 
their effector function and CD4 TEM continue to express cytokines such as IFNγ 
and TNFα and CD8 TEM continue to express granzyme B and perforin (reviewed 
in Sallusto et al., 2004). Upon re-infection TEM cells will immediately migrate to 
the site of inflammation and readily display effector function whereas TCM cells 
retain little effector function but proliferate and differentiate into effector cells 
upon antigen stimulation (reviewed in Sallusto et al., 2004). TEM cells can also 
become long-term tissue residents in the small intestine, skin, brain, lung and 
salivary glands where they are characterised by high expression of CD103, 
CD69 and granzyme B but express less IL-7Rα and IL-15Rβ than recirculating 
TEM (reviewed in Masopust and Schenkel, 2013). 
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The enhanced ability of memory T cells to control re-infection is based on their 
longevity but is also the result of enhanced TCR signalling. Memory T cells have 
a greater phosphoprotein content before TCR ligation (Kersh et al., 2003). 
Proximal TCR induced signalling events are similar in memory and naïve T cells, 
however, memory T cells phosphorylate LAT, ERK, Jnk and p38 more efficiently 
following TCR stimulation resulting in enhanced TCR sensitivity (Kersh et al., 
2003). Interestingly, despite these clear signalling and functional differences, 
very few genes are expressed at significantly different levels in naïve and 
memory T cells (reviewed in Weng et al., 2012). The kinetics of gene 
expression following activation, however, is different in naïve and memory T 
cells with certain genes being upregulated much faster in memory than naïve T 
cells. These differences are largely thought to be regulated epigenetically 
(reviewed in Weng et al., 2012). 
1.5 Peripheral αβ T cell homeostasis 
Peripheral T cell homeostasis involves the strict regulation of T cell 
development, on the one hand, and T cell proliferation and survival, on the other 
hand. Competition for limiting resources, including spMHC and cytokines like IL-
7 and IL-15 shapes and regulates the overall size and composition of the 
peripheral T cell pool (Freitas and Rocha, 2000). Increased resources lead to 
enhanced T cell survival and proliferation while reduced resources limit T cell 
numbers (Freitas and Rocha, 2000). Naïve and memory T cell proliferation and 
survival are regulated largely independently although CD4 and CD8 T cells 
occupy the same niche (reviewed in Freitas and Rocha, 2000). 
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1.5.1 Homeostatic and lymphopaenia-induced proliferation 
T cells proliferate even in the absence of antigen and, the factors that govern 
this lymphopaenia-induced proliferation (LIP) are also important regulators of 
naïve αβ T cell survival (reviewed in Surh and Sprent, 2008). Although most 
prominent following T cell depletion, homeostatic proliferation is thought to 
occur all the time as a mechanism to regulate the overall size of the naïve T cell 
pool. Despite the absence of antigen, homeostatically proliferating T cells 
gradually and irreversibly acquire a memory phenotype including increased 
CD44 expression and more rapid IFNγ and granzyme B production following 
TCR activation (Min et al., 2005).  In fact, OT-I TCR transgenic memory cells 
generated during homeostatic proliferation provided similar protection against 
Listeria monocytogenes infection as conventional memory T cells (Hamilton et 
al., 2006). Both CD4 and CD8 naïve T cells undergo homeostatic proliferation 
and LIP although CD8 T cells proliferate more rapidly than CD4 T cells 
(reviewed in Surh and Sprent, 2008).  
LIP depends on both IL-7 (Schluns et al., 2000; Tan et al., 2001), spMHC (Ernst 
et al., 1999; Goldrath and Bevan, 1999) and access to SLO where these signals 
are thought to be concentrated (Dai and Lakkis, 2001; Dummer et al., 2001). 
Enhanced homeostatic proliferation in lymphopaenic hosts is thought to be the 
result of increased availability of spMHC and IL-7. The exact mechanisms by 
which TCR and IL-7Rα regulate homeostatic proliferation are not fully 
characterised (reviewed in Surh and Sprent, 2008). Interestingly, similar spMHC 
ligands are thought to mediate positive selection in the thymus and peripheral 
homeostatic proliferation (Ernst et al., 1999; Goldrath and Bevan, 1999; Viret et 
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al., 1999). Furthermore, the TCR affinity for spMHC correlates with the rate of 
proliferation (Kassiotis et al., 2003; Kieper et al., 2004). The Y449 residue of the 
IL-7Rα is required for IL-7-induced proliferation and is also important for IL-7-
induced Bcl-2 synthesis and recruitment of STAT5 to IL-7Rα (Jiang et al., 2004). 
Transgenic Bcl2 expression, however, rescues αβ T cell development in IL-
7Rα-deficient mice (Akashi et al., 1997) but fails to rescue LIP (Tan et al., 2001) 
suggesting that IL-7-induced proliferation is regulated differently from IL-7-
induced survival during T cell development. In fact, IL-7 regulation of 
proliferation is more likely mediated by the cyclin-dependent kinase inhibitor 
p27kip1, which is thought to be destabilised by IL-7 (Li et al., 2006). Consistent 
with this, p27kip1 overexpression induces cell cycle arrest in vitro in the presence 
of IL-7 whilst p27kip1 deficiency promotes cell cycle entry in vitro in absence of 
IL-7 (Li et al., 2006). Furthermore, p27kip1 deficiency allows CD4 and CD8 T 
cells to undergo some proliferation in IL-7-deficient hosts although to a lesser 
extent than WT cells in IL-7 sufficient lymphopaenic hosts (Li et al., 2006) 
1.5.2 Regulation of apoptosis  
The number of peripheral naïve T cells is a consquence of T cell development in 
the thymus and homeostatic proliferation in the periphery but is also the result 
of peripheral T cell survival, which critically depends on TCR and cytokine 
receptor signalling (reviewed in Surh and Sprent, 2008). In the absence of 
appropriate survival signals naïve and memory T cells die by apoptosis, 
characterised by caspase-induced DNA and cell fragmentation, nuclear 
shrinkage, cell blebbing and plasma membrane changes before the dying cell is 
removed by phagocytes (reviewed in Krammer et al., 2007). Initiator caspases 
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are activated downstream of mitochondrial outer membrane permeabilisation 
(MOMP), which leads to the release of soluble cytochrome C into the cytosol. 
Cytochrome C oligomerises with Apaf1 to form the apoptosome, which binds 
and activates initiator caspases like caspase-8 and -9 (reviewed in Tait and 
Green, 2010). Active caspase-8, in turn, activates effector caspases such as 
caspase-3 and -7 which ultimately induce apoptosis (reviewed in Tait and 
Green, 2010). Alternatively, caspases can be activated downstream of ligands 
including TNFα, CD95L and Fas ligand (FASL) resulting in the formation of a 
death-inducing signalling complex (DISC) which recruits and activates initiator 
caspases. In certain cells, this extrinsic pathway requires amplification involving 
caspase-8-mediated cleavage and activation of Bid to tBid leading to MOMP 
(reviewed in Krammer et al., 2007). Hepatocytes are known to require this 
amplification and Fas injection does not induce hepatocellular apoptosis in Bid-
deficient mice in vivo (Yin et al., 1999). In fact, most vertebrate cells require 
MOMP for caspase activation and apoptosis (reviewed in Tait and Green, 2010). 
MOMP activation is regulated by pro- and anti-apoptotic members of the Bcl-2 
family, which interact with Bcl-2-homology-domain-3-(BH3)-only proteins, so 
named because they all contain a BH3 domain, although they share little further 
homology (summarised in Figure 1.4) (reviewed in Chipuk et al., 2010). Anti-
apoptotic Bcl-2 proteins are typically located within the outer mitochondrial 
membrane  and include Bcl-2, B cell leukaemia/lymphoma x (Bcl-xL), Bcl-2-
related protein A1 (A1) and myeloid cell leukemia sequence 1 (Mcl-1), which 
mostly inhibit pro-apoptotic Bcl-2 proteins directly (reviewed in Chipuk et al., 
2010). BH3-only proteins include Bcl-2 associated antagonist of cell death (Bad) 
and phorbol-12-myristate-13-acetate-(PMA)-induced protein 1 (Noxa), which 
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only interact with anti-apoptotic Bcl-2 proteins, and Bid, Bcl-2 interacting 
mediator of cell death (Bim) and Bcl-2 modifying factor (Bmf), which can interact 
both with the anti-apoptotic Bcl-2 proteins and the effector proteins Bcl-2 
antagonist/killer (Bak) and Bax (reviewed in Chipuk et al., 2010). Activation and 
subsequent oligomerisation of Bak and Bax within the outer mitochondrial 
membrane is essential for the initiation of MOMP and cells lacking both Bak and 
Bax fail to undergo MOMP or apoptosis (Wei et al., 2001). Activation of Bak and 
Bax involves substantial conformational changes, which result in the targeting of 
Bax to the outer mitochondrial membrane and the oligomerisation of both Bak 
and Bax into pores within the outer mitochondrial membrane to promote MOMP 
(reviewed in Chipuk et al., 2010). Both Bim and Bid can interact with and 
activate Bax directly (Gavathiotis et al., 2008; Lovell et al., 2008) although it 
seems that additional mechanisms for activating Bak and Bax exist since Bak 
and Bax activation and subsequent apoptosis can also occur in absence of Bim 
or Bid (Willis et al., 2007). Other BH3-only proteins including Bad, Bik, Hrk and 
Puma induce apoptosis by interacting with anti-apoptotic Bcl-2 family members 
preventing their inhibition of direct activators like Bim and Bid (reviewed in 
Chipuk et al., 2010). In addition, to sensitisation and derepression, BH3-only 
protein neutralisation of anti-apoptotic Bcl-2 proteins might be sufficient for 
MOMP and apoptosis independently of Bid and Bim (Willis et al., 2007) 
although apoptosis is thought to be most efficient when it involves Bid, Bim as 
well as sensitisation and derepression (reviewed in Chipuk et al., 2010).  
The binding of anti-apoptotic Bcl-2 proteins by BH3-only proteins mediated by 
their BH3 domain is essential for the initiation of apoptosis. Interestingly, the 
affinity of BH3-only proteins for anti-apoptotic Bcl-2 proteins varies substantially 
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(Chen et al., 2005b). Bim and Puma interact similarly with all anti-apoptotic Bcl-
2 proteins but Bad only binds Bcl-2 and Bcl-xL strongly, A1 weakly and Mcl-1 
not at all (Chen et al., 2005b). Noxa, meanwhile only binds Mcl-1 and A1 and 
thus cooperates with Bad to induce apoptosis (Chen et al., 2005b). The BH3 
domain is thought to confer binding properties to BH3-only proteins and 
consistent with this, chimeric Bim expressing the BH3 domain of Puma, Bad or 
Noxa behaved like Puma, Bad or Noxa, respectively (Chen et al., 2005b). The 
binding properties of Bmf are similar to Bad and despite originally being 
discovered following co-immunoprecipitation with Mcl-1 (Puthalakath, 2001) 
Bmf only weakly binds Mcl-1 (Chen et al., 2005b). Both Bim and Bmf are 
associated with cytoskeletal components, microtubules (Puthalakath et al., 
1999), and actin filaments (Puthalakath, 2001), respectively, and both Bim and 
Bmf co-immunoprecipitate with Bcl-2 following certain cellular stress (reviewed 
in Piñon et al., 2008). 
Bcl-2 protein activity is regulated in a variety of ways. Bid activation requires 
cleavage to tBid by caspases or granzyme B. Meanwhile, Bad activity is 
regulated by phosphorylation of its BH3 domain by Akt following growth factor 
withdrawal, which promotes its sequestration in the cytoplasm by 14-3-3 
proteins (reviewed in Chipuk et al., 2010). Both Bim and Bmf activity is 
regulated by Erk signalling (Ley et al., 2005; Shao and Aplin, 2012). 
Interestingly, while Erk-mediated serine phosphorylation of Bim promotes 
survival by promoting Bim degradation, Jnk-mediated threonine phosphorylation 
increases the pro-apoptotic potential of Bim possibly by releasing it from 
microtubules (Lei and Davis, 2003). This threonine residue is conserved in Bmf 
and is phosphorylated by Jnk in vitro and in vivo (Lei and Davis, 2003). 
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1.5.3 Cytokine regulation of naïve T cell survival 
Cytokines like IL-7 play an essential role in naïve T cell homeostasis and in 
absence of IL-7 or IL-7Rα, T cell development is impaired resulting in severely 
reduced thymocytes and peripheral T cell numbers (Freeden-Jeffry et al., 1995; 
Peschon et al., 1994). IL-7 also regulates naïve T cell survival in the periphery 
and IL-7Rα-deficient OT-I Rag1-/- T cells disappear more rapidly than WT OT-I 
Rag1-/- T cells after transfer into C57Bl/6 hosts (Schluns et al., 2000). In the 
study, naïve OT-I T cells were also shown to require IL-7 to undergo 
homeostatic proliferation (Schluns et al., 2000). WT CD4 and CD8 T cells also 
required IL-7 for their survival and disappeared more rapidly after transfer into 
IL-7-deficient hosts than after transfer into C57Bl/6 hosts (Tan et al., 2001). The 
number of naïve T cells in thymectomised C57Bl/6 mice treated with anti-IL-7Rα 
antibodies also declines rapidly whereas naïve T cell numbers remain constant 
in untreated thymectomised control mice reflecting their long half-life (Vivien et 
al., 2001). Meanwhile, administration of recombinant IL-7 (Geiselhart et al., 
2001) or IL-7 overexpression (Kieper, 2002), leads to an increase in naïve and 
memory T cell numbers as a result of an increase in their basal homeostatic 
proliferation.  
IL-7 is produced by non-haematopoietic stromal and epithelial cells in the 
thymus (Namen et al., 1988; Wiles et al., 1992), spleen, kidney, liver (Namen et 
al., 1988) and skin (Heufler et al., 1993) at a fixed rate so that IL-7 levels are 
regulated by IL-7 consumption (reviewed in Mazzucchelli et al., 2007 and in Fry 
and Mackall, 2005) (see section 1.2.1). SLOs are thought to be an important 
source of IL-7 and naïve T cells require access to SLOs in order to undergo 
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homeostatic proliferation (Dummer et al., 2001) and survive (Cinalli et al., 2005). 
Recently, follicular reticular cells (FRCs) in LN T cell zones were shown to 
produce IL-7 and only purified LN FRCs were able to promote CD4 and CD8 T 
cell survival in vitro in an IL-7- and CCL19-dependent manner (Link et al., 2007). 
Furthermore, blocking IL-7Rα signalling or access to SLOs in vivo lead to 
similar reductions in naïve T cell numbers in peripheral blood, which is 
consistent with the view that naïve T cells receive IL-7 survival signals in SLOs 
(Link et al., 2007). 
Despite its clear role in promoting naïve T cell survival in vivo the mechanism by 
which IL-7 prevents T cell death remains controversial. The defect in 
thymopoiesis in absence of IL-7 signalling is at least partially rescued by 
transgenic expression of Bcl-2 (Akashi et al., 1997; Maraskovsky et al., 1997) 
suggesting that IL-7 might regulate mitochondrial homeostasis. Furthermore, 
deficiency in either Bax (Khaled et al., 2002) or Bim (Pellegrini et al., 2004) also 
partially rescues T cell development in IL-7Rα-deficient mice. IL-7 induces the 
upregulation of Bcl-2 (Akashi et al., 1997; Armant et al., 1995; Freeden-Jeffry et 
al., 1997; Graninger et al., 2000; Karawajew et al., 2000; Vella et al., 1997) as 
well as Mcl-1 (Opferman et al., 2003) in vitro, which are both anti-apoptotic 
members of the Bcl-2 family (reviewed in Chipuk et al., 2010). Finally, Bcl-2 
expression in vivo is reduced in T cells from C57Bl/6 treated with anti-IL-7Rα 
antibodies (Vivien et al., 2001) and in IL-7Rα-deficient OT-I T cells following an 
infection (Schluns et al., 2000). In contrast, a number of studies have failed to 
observe a reduction in Bcl-2 in IL-7Rα-deficient T cells and IL-7 is still able to 
prevent apoptosis of Bcl-2-deficient T cells (Nakayama et al., 1995) suggesting 
that, at least in lymphoreplete mice, IL-7 survival signals might be Bcl-2 
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independent (Jacobs et al., 2010; Pearson et al., 2012). Consistent with this, 
Bcl-2 expression does not decrease following IL-7 withdrawal in vitro despite 
considerable cell death (Rathmell et al., 2001). Mitochondrial homeostasis is 
perturbed in IL-7Rα-deficient cells in lymphoreplete mice as evidenced by their 
reduced tetramethylrhodamine ethyl ester (TMRE) staining indicative of a 
reduced mitochondrial membrane potential (Pearson et al., 2011). IL-7 has also 
been shown to regulated T cell size and glucose metabolism in PI3K-dependent 
manner in vitro in C57Bl/6 T cells (Rathmell et al., 2001) and T-ALL cells 
(Barata et al., 2004). It has subsequently been shown that the Y449 residue of 
IL-7Rα, important for the IL-7-induced activation of STAT5 (Jiang et al., 2004), 
is required for IL-7-induced upregulation of Glut1 expression at the cell surface 
(Wofford et al., 2008). However, the PI3K-dependent regulation of glucose 
metabolism appears to be largely dispensable for the maintenance of T cell 
viability by IL-7 in vitro (Pearson et al., 2012; Rathmell et al., 2001) and so it 
remains unclear what the in vivo target is of IL-7-mediated T cell survival signals. 
1.5.4 Cytokine regulation of memory T cell survival 
In contrast to naïve T cell survival, the survival of CD4 and CD8 memory T cells 
does not require MHC (Murali-Krishna et al., 1999; Swain, 1999) or TCR (Polic 
et al., 2001) but like naïve T cells, memory T cells do depend on IL-7 and IL-15 
for their survival (reviewed in Surh and Sprent, 2008). CD8 memory T cell 
homeostasis, in particular, depends on IL-15 signalling and IL-15-deficient mice 
have fewer memory phenotype CD8 T cells and NK cells but normal numbers of 
memory phenotype CD4 T cells (Kennedy et al., 2000). Unusually, IL-15 is 
presented at the cell surface bound to IL-15Rα (Bulanova et al., 2007) and as 
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such IL-15Rα-deficient mice show a reduction in memory phenotype CD8 T 
cells and NK cells similar to IL-15-deficient mice (Lodolce et al., 1998). Memory 
CD8 T cells and NK cells express higher levels of the IL-15R, composed of 
CD122 or IL-15Rβ and the γc-chain, than memory CD4 T cells (Zhang et al., 
1998c) and are thus thought to outcompete them (Purton et al., 2007). 
Consistent with this, removal of CD8 T cells and NK cells significantly increases 
the homeostatic proliferation of memory CD4 T (Purton et al., 2007). Memory T 
cell homeostasis also depends on IL-7Rα signalling and IL-7 overexpression 
rescues memory phenotype CD8 T cells in IL-15 deficient mice (Kieper, 2002), 
while IL-7Rα-deficient OT-I memory T cells have a survival defect in vivo that is 
rescued by transgenic Bcl-2 expression (Carrio et al., 2007). Since memory 
CD4 T cells express low CD122 and high IL-7Rα, IL-7 signalling is proposed to 
play a particularly important role in the maintenance of memory CD4 T cells 
(reviewed in Surh and Sprent, 2008) and is essential for their homeostatic 
proliferation (Lenz et al., 2004; Purton et al., 2007).  
1.5.5 TCR signals that regulate naïve T cell survival  
In addition to cytokine signal, naïve T cells require TCR signals for their long-
term survival in the periphery. That naïve CD4 T cells require spMHC TCR 
interactions for their survival was first shown by grafting WT thymi into either 
Rag1-/- or MHCII α-chain-deficient Rag1-/- mice (Takeda et al., 1996). Naïve 
CD4 T cell proliferation was equivalent regardless of MHCII Aα (I-Aα) 
expression but the long-term survival of CD4 T cells was impaired in absence of 
I-Aα (Takeda et al., 1996). Restoring thymic MHCII expression in I-Aβ-deficient 
mice (Cosgrove et al., 1991) rescues CD4 T cell development while CD4 T cells 
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still rapidly decay in the Aβ-deficient periphery, confirming that contact with 
MHCII is important for naïve CD4 T cell survival (Rooke et al., 1997). 
Furthermore, naïve CD4 T cells accumulate in I-Aα-deficient mice that also 
expressed MHCII Eα (I-Eα) in CD11c+ but not in mice lacking only I-Aα 
expression (Kontgen et al., 1993) suggesting that MHCII-expressing DCs might 
provide naïve CD4 T cells with survival signals. Interestingly, the reduced half-
life of H-2d-restricted TCR transgenic CD4 T cells transferred into H-2b mice 
compared to their relative persistence in H-2d mice suggests that TCR spMHC 
interactions are MHC-restricted (Kirberg et al., 1997). Similarly, H-2b restricted 
TCR transgenic CD4 T cells survive well after transfer into β2m-deficient mice 
or C57Bl/6 mice, but fail to persist in I-Aβ-deficient or Balb/c mice, which are H-
2d-restricted (Viret et al., 1999). Like CD4 T cells, naïve CD8 T cell survival also 
depends on MHC-restricted TCR signals and H-2Db restricted HY TCR 
transgenic CD8 T cells do not persist after transfer into either H-2Db-deficient or 
β2m-H-2Db-double-deficient mice (Tanchot et al., 1997). 
Other studies have suggested spMHC TCR interactions only have a minor role 
in the long-term survival of naïve CD4 T cells. In particular, the rapid decline of 
CD4 T cells in absence of MHCII has been suggested to be a failure to undergo 
homeostatic proliferation rather than a failure to survive (Clarke and Rudensky, 
2000). In these studies, naïve CD4 T cells transferred into I-Aβ-deficient hosts 
show a small defect in survival after 56 days (Clarke et al., 2000) or no survival 
defect at all (Dorfman et al., 2000) if cell division is taken into account. It has 
subsequently been shown, however, that I-Aβ-deficient mice are not truly 
MHCII-deficient (Martin et al., 2003) and that hybrid AαEβ in I-Aβ-deficient mice 
can support both the homeostatic proliferation and survival of naïve CD4 T cells 
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(Martin et al., 2003). Naïve CD4 T cells transferred into MHCII-deficient mice 
lacking not only I-Aβ but also I-Aα, I-Eα and I-Eβ (Madsen et al., 1999) survive 
poorly suggesting that naïve CD4 T cell survival is indeed MHC-dependent 
(Martin, 2006). Interestingly, when the MHCII-deficient mice were also 
lymphopaenic CD4 T cells fail to proliferate but survive well, suggesting that 
CD4 T cell survival in lymphopaenia might be MHC-independent (Martin, 2006). 
Cre-mediated deletion of Tcra in naïve T cells resulted in reduced half-lives of 
both CD4 and CD8 naïve T cells (Polic et al., 2001) as did the Tet-inducible 
deletion of transgenic OT-1 TCRα (Labrecque et al., 2001) suggesting both 
CD4 and CD8 naïve T cells reqquire TCR expression for their survival under 
lymphoreplete conditions. Src family kinase expression, was initially thought to 
be dispensable for naïve T cell survival since naïve CD4 and CD8 T cell survival 
was unaffected by Lck expression in mice expressing a conditional Lck allele 
(Seddon et al., 2000). In absence of both Lck and Fyn, however, CD4 and CD8 
naïve T cells failed to survive suggesting that Fyn can compensate for Lck to 
maintain naïve T cell survival in Lck-deficient mice (Seddon and Zamoyska, 
2002a). Conversely, the persistence of CD4 and CD8 naïve T cells in absence 
of Fyn, confirms that Lck alone is also sufficient for naïve T cell survival 
(Seddon and Zamoyska, 2002a). Interestingly, Lck-deficient naïve T cells failed 
to undergo homeostatic proliferation, suggesting that the homeostatic TCR 
signals that promote naïve T cell survival and proliferation are different (Seddon 
et al., 2000). Furthermore, Fyn alone appears unable to phosphorylate the 
downstream target of TCR signalling, Zap70 (Lovatt et al., 2006) and so it 
remains unclear whether Zap70 is required for naïve T cell survival.  
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The impaired long-term survival of naïve T cells in absence of MHC contact 
(Dorfman et al., 2000; Witherden et al., 2000) or in absence of Src family 
kinases (Seddon and Zamoyska, 2002a) correlates with a reduction in the basal 
phosphorylation of CD3ζ. TCR-associated CD3ζ is phosphorylated in T cells in 
absence of antigen (van Oers et al., 1993) and a fraction of Zap70 is 
constitutively associated with this basally phosphorylated CD3ζ (van Oers et al., 
1994). Like phosphorylated CD3ζ, naïve T cell CD5 expression is modulated by 
homeostatic TCR signals and correlates well with constitutively phosphorylated 
CD3ζ (Smith et al., 2001). It has therefore been suggested that constitutively 
phosphorylated CD3ζ might represent the transduction of a TCR survival signal 
although other studies that although dependent on homeostatic TCR signals, 
constitutively phosphorylated CD3ζ enhances TCR signalling sensitivity upon 
antigen recognition (Stefanova et al., 2002). Interestingly, a recent study 
showed that DCs isolated by plastic adherence could both form immunological 
synapses with naïve T cells and promote their survival in vitro in absence of 
antigen (Revy et al., 2001). Furthermore, this DC-mediated survival signal is at 
least partially dependent on MHC and requires Src family kinase activity and 
also correlates with the constitutive phosphorylation of CD3ζ (Feuillet et al., 
2005) and so DCs might provide naïve T cells with an MHC-dependent TCR-
mediated survival signal. The importance of DCs in promoting naïve T cell 
survival remains controversial, however, since a more recent study was unable 
to show any effect of fluorescence-activated-cell-sorting-(FACS)-purified DCs 
on naïve T cell survival in vitro (Link et al., 2007). 
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1.5.6 Cross-regulation of TCR and IL-7Rα signalling 
In view of the importance of TCR and IL-7Rα signalling for T cell homeostasis, it 
has been proposed that IL-7Rα and TCR signalling feedback mechanisms 
might regulate one another in T cells in a similar way to the regulation of B cell 
activating factor receptor (BAFFR) signalling by BCR signalling in B cells 
(Rickert et al., 2011). In one model, IL-7 and other γc cytokines are proposed to 
increase Cd8a transcription thereby enhancing TCR spMHC interactions, which 
in turn block IL-7Rα signalling and thus reduce Cd8a transcription. Evidence to 
support this cyclical model comes largely from in vitro experiments showing that 
CD8α expression is upregulated following culture with IL-7 (Park et al., 2007). 
The study also shows that IL-7Rα expression is higher on male HY TCR 
transgenic T cells, which receive strong TCR signalling in vivo, whereas CD8α 
expression is higher on female HY TCR transgenic T cells (Park et al., 2007). 
Ultimately, this cross-regulation of TCR and IL-7Rα is proposed to ensure that 
no CD8 T cell receives excessive TCR or IL-7Rα stimulation (Park et al., 2007). 
In an extension of this cyclical model, IL-7R signalling needs to be interrupted 
by homeostatic TCR signals to prevent cytokine-induced-cell death of naïve 
CD8 T cells (Kimura et al., 2012). The authors found no evidence of CD4 being 
subject to a similar ‘co-receptor tuning’ by IL-7 signalling (Park et al., 2007).  
Despite the evidence in favour of this model of IL-7Rα-mediated modulation of 
Cd8 transcription, the in vivo data correlating CD8, IL-7Rα and CD5 expression 
are largely derived from TCR transgenic mice, which are commonly 
lymphopaenic (Ge et al., 2004). Furthermore, HY TCR transgenic T cells from 
male mice receive substantially stronger TCR signals than HY TCR transgenic 
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T cells from female mice calling into question the biological significance of ‘co-
receptor tuning’ in cells that receive weaker homeostatic TCR signals. Since 
ablation of Lck has no effect on IL-7Rα-expression in vivo (Seddon and 
Zamoyska, 2003) it seems likely that TCR signals do not regulate IL-7Rα 
expressions directly. Consistent with this, a recent study showed that TCR 
signals did not regulate IL-7Rα expression in naïve T cells, but that TCR signals 
received during T cell positive selection programmed the IL-7Rα expression that 
is subsequently maintained on naïve T cells (Sinclair et al., 2011). There is even 
evidence that TCR signalling, rather than inhibiting IL-7Rα signalling, enhances 
sensitivity to IL-7 by promoting the localisation of γc in lipid rafts (Cho et al., 
2010). It has also been shown that IL-7Rα and CD5 are downregulated, while 
CD8α is upregulated, in absence of TCR signalling (Takada and Jameson, 
2009) and so it remains controversial, whether and how TCR and IL-7Rα 
signalling are cross-regulated in peripheral CD8 T cells. 
 
 
 
 
 
 
 
 85 
1.6 Thesis aims 
TCR and IL-7Rα signalling are important for T cell development and naïve T cell 
survival. In contrast to IL-7Rα signalling the source and downstream targets of 
TCR survival signals in naïve T cells remain largely uncharacterised. Src family 
kinases Lck and Fyn are indispensable for naïve T cell survival although Fyn 
can compensate for Lck-deficiency and only when both Fyn and Lck are deleted 
is naïve T cell survival impaired (Seddon and Zamoyska, 2002a). Impaired 
naïve T cell survival also correlates with reduced phosphorylation of CD3ζ in 
absence of MHC contact (Dorfman et al., 2000; Witherden et al., 2000) or in 
absence of Src family kinases (Seddon and Zamoyska, 2002a) and Zap70 is 
constitutively associated with constitutively phosphorylated CD3ζ. TCR-
associated CD3ζ is phosphorylated in T cells in absence of antigen (van Oers et 
al., 1993) and a fraction of Zap70 is constitutively associated with constitutively 
phosphorylated CD3ζ (van Oers et al., 1994). The role of Zap70 in the 
transduction of TCR survival signals has not been characterised and neither 
have the downstream pathways and targets of TCR survival signals in naïve T 
cells. Using mice that conditionally express Zap70 we hope to investigate the 
following aspects of Zap70 signalling in naïve T cells: 
1) The role of Zap70 in the transduction of TCR survival signals in naïve T cells 
2) The ability of two Zap70 mutants to transduce TCR survival signals  
3) The downstream targets of TCR survival signals in naïve T cells 
4) The temporal requirements of Zap70 signalling during T cell activation and 
expansion 
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Figure 1.1 IL-7Rα signalling 
Schematic diagram of IL-7Rα signalling initiated by cross-linking of the IL-7Rα 
chain and the γc chain by IL-7, which induces the recruitment and 
phosphorylation of Jak1 and Jak3 to the IL-7Rα chain and γc chain, respectively.  
STAT5 is subsequently recruited to Jak1 and Jak3 and phosphorylated after 
which STAT5 dimerises and translocate to the nucleus to activate specific gene 
transcription thought to include a number of Bcl-2 family members. IL-7 also 
induces the phosphorylation and recruitment of the p85 subunit of PI3K to the 
plasma membrane where it promotes the conversion of PIP2 to PIP3, which 
recruits PH-domain-containing proteins, like Akt, to PIP3. Activation of Akt by 
Pdk1 subsequently regulates Foxo1 phosphorylation and subsequent 
degradation, which in turn regulates Ccr7, Il7ra and Klf2 transcription. Akt is 
also thought to regulate GLUT1 localisation and thus glucose uptake. 
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Figure 1.2 TCR signalling 
Schematic diagram of TCR signalling initiated by TCRαβ engagement with 
spMHC or pMHC, which induces the phosphorylation of ITAMS of the CD3δ, 
CD3γ CD3ε and CD3ζ chains by Src family kinases Lck or Fyn. Phosphorylated 
ITAMs then recruit Zap70, which is autophosphorylated and phosphorylated by 
Lck allowing active Zap70 to phosphorylate its targets, LAT and Slp76. 
Phosphorylated LAT then associates with Vav1, Nck PLCγ, Slp76, Adap, Itk 
Gads, Grb2 and Sos1. Further downstream signals then include the activation 
MAPK and NFκB downstream of PLCγ-mediated conversion of PIP2 to IP3 and 
DAG. IP3 then induces an increase in intracellular Ca2+, which results in the 
calcineurin-dependent dephosphorylation and activation of NFAT. DAG 
activates PKCθ and RasGRP, which in turn lead to the activation of NFκB and 
AP1, respectively. The association of phosphorylated Slp76 with Vav1 and Nck 
leads to the recruitment of Cdc42, WASP and Pak, which are involved in the 
TCR-dependent reorganisation of the cytoskeleton. Finally, Zap70, LAT, Vav1 
and PLCγ have also been implicated in the activation of integrins downstream 
of TCR signalling via the Slp76-mediated recruitment Adap and a number of 
other adaptor proteins to the plasma membrane. 
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Figure 1.3 Structure of murine Zap70 
Schematic diagram of Zap70 domains showing a C-terminal kinase domain and 
two tandem N-terminal SH2 domains. Two tyrosine residues in the interdomain 
linking the SH2 domains and the kinase domain, Y315 and Y319, regulate the 
auto-inhibitory conformation of inactive Zap70 but are also thought to mediate 
the adaptor function of Zap70. Y315 and Y319 are mutated to alanine in YYAA 
mice. Y292 is implicated in the negative regulation of Zap70 function. The SH2 
domains are essential for the recruitment of Zap70 to doubly phosphorylated 
ITAMs of CD3ζ chains and mutation of tryptophan 163 in the C-terminal SH2 
domain to cysteine in the SKG mice results in hypomorphic TCR signalling. The 
tyrosine residues, Y492 and Y493, in the kinase domain, are phosphorylated by 
Lck or are autophosphorylated to activate Zap70, allowing it to phosphorylate 
downstream targets.  
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Figure 1.4 The regulation of apoptosis 
Schematic diagram the intrinsic pathway of aptoptosis resulting in MOMP and 
the subsequent release of soluble cytochrome C into the cytosol. Cytochrome C 
oligomerises with Apaf1 to form the apoptosome, which binds and activates 
initiator caspases like caspase-8 and -9, which in turn activate effector 
caspases like caspase-3 and -7. In most vertebrate cells both the extrinsic and 
intrinsic pathway of apoptosis require the activation of MOMP. MOMP occurs 
following the activation and oligomerisation of active Bak and Bax, which form 
mediate MOMP by forming pores in the outer mitochondrial membrane. Anti-
apoptotic Bcl-2 proteins typically located within the outer mitochondrial 
membrane include Bcl-2, Bcl-xL and Mcl-1, which inhibit pro-apoptotic Bcl-2 
proteins directly. BH3-only proteins include Bid, Bim and Bmf, which can 
interact both with the anti-apoptotic Bcl-2 proteins and the effector proteins Bak 
and Bax but also Bad and Noxa (not depicted), which only interact with anti-
apoptotic Bcl-2 proteins, 
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Chapter 2 Materials and methods 
2.1 Mice 
2.1.1 Experimental mice used in this study 
Table 2.1 List of mice used in this study 
Mouse strain References 
C57Bl/6 (Ly5.2)   
Ly5.1 C57Bl/6  
B6 Rag1-/- (Mombaerts et al., 1992) 
F5 Rag1-/- (Ly5.2) (Mamalaki et al., 1993) 
F5+/- Zap70+/- Rag1-/-  
Ly5.1 F5 Rag1-/-  
OT-I Rag1-/- (Ly5.2) (Hogquist et al., 1993) 
IL-7-/- Rag1-/- (Freeden-Jeffry et al., 1995) 
β2m-/- Rag1-/- (Koller et al., 1990) 
SKG (Sakaguchi et al., 2003) 
YYAA (Hsu et al., 2009) 
F5 Rag1-/- Zap70TrertTA.ChuCD2Zap70-/- (Saini et al., 2010) 
F5 Rag1-/- Zap70TrertTA.ChuCD2Zap70Skg/-  
F5 Rag1-/- Zap70TrertTA.ChuCD2Zap70Yyaa/-  
Mice used in this study (Table 2.1) were bred in a conventional colony under 
SPF conditions at The National Institute for Medical Research (NIMR), London, 
UK. Animal experiments were performed according to institutional guidelines 
and Home Office regulations. Mice strains were genotyped by flow cytometry of 
blood lymphocytes and PCR analysis of tail DNA. All experimental mice were 
used at 6-16 weeks of age. C57Bl/6 or mixed mice are on an H-2b background. 
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2.1.2 Generation of F5 TetZap70, F5 TetZap70 Zap70Yyaa/- and F5 TetZap70 
Zap70Skg/- mice 
Mice with doxycycline-(dox)-inducible expression of Zap70 (Figure 2.1) were 
described previously (Saini et al., 2010; Sinclair et al., 2011) but briefly, mice 
that expressed a Zap70 transgene and downstream internal ribosomal entry site 
(IRES)-human CD2 (hCD2) tailless reporter under the control of a tetracycline-
response element (TRE) (Zap70TRE) (Gossen and Bujard, 1992) were crossed 
with mice that constitutively expressed a reverse tetracyclin TransActivator 
(rtTA.C) whose expression was directed to T cells by human CD2 regulatory 
elements (rtTA.ChCD2) (Legname et al., 2000; Zhumabekov et al., 1995). These 
mice were further crossed onto an endogenous Zap70-deficient background 
(Negishi et al., 1995). Finally, we crossed these mice with F5 Rag1-/- TCR 
transgenic mice (Mamalaki et al., 1993) generating F5 Rag1-/- Zap70Tre 
rtTA.ChCD2 Zap70-/- (intact F5 TetZap70 mice hereon). F5 T cells express an 
MHCI H-2Db restricted TCR, which recognises αα366-374 of the influenza 
nucleoprotein (NP366-374) of influenza A/NT/60/68. F5 TetZap70 were also 
crossed with YYAA and SKG mice, both on a C57Bl/6 background, to generate 
F5 TetZap70 Zap70Yyaa/- and F5 TetZap70 Zap70Skg/- mice, respectively.  
2.1.3 Radiation bone marrow chimeras 
2.1.3.1 Donor BM isolation 
BM was extracted from the tibial and femoral bones of Ly5.1 F5 Rag1-/- and F5 
TetZap70unind, F5 TetZap70unind Zap70Yyaa/- and F5 TetZap70unind Zap70Skg/-mice. 
Following removal of the epiphyses, BM was isolated by flushing handling 
media through the medullary canal with a 25-gauge needle and 5mL syringe. 
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The BM was washed, centrifuged (Multifuge 3 s-r, Heraeus) (300g for 4min at 
4°C) and resuspended in handling media before being filtered through a 30μm 
cell strainer. Ly5.1 F5 Rag1-/- BM was T-cell-depleted by incubating cell 
suspensions with biotinylated TCR antibodies (1:100 dilution) at 4°C with 
rotation for 30 min in handling media (1mL/108 cells) after which samples were 
washed and resuspended in 4mL phosphate-buffered saline (PBS) (GIBCO). 
Dynal® beads were added (80x106/4mL) to the cell suspension and incubated 
at 4°C with rotation for 20 min. Labelled BM cells bound to the Dynal® beads 
were removed by placing the cell suspension in a magnetic Dynal® bead 
separator (Dynal®), first for 2min, then for 30sec. Finally, the cell suspension 
was washed and resuspended in freezing buffer (90% foetal calf serum, FCS, 
10%DMSO) at 30x106 cells/mL to be stored at -80°C until use or in handling 
media at 10-25x106 cells/mL to be used immediately. 
2.1.3.2 Host irradiation and bone marrow reconstitution 
B6 Rag1-/- host mice were sub-lethally irradiated with 500 Rad (caesium source) 
and allowed to reconstitute for a minimum of 6-8hrs. BM cells were filtered 
through a 35μm-pore cell strainer (BD) and injected intravenously (IV) with 
~200μL of 2-5x106 cells into the lateral tail vein of irradiated B6 Rag1-/- hosts 
using a 500μL microfine insulin syringe. Hosts were treated with water 
supplemented with 0.02% (v/v) Baytril® for >6 weeks and were placed on food 
supplemented with the tetracycline derivative dox (3mg/g). Chimeras were left 
for at least 6 weeks to allow reconstitution of the haematopoietic compartment, 
which was confirmed by the presence of CD8+ TCR+ cells in the peripheral 
blood, assessed by flow cytometry as described in section 2.3.2 and 2.4.2.  
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2.2 Media 
ACK lysis buffer 
 
dH2O with150mM NH4Cl, 10mM KHCO3, 0.1mM 
ethylenediaminetetraaceticacid (EDTA). 
Annexin-V binding buffer 
 
Annexin-V binding buffer was made by diluting 
annexin-V binding buffer 10x concentrate (BD) 
(0.1M hydroxyethyl piperazineethanesulfonic acid 
(Hepes) (pH 7.4), 1.4M NaCl, and 25 mM CaCl2). 
Complete medium  
(for in vitro experiments) 
 
Roswell Park Memorial Institute 1640 (RPMI) 
medium (GIBCO) supplemented with 5% (v/v) FCS, 
0.5% (w/v) bovine serum albumin (BSA) (Sigma), 
4mM L-glutamine (Sigma), 50μM β-
mercaptoethanol (Sigma), 100μg/mL penicillin G 
sodium (Sigma) and 100μg/mL streptomycin 
sulphate (Sigma). 
Digestion media 
 
RPMI medium (GIBCO) supplemented with 1.67 
Wünsch units Liberase (Roche) and 0.2mg/mL 
DNase (Roche). 
Dynabead buffer 
 
PBS (GIBCO) supplemented with 0.1% BSA and 
2mM EDTA. 
FACS buffer 
 
PBS (made in-house) supplemented with 0.5% (v/v) 
sodium azide and 5% (v/v) FCS. 
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Handling media 
 
Air-buffered Iscove’s Modified Dulbecco’s medium 
(AB-IMDM) (made in-house) supplemented with 
0.2% (v/v) BSA. 
MACS buffer 
 
PBS (GIBCO) supplemented with 0.5% BSA and 
2mM EDTA. 
2.3 Preparation of single cell suspensions 
2.3.1 Thymus, lymph nodes and spleen 
The thymus, spleen, cervical, axillary, brachial, mesenteric and inguinal LN 
were dissected from mice and placed on ice. Single cell suspensions were 
prepared by gently crushing organs between two layers of 75μm nylon mesh in 
ice-cold handling media. After this, cells were washed in handling media, 
centrifuged (300g for 4min at 4°C), resuspended in ice-cold fresh handling 
media and kept on ice for the remainder of the assay. Cells were then counted 
using a Casy-1 cell counter (Scharfe System, Germany) after which they were 
stained as described in section 2.4.2 and 2.4.3. 
2.3.2 Peripheral blood 
Approximately 100μL of blood was collected from experimental mice by nicking 
the lateral tail vein with a scalpel blade. Blood was mixed with ~100μL of 
heparin (Sigma) after which it was lysed in 2mL of ACK lysis buffer for 3min at 
room temperature (RT) or until the solution appeared transparent (but no longer 
than 5min). Cells were then washed in 2mL ice-cold FACS buffer, centrifuged 
(300g for 4min at 4°C) and stained as described in sections 2.4.2 and 2.4.3. 
 98 
2.3.3 Splenocytes for CD11c+ enrichment 
Spleens were dissected and placed on ice after which they were injected 
with800μL-1mL digestion media using a 25-gauge needle and a 2mL syringe 
and placed in a petri dish at 37°C and 5% carbon dioxide (CO2) for 30min. 
Digested spleens were then gently crushed in a 70μm sieve using the end of a 
1mL syringe and washed in ice cold handling media. Splenocytes were counted 
(Scharfe System, Germany) and then enriched for CD11c+ cells as described in 
section 2.7.2. 
2.4 Flow cytometry 
2.4.1 Antibodies and reagents used for flow cytometry 
A list of primary antibodies used for flow cytometry in this study is shown in 
Table 2.2.  
Table 2.2 List of primary antibodies used in this study 
Marker Clone Conjugate Supplier Concentration 
B220 RA3-6B2 PE eBioscience 1μg/mL 
CD11c HL3 FITC BD 2.5μg/mL 
CD11c N418 PE eBioscience 1μg/mL 
CD19 eBio1D3 PE Cy5 eBioscience 1μg/mL 
CD4 RM4-5 PE TR Invitrogen 1μg/mL 
CD4 RM4-5 eF450, PE eBioscience 2μg/mL 
CD44 IM7 APC eF780 eBioscience 0.5μg/mL 
CD45RB C363.16A PE eBioscience 1μg/mL 
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CD5 53-7.3 
FITC, eF450,  
PE Cy7 
eBioscience 1-1.25μg/mL 
CD8α 5H10 PO, PE TR Invitrogen 1μg/mL 
CD8α SK1 PE Cy7 eBioscience 0.5μg/mL 
hCD2 RPA-2.10 PE Cy5 eBioscience  
HSA M1/69 FITC Biolegend 2.5μg/mL 
HSA M1/69 PE Cy7 eBioscience 0.5μg/mL 
IL-7Rα A7R34 PE eBioscience 1μg/mL 
Ly5.1 A20 APC eBioscience 1μg/mL 
Ly5.2 104 PE eBioscience 1μg/mL 
Ly5.2 104 FITC eBioscience 0.5μg/mL 
MHCII M5/114.15.2 PE Cy7 eBioscience 0.5μg/mL 
MHCII M5/114.15.2 eF450 eBioscience 1μg/mL 
mPDCA1 JF05-1C2.4.1 FITC Miltenyi Biotec 9μg/mL 
Qa2 69H1-9-9 FITC eBioscience 2.5μg/mL 
TCRβ H57-597 
PE Cy5, APC, 
APC eF780 
eBioscience 1μg/mL 
TCR Vα2 B20.1 PE eBioscience 1μg/mL 
TCR Vβ11 RR3-15 FITC BD 2.5μg/mL 
A list of recombinant annexin-V conjugates used for flow cytometry in this study 
is shown in Table 2.3. A list of intracellular antibodies used for flow cytometry in 
this study is shown in in Table 2.4. 
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Table 2.3 List of recombinant annexin-V conjugates used in this study 
Marker Conjugate Supplier Concentration 
Annexin-V  FITC eBioscience 1 in 10 
Annexin-V APC BD 1 in 10 
Table 2.4 List of intracellular antibodies used in this study 
Marker Clone Conjugate Supplier Concentration 
Zap70 1E7.2 PE eBioscience 1μg/mL 
Bcl-2 
and IgG isotype 
3F11 
A19-3 
PE 
PE 
BD 
BD 
0.1mg/mL 
0.1mg/mL 
APC – Allophycocyanin; APC eF780 – Allophycocyanin e-Fluor 780; eF450 – e-
Fluor 450; eF780 – e-Fluor 780; FITC – Fluorescein isothiocyanate; PE –
Phycoerythrin; PE Cy5 – Phycoerythrin cyanine 5; PE Cy7 – Phycoerythrin 
cyanine 7; PerCP – Peridinin-chlorophyll protein; PE TR – PE Texas red; PO – 
Pacific orange. 
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2.4.2 Surface staining  
2.4.2.1 Primary staining and flow cytometry 
Antibodies were made up to concentrations as indicated in Table 2.2 in ice-cold 
FACS buffer. Cells were incubated for at least 40min at 4°C and in the dark in 
100-200μL at a density of 1-5x106 with antibodies conjugated to fluorescent 
labels. Cells were then washed 1-2 times in ice-cold FACS buffer, centrifuged 
(300g for 4min at 4°C) and resuspended in 100-300μL of FACS buffer before 
being filtered through a 35μm-pore cell strainer (BD). Flow cytometry was 
performed on the CyAN ADP (Beckman Coulter), BD FACSCantoII (BD), BD 
LSRII (BD) and FACSCalibur (Becton Dickinson) and data analysis was 
performed using FlowJo software (Tree Star). 
2.4.2.2 Recombinant annexin-V staining 
Cells were first stained for surface antigens as detailed in section 2.4.2.1 after 
which cells were washed in annexin-V binding buffer, centrifuged (300g for 4min 
at 4°C) and resuspended in 100μL annexin-V binding buffer with recombinant 
annexin-V made up to concentrations as indicated in Table 2.3. Cells were then 
incubated for 15min at RT and in the dark at a density of 1-5x106 after which 
they were washed in annexin-V binding buffer, centrifuged (300g for 4min at 
4°C) and resuspended in 100-300μL of FACS buffer before being filtered 
through a 35μm-pore cell strainer (BD) and analysed by flow cytometry. 
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2.4.2.3 Intracellular flow cytometry 
Cells were first stained for surface antigens as detailed in section 2.4.2.1 after 
which they ware washed in PBS (GIBCO), centrifuged (300g for 4min at 4°C) 
and fixed with IC fixation buffer (eBioscience) at RT for 10min. After this, cells 
were washed again in PBS (GIBCO), centrifuged (300g for 4min at 4°C) and 
resuspended in 0.1% NP40 (Igepal ca-360) (Sigma-Aldrich) in dH2O (v/v) for 
3min at RT. Cells were then washed, centrifuged (300g for 4min at 4°C) and 
resuspended in 100-200μL ice-cold FACS buffer with intracellular (or isotype 
control) antibodies made up to concentrations as indicated in Table 2.4. Cells 
were incubated overnight at 4°C and in the dark and were washed in FACS 
buffer, centrifuged (300g for 4min at 4°C) and resuspended in 100-300μL of 
FACS buffer before being filtered through a 35μm-pore cell strainer (BD) and 
analysed by flow cytometry. 
2.4.3 Calculation of absolute cell numbers and number of precursors  
2.4.3.1 Calculation of absolute cell numbers  
In order to calculate T cell recoveries from different hosts the following 
calculation was used: 
Total single live cell number (counted by Casy-1 cell counter)      a 
Frequency of total single live lymphocytes      b 
Frequency specified cell population x        c  
Absolute number of cells within specified cell population x        a.b.c  
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2.4.3.2 Calculation of number of precursors 
Analysis of cell division by CellTrace™ Violet (CTV) labeling involved the 
following calculations to determine the total number of precursors that 
generated the observed number of cells within a specific cell population x: 
Absolute number of cells within specified cell population x    a.b.c  
Frequency of cells in division i within x     fi 
Absolute number of cells in division i (within x)     Ni  = a.b.c.fi 
Number of precursors required to divide i times to generate the observed 
number of cells within division I (within x)  
𝑛! = 𝑁!2!  
Total number of precursors required to divide i times to generate the total 
observed number of cells within all divisions (within x)  
𝑛!!!→!  
2.5 In vivo experiments 
2.5.1 In vivo T cell survival in intact chimeras and mice 
In vivo survival of F5 T cells in F5 TetZap70, F5 TetZap70 Zap70Yyaa/- and F5 
TetZap70 Zap70Skg/- chimeras and mice was assessed by following the 
frequency of peripheral blood lymphocytes in a cohort of chimeras maintained 
on dox in comparison to a cohort of chimeras taken off dox-supplemented food. 
Peripheral blood was obtained as detailed in section 2.3.3 and stained as 
described in section 2.4.1. 
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2.5.2 CTV staining before adoptive transfer experiments 
Cells isolated as described in 2.3.1 were counted, centrifuged (300g for 4min at 
4°C) and resuspended in PBS (GIBCO) pre-warmed at 37°C at a density of 
20x106/mL.  The cell suspension was then combined with an equal volume of 
2.5-5μM CTV in pre-warmed PBS (GIBCO) and incubated for 10min at 37°C 
(final cell density 10x106/mL, final CTV concentration 1.25-2.5μM). Cells were 
washed twice in at least 4x more PBS (GIBCO), centrifuged (300g for 4min at 
4°C) and re-counted before being resuspended at 5x106/mL in handling media 
and injected into donor mice as detailed in sections 2.5.3.1 and 2.5.3.2. 
2.5.3 Adoptive transfer experiments – homing, survival and proliferation 
Cells isolated as described in 2.3.1 were counted, centrifuged (300g for 4min at 
4°C) and resuspended in handling media before being filtered through a 35μm-
pore cell strainer (BD). Filtered cells were CTV-labelled as described in section 
1.5.2 and pooled with control cells as indicated, after which they were injected 
by IV administration of ~200μL of 1x106 cells into the lateral tail vein of host 
mice using a 500μL microfine insulin syringe. To assess the proliferation 
response to influenza, mice were additionally injected IV with 100 
haemagglutinating units (HAU) of virus (A/NT/60-68) provided by Dr Andreas 
Wack, as previously described (Saini et al., 2009). Where cells were pooled 
with control cells, the ratio of Ly5.1 to Ly5.2 cells was assessed before injection. 
Hosts were placed on dox-supplemented food, where indicated, and bled or 
sacrificed after the indicated number of days to assess the frequency or 
expansion of injected cells by flow cytometry as detailed in section 1.4.2. 
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2.6 Cell purification by FACS 
Cells isolated as described in 2.3.1 were stained for surface antigens as 
detailed in section 2.4.2.1, using handling media instead of FACS buffer. Cells 
were then washed 1-2 times in ice-cold handling media, centrifuged (300g for 
4min at 4°C) and resuspended at a density of ~50x107/mL of handling media 
before being filtered through a 35μm-pore cell strainer (BD). FACS sorting was 
performed on the MoFlo XDP (Beckman Coulter) or BD FACSAria (BD) cell 
sorters. Sorted cells were collected in ice-cold handling media and used in vitro 
as described in section 1.7 or for mRNA-sequencing as described in section 1.8. 
2.7 In vitro experiments 
2.7.1 In vitro T cell survival  
Cells isolated as described in 2.3.1 were FACS-purified where indicated and 
cultured at 37°C in a Sanyo CO2 incubator (Sanyo) at 5% CO2 for 24, 48 or 27h 
as indicated in 24-well plates in 2mL of complete media at a density of 
0.5x106/mL. Complete medium was supplemented with IL-7 at 10ng/mL unless 
otherwise specified. Where indicated FACS-purified CD4 T cells, B cells or DC 
subsets or splenocytes enriched for CD11c+ cells as described in section 1.7.2 
were added to the T cells in addition to inhibitors at the following concentrations: 
UO126 (10uM) (Sigma), rapamycin (20nM) (VWR) and LY294002 (10uM) 
(Callbiochem) or the corresponding volume of DMSO. Cells were harvested at 
the indicated time and analysed by flow cytometry as described in section 2.4. 
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2.7.2 CD11c+ enrichment 
Splenocytes isolated as described in section 2.3.3 were enriched for CD11c+ 
cells either by MACS purification of CD11c PE+ cells or by negative depletion of 
CD11c- cells using a Dynabead® Mouse DC Enrichment Kit (Invitrogen). Similar 
post-enrichment purity was achieved using either method. 
MACS® purification 
Splenocytes were washed in MACS buffer, centrifuged (300g for 4min at 4°C) 
and passed through an LS column, unlabelled, to remove the majority of dead 
and adherent cells. Cells were then washed again, centrifuged (300g for 4min at 
4°C) and counted before being incubated with for CD11c conjugated to PE at 
2μg/mL at a density of 1-10x107/mL for 20-30min at 4°C and in the dark. After 
this, cells were washed in MACS buffer, centrifuged (300g for 4min at 4°C) and 
incubated with anti-PE MicroBeads (Myltenyi Biotec) (1:5) in MACS® buffer at a 
density of 10x107/mL for 15min at 4°C with constant rotation. Cells were then 
washed again in MACS buffer, centrifuged (300g for 4min at 4°C) and 
resuspended at a density of 1-10x107/mL after which they were passed through 
a second, fresh LS column in the magnetic field of a MACS® separator 
(Myltenyi Biotec). Labelled cells were collected in 5mL of MACS buffer, 
centrifuged (300g for 4min at 4°C) and counted to be used for in vitro 
experiments as described in section 2.7.1 or to be analysed by flow cytometry 
as described in section 2.4.  
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Dynabead® purification 
Splenocytes were washed in Dynabead buffer, centrifuged (300g for 4min at 
4°C) and counted before being incubated with the Dynabead® Mouse DC 
Enrichment Kit Antibody Mix (Invitrogen) (1:6) in Dynabead buffer at a density of 
1-107/mL for 20min at 4°C with constant rotation. Cells were then washed in 
Dynabead buffer, centrifuged (300g for 4min at 4°C) and incubated with 
calibrated Depletion MyOne™ SA Dynabeads® (Invitrogen) (1:10) in Dynabead 
buffer at a density of 1-10x106/mL for 15min at 4°C with constant rotation. 
Labelled splenocytes bound to the Dynabeads were removed by placing the cell 
suspension in a magnetic Dynal® bead separator (Dynal), first for 2min, then for 
30sec. Unlabelled cells were then counted to be used for in vitro experiments as 
described in section 2.7.1 or to be analysed by flow cytometry as described in 
section 2.4.  
2.8 mRNAseq 
2.8.1 RNA isolation 
FACS-purified T cells as described in section 1.6 were washed in PBS (GIBCO), 
centrifuged (300g for 4min at 4°C) and counted before being lysed in 750uL 
Trizol® (Invitrogen) in Non-Stick RNase-free Microfuge Tubes (Invitrogen) at a 
density of 2-10x106/mL. Samples were mixed by repetitive pipetting and 
incubated at RT for 10min after which 200μL of phenol-chloroform was added. 
Samples were then shaken vigorously for 15sec and left for 2-3min at RT to 
allow phase separation. Samples were centrifuged at 12,000rp for 15mim at 
4°C and the aqueous phase was transferred into a fresh microfuge tube with an 
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equal volume of isopropranol. Samples were left for 10min at RT and then 
centrifuged at 21,000g for 30min at 4°C before the supernatant was carefully 
removed. Pellets were washed in 300μL of 70% ethanol in dH2O (v/v) and 
centrifuged at 21,000g for 5min at 4°C. The RNA pellet was then resuspended 
in 15uL UltraPure™ DEPC-Treated Water  (Invitrogen) and RNA was quantified 
by Nanodrop and a Total RNA Nanochip. 
2.8.2 Sequencing 
Libraries for sequencing were prepared with the mRNA Seq 8-Sample 
Preparation Kit (Illumina) according to manufacturer’s instructions. Briefly, 
>100ng RNA was first fragmented after which two strands of cDNA were 
synthesised. After this cDNA 3’ and 5’ overhangs were converted to blunt ends 
using T4 DNA polymerase and Klenow DNA polymerase. Finally, 3’ ends of 
blunt DNA fragments were adenylated and adapters were ligated to the ends of 
DNA fragments before the 200-300bp-long DNA fragments were purified using 
an E-Gel® SizeSelect Gel (Invitrogen). 80-100ng of enriched DNA was then 
normalised using Duplex-Specific Thermostable Nuclease (DSN) in the DSN Kit 
(Illumina) (Christodoulou et al., 2011). Samples were sequenced at the MRC 
NIMR High-Throughput Sequencing Facility and 40 base-pair single-end reads 
were obtained using an Illumina Genome Analyser IIx. 
2.8.3 Quantification of gene expression  
Reads were aligned to the Mus musculus genome in the CLC Genomics Bench 
(V5) (CLC Bio) with default settings and exported to Avadis NGS (V1.3.1) 
(Strand Scientific Intelligence) to be mapped to the Refseq database. Mapped 
reads were then normalised using DEseq, as described previously (Anders and 
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Huber, 2010) and displayed as normalised reads per kilobase of exon per 
million mapped reads (nRPKM) (Mortazavi et al., 2008). 
2.9 Calculations and statistical testing 
The statistical significance of differences between and within groups and time-
points was assessed using one- and two-way analysis of variance followed by 
Bonferroni correction for multiple comparisons and were calculated in Prism 5 
and 6 for Mac OS X (Graphpad). F5 T cell half-lives were estimated from time-
course data fitted with non-linear regression one-phase decay curves in Prism 5 
and 6 for Mac OS X (Graphpad). 
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Figure 2.1 Dox-inducible expression of Zap70 in F5 TetZap70 mice 
Schematic diagram of dox-inducible Zap70 in F5 TetZap70 mice which 
constitutively express a reverse tetracyclin TransActivator (rtTA.C) directed to T 
cells by human CD2 regulatory elements (rtTA.ChCD2) (1-2). They also express a 
Zap70 transgene (yellow) and downstream internal ribosomal entry site (IRES)-
human CD2 (hCD2) tailless reporter (grey/green) under control of tetracycline-
response elements (TRE) (Zap70TRE). In the presence of dox or any other 
tetracycline-derivative in vivo or in vitro (3) rtTA is able to interact with the TRE 
(4), where it acts as a transcription factor inducing the transcription of Zap70 
and hCD2 (5). T cells in F5 TetZap70 mice also express the F5 TCR and are 
Rag1-/- so that they all recognise influenza nucleoprotein (NP366-374). Finally, 
F5 TetZap70 mice are also Zap70-/- that the only Zap70 expressed is dox-
inducible transgenic Zap70.  
 
 
 
 111 
Chapter 3 The role of Zap70 in naïve T cell 
survival in vivo  
3.1 Introduction 
Both cytokine and TCR signalling play a crucial role in the survival of naïve T 
cells and competition for these signals maintains the size of the peripheral T cell 
pool (Seddon and Zamoyska, 2003).  IL-7 is essential for naïve T cell 
homeostasis in vivo and mice lacking either IL-7 (Freeden-Jeffry et al., 1995) or 
its receptor, IL-7Rα (Maraskovsky et al., 1997; Peschon et al., 1994) have 
reduced number of peripheral T cells. Increasing IL-7 availability, leads to an 
increase in the size of the peripheral T cell pool and favours homeostatic 
proliferation suggesting that in normal lymphoreplete hosts IL-7 limits the size of 
the peripheral T cell pool (Geiselhart et al., 2001; Kieper, 2002). Meanwhile, 
naïve T cell survival in vivo is impaired in absence of IL-7 signalling (Schluns et 
al., 2000; Seddon and Zamoyska, 2002b; Tan et al., 2001; Vivien et al., 2001).  
In addition to cytokine signals, naïve T cells also require TCR interactions with 
spMHC for their survival signal and both CD4 (Bröcker, 1997; Kirberg et al., 
1997; Martin, 2006; Rooke et al., 1997; Takeda et al., 1996; Viret et al., 1999; 
Witherden et al., 2000) and CD8 (Tanchot et al., 1997) T cell survival is 
impaired in absence of MHCII or MHCI, respectively. The spMHC TCR 
interactions required for survival are MHC-restricted and H-2d-restricted TCR 
transgenic CD4 T cells persist after transfer into H-2d mice but not after transfer 
into H-2b mice (Kirberg et al., 1997). The same is true for CD8 T cells and H-
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2Db-restricted HY TCR transgenic CD8 T cells are not maintained after transfer 
into H-2Db-deficient mice (Tanchot et al., 1997). TCR expression is also 
required for the prolonged survival of naïve CD4 and CD8 T cells but is 
dispensable for memory T cell survival (Labrecque et al., 2001; Polic et al., 
2001). Furthermore, transduction of this TCR survival signal also requires 
expression of Src family kinases (Seddon and Zamoyska, 2002a). Fyn or Lck 
alone are sufficient to transduce TCR survival signals but Lck is essential for 
TCR-mediated homeostatic proliferation (Seddon et al., 2000). Basal 
phosphorylation of CD3ζ chains in T cells has been shown to correlate with T 
cell survival and depends on the expression of MHC (Dorfman et al., 2000; 
Witherden et al., 2000) and Src family kinases (Seddon and Zamoyska, 2002a). 
This basal CD3ζ phosphorylation has also been shown to correlate with T cell 
surface CD5 expression (Smith et al., 2001) and is thought to represent the 
transduction of homeostatic TCR survival signals. Zap70 has been shown to 
associate with constitutively phosphorylated CD3ζ (van Oers et al., 1994) yet 
while Fyn can transduce TCR survival signals, it cannot efficiently 
phosphorylate Zap70 (Lovatt et al., 2006).  
In this chapter, we hope to investigate the requirement of Zap70 for the 
transduction of TCR survival signals using F5 Rag1-/- mice expressing dox-
inducible Zap70 on an endogenous Zap70-deficient background. We anticipate 
that transgenic Zap70 expression will overcome the block in T cell development 
in Zap70-/- mice (Negishi et al., 1995). Following dox-withdrawal we then hope 
to study the survival of Zap70-deficient F5 Rag1-/- T cells in vivo. 
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3.2 Results 
3.2.1 Reconstitution of T cell development in F5 TetZap70 mice following 
transgene induction 
Since Zap70-/- mice have a block in T cell development and thus no peripheral T 
cells (Negishi et al., 1995), we used mice that expressed a conditional Zap70 
transgene to study the role of Zap70 in mediating a TCR survival signal in naive 
T cells. Mice that expressed a Zap70 transgene and downstream IRES-hCD2 
tailless reporter under the control of a TRE (Zap70TRE) (Gossen and Bujard, 
1992; Saini et al., 2010; Sinclair et al., 2011) were crossed with mice that 
constitutively expressed rtTA directed to T cells by human CD2 regulatory 
elements (rtTA.ChCD2) (Legname et al., 2000; Zhumabekov et al., 1995). To 
ensure that all Zap70 expression was due to the inducible transgene, these 
mice were further crossed onto an endogenous Zap70-deficient background 
(Negishi et al., 1995). Finally, we crossed these mice with F5 Rag1-/- TCR 
transgenic mice (Mamalaki et al., 1993) generating F5 Rag1-/- Zap70Tre 
rtTA.ChCD2 Zap70-/- (intact F5 TetZap70 mice hereon). F5 Rag1-/- T cells express 
an MHCI H-2Db restricted TCR, which is specific for influenza nucleoprotein 
(NP366-374) of influenza A/NT/60/68. Induction of transgenic Zap70 could then 
be achieved through oral administration of the tetracycline derivative dox (refer 
to Materials and Methods and Figure).  
We initially bred and maintained intact F5 TetZap70 mice constitutively on dox. 
We had difficulty maintaining the strain with this breeding strategy and so we 
used BM from F5 TetZap70 mice to make BM chimeras in sub-lethally irradiated 
B6 Rag1-/- hosts. F5 TetZap70 chimeras were left for 6 weeks on dox to allow 
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reconstitution of their haematopoietic compartment. We observed no significant 
differences in CD8 SP thymocyte number between either intact F5 TetZap70 
mice and F5 TetZap70 chimeras or intact F5 Rag1-/- mice and F5 Rag1-/- 
chimeras (Figure 3.1F) and so both were used in subsequent experiments. 
Whether data comes from intact or chimeric mice will be specified in both the 
relevant results section and figure legends. 
Before characterising the peripheral T cell compartment in F5 TetZap70 mice 
we wanted to describe T cell development in F5 TetZap70 mice. Firstly, we 
wanted to establish whether, like in the polyclonal TetZap70 mice, the TetZap70 
system could lead to dox-inducible transgene expression in F5 TetZap70 mice 
(Saini et al., 2010). To do this we looked at the thymocyte phenotype of 
constitutively dox-fed F5 TetZap70 mice (F5 TetZap70ON hereon) by flow 
cytometry. Indeed, thymocytes from F5 TetZap70 chimeras expressed both 
hCD2 and Zap70 while mice that had never been fed dox, did not (F5 
TetZap70unind hereon) (Figure 3.1A). In fact, the Zap70 abundance in total 
thymocytes from F5 TetZap70ON and F5 Rag1-/- chimeras was similar (Figure 
3.1A). Consistent with previous data (Saini et al., 2010) we observed variegated 
transgene expression with some thymocytes failing to express Zap70 or hCD2 
in F5 TetZap70 chimeras (Figure 3.1A). The proportion of thymocytes that were 
hCD2 positive was 75±6% in intact F5 TetZap70ON mice and 73±11% in the F5 
TetZap70ON chimeras. This transgene variegation could be due to the absence 
of a locus control region (LCR) from the Zap70Tre transgene (reviewed in 
Festenstein and Kioussis, 2000). hCD2 expression correlated well with Zap70 
abundance in F5 TetZap70ON thymocytes as a faithful reporter of Zap70 
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expression (Figure 3.1B). Taken together, these data show dox-inducible Zap70 
expression in vivo in F5 Rag1-/- mice on an endogenous Zap70-/- background. 
Next we wanted to characterise F5 TetZap70 T cell development in some more 
detail. We wanted to confirm that transgenic expression of Zap70 in F5 
TetZap70 was sufficient to allow T cells to develop beyond the developmental 
block seen in Zap70-/- mice (Negishi et al., 1995). We also characterised the 
reconstitution of the DP and CD8 SP compartments in F5 TetZap70 and control 
F5 Rag1-/- thymi (Figure 3.1C). The F5 TCR is MHCI-restricted (Mamalaki et al., 
1993) and so on a Rag1-/- background only CD8 T cells develop in F5 TCR 
transgenic mice. In F5 TetZap70ON chimeras both DP and CD8 SP populations 
were readily detectable and the proportion of CD8 SP developing was 
comparable to F5 Rag1-/- (Figure 3.1C). CD8 SP were only present in the 
hCD2+ fraction of the F5 TetZap70ON thymus and the hCD2- fraction of the 
thymus exhibited a block in T cell development similar to that seen in the thymic 
of Zap70-/- (Negishi et al., 1995) and F5 TetZap70unind mice (Figure 3.1C). To 
investigate T cell development in F5 TetZap70ON chimeras in more detail we 
investigated CD5 and TCR expression within the DP subset. Both the TCR 
(Havran et al., 1987; Pénit et al., 1995; Shortman and Liu, 2002) and CD5 
(Azzam et al., 1998; Tarakhovsky et al., 1995), a negative regulator of TCR 
signalling (Azzam et al., 2001) are upregulated during and after positive 
selection. Previously, three developmentally and phenotypically distinct DP 
thymocyte subsets were described based on CD5 and TCR expression, a CD5lo 
TCRlo DP1, a CD5hi TCRint DP2 and a CD5int TCRhi Dp3 population (Saini et al., 
2010). We can readily observe these three DP subsets while the DP 
thymocytes in the F5 TetZap70unind and the hCD2- F5 TetZap70ON fraction were 
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blocked at the CD5lo TCRlo DP1 stage of development (Figure 3.1C). 
Interestingly, the CD5 expression on F5 TetZap70ON DP thymocytes does not 
seem to be upregulated to the same extent as on F5 Rag1-/- DP thymocytes 
(Figure 3.1D) while TCR expression on F5 TetZap70ON DP thymocytes does 
reach the level of F5 Rag1-/- DP thymocytes (Figure 3.1D). Furthermore, unlike 
F5 Rag1-/- thymocytes, F5 TetZap70ON thymocytes did not downregulate 
surface CD5 expression as they transited from the DP2 to DP3 subset (Figure 
3.1C). Inducible expression of Zap70, thus, was sufficient to allow normal DP 
and CD8 SP T cell development in F5 TetZap70unind mice although the 
regulation of CD5 expression on F5 TetZap70ON DP thymocytes was altered 
compared to F5 Rag1-/-. 
We also wanted to characterise Zap70 and hCD2 transgene expression by the 
DP thymocyte subpopulations in F5 TetZap70ON chimeras. Previously, it was 
shown that Zap70 abundance is upregulated during positive selection of DP 
thymocytes in WT C57Bl/6, with the highest DP Zap70 expression in the CD5int 
TCRhi DP3 subset (Saini et al., 2010). In fact, this Zap70 upregulation, was 
shown to be very important for CD8 T cell development in particular. In 
polyclonal TetZap70 mice, thymocytes fail to upregulate Zap70, which leads to 
a specific defect in CD8 development (Saini et al., 2010). Like DP thymocytes in 
WT C57Bl/6 mice, F5 Rag1-/- thymocytes upregulate Zap70 as they mature but 
DP thymocytes in F5 TetZap70ON chimeras do not (Figure 3.1E). In fact, Zap70 
abundance dropped in the most mature DP3 subset compared to the DP1 and 
DP2 subsets (Figure 3.1E). This is not inconsistent with data from other models 
using the TRE-dependent transgene expression (Buentke et al., 2006; Seddon 
and Zamoyska, 2002a; 2002b). We wanted to examine whether this failure to 
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upregulate Zap70 during positive selection had any effect on T cell development 
in F5 TetZap70 chimeras. We did this by looking at the overall number of CD8 
SP thymocytes in F5 TetZap70ON compared to F5 TetZap70unind and F5 Rag1-/- 
(Figure 3.1F). Indeed, F5 TetZap70ON chimeras had significantly fewer CD8 SP 
thymocytes than F5 Rag1-/- mice (Figure 3.1F and (Saini et al., 2010)). 
Collectively, these data show that inducible Zap70 expression can rescue T cell 
development in F5 TetZap70 mice and chimeras but fewer CD8 SP develop in 
intact F5 TetZap70ON mice and chimeras. 
3.2.2 Reconstitution of the peripheral T cell compartment in F5 TetZap70 
mice following transgene induction 
We next wanted to characterise the reconstitution of the peripheral T cell 
compartment in F5 TetZap70ON chimeras. We found that dox-feeding of F5 
TetZap70 chimeras rescued the peripheral T cell compartment (Figure 3.2). 
Both intact F5 TetZap70ON mice and chimeras had a readily detectable 
population of CD8+ TCR+ peripheral T cells in both the LN and spleen (Figure 
3.2A and B). F5 TetZap70unind mice had no mature peripheral CD8 T cells 
(Figure 3.2A and B). Interestingly, the reconstitution of the spleen in intact and 
chimeric F5 TetZap70ON mice was poor and variable compared to the 
reconstitution of CD8 T cells in the LN (Figure 3.2A and B). We found again that 
there were no significant differences in peripheral T cell number between intact 
and chimeric F5 Rag1-/- and F5 TetZap70ON mice (Figure 3.2B). Meanwhile, F5 
TetZap70ON mice had significantly more peripheral CD8 T cells than F5 
TetZap70unind mice (Figure 3.2B). Together these data show that constitutive 
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dox-feeding successfully reconstitutes the periphery of F5 TetZap70 mice but 
that F5 TetZap70ON have fewer peripheral CD8 T cells than F5 Rag1-/- mice. 
We next assessed peripheral Zap70 and hCD2 transgene expression. Naïve 
CD8 T cells from F5 TetZap70ON chimeras expressed only slightly higher hCD2 
than F5 Rag1-/- T cells (Figure 3.2C). Meanwhile, Zap70 abundance in F5 
TetZap70ON T cells was much lower than in F5 Rag1-/- T cells (Figure 3.2C). 
Low peripheral transgene expression has previously been described in other 
TRE-dependent transgene models (Buentke et al., 2006; Seddon and 
Zamoyska, 2002a; 2002b). Both hCD2 expression and Zap70 abundance were 
dox-dependent however, since we observed no transgene expression in F5 
TetZap70 T cells from chimeras that had been taken off dox ≥5 days previously  
(F5 TetZap70OFF chimeras hereon) (Figure 3.2C). Together, these data indicate 
that both Zap70 and hCD2 are expressed in a dox-dependent manner in T cells 
in F5 TetZap70ON chimeras albeit at a lower level than in thymocytes. 
Since surface CD5 expression on mature T cells has been linked to homeostatic 
TCR signalling in naïve T cells (Saini et al., 2009; Smith et al., 2001), we 
wanted to characterise CD5 expression on F5 TetZap70ON T cells. Consistent 
with the view that F5 TCR transgenic T cells have low affinity for spMHC (Ge et 
al., 2004), peripheral F5 Rag1-/- T cells did indeed express lower CD5 than CD8 
T cells from WT C57Bl/6 mice (Figure 3.2D) (Sinclair et al., 2011). F5 
TetZap70ON T cells expressed an even lower level of CD5 than F5 Rag1-/- T 
cells even though F5 TetZap70ON and F5 Rag1-/- expressed only slightly 
different levels of TCR (Figure 3.2D). Interestingly, CD8 T cells in F5 
TetZap70OFF chimeras expressed even lower CD5 than F5 TetZap70ON T cells 
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(Figure 3.2D), suggesting that F5 TetZap70OFF, F5 TetZap70ON and F5 Rag1-/- T 
cells receive different homeostatic TCR signals (Saini et al., 2009; Sinclair et al., 
2011). It also suggests that despite the very low levels of Zap70 expression F5 
TetZap70ON T cells receive more homeostatic TCR signals than F5 
TetZap70OFF T cells. 
3.2.3 Kinetics of transgene ablation following dox-withdrawal 
Before studying the effect of Zap70 ablation on naïve T cell survival in F5 
TetZap70 mice and chimeras, we wanted to characterise the kinetics of Zap70 
and hCD2 decay after dox-withdrawal. We did this by analysing the expression 
of hCD2 and abundance of Zap70 in thymocytes and T cells from F5 Rag1-/-, F5 
TetZap70ON and F5 TetZap70OFF chimeras (Figure 3.3). hCD2 expression in F5 
TetZap70OFF thymocytes dropped 1 day following dox-withdrawal (Figure 3.3A). 
By day 3 most, and by day 7 almost all thymocytes no longer expressed hCD2 
(Figure 3.3A). We observed a similar but more rapid reduction of Zap70 
abundance in F5 TetZap70OFF thymocytes following dox-withdrawal. In fact, 
most F5 TetZap70OFF thymocytes appeared to be Zap70-deficient by day 5, as 
assessed by flow cytometry (Figure 3.3A). In the LN we detected a loss of 
hCD2 expression by day 3 following dox-withdrawal (Figure 3.3B). Zap70 
abundance in F5 TetZap70OFF T cells dropped by day 2 and was almost 
undetectable by day 5 following dox-withdrawal. Differences in protein turnover 
might account for the loss of Zap70 before hCD2 in both the LN and the thymus.  
3.2.4 F5 TetZap70 fail to persist in the absence of Zap70 induction 
Naïve T cell survival in lymphoreplete animals is dependent on TCR signals 
(Labrecque et al., 2001; Polic et al., 2001; Seddon and Zamoyska, 2002a; 
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Witherden et al., 2000). Despite its role in transducing TCR signals, Lck 
deficiency alone does not lead to a survival defect in naïve T cells (Seddon et 
al., 2000). Only when both Src family kinases, Fyn and Lck, are ablated, a 
defect in naïve T cell survival becomes apparent (Seddon and Zamoyska, 
2002a). We wanted to investigate the role of Zap70, activated downstream of 
Lck and Fyn, in naïve T cell survival. Transgenic Zap70 expression rescued T 
cell development and reconstituted the peripheral T cell compartment in F5 
TetZap70ON mice and chimeras (Figure 3.1 and 2). We took a cohort of F5 
TetZap70 mice off dox and followed the frequency of naïve CD8 T cells in the 
blood of these mice (Figure 3.4) to assess the effect of Zap70 ablation on naïve 
T cell survival. The frequency of CD8 T cells in the blood of intact F5 
TetZap70ON mice was lower than in F5 Rag1-/- mice. To be able to compare 
between groups, we normalised the frequency of blood T cells to the starting 
frequency at d0. Following dox-withdrawal we observed a dramatic drop in the 
frequency of CD8 T cells in intact F5 TetZap70OFF mice and chimeras (Figure 
3.4B and C). Interestingly, in both cases the drop in the frequency of CD8 T 
cells in the blood seemed to slow down and reach a plateau (Figure 3.4B and 
C). We performed non-linear one-phase decay fits to six independent time-
courses using intact F5 TetZap70 mice and F5 TetZap70 chimeras to determine 
that the half-life of F5 TetZap70OFF T cells was 9.4±3.4 days. The decrease in 
CD8 T cells in the blood was replicated in the LN (Figure 3.4B and D). Taken 
together these data show that Zap70 is crucial for F5 TetZap70 T cell 
maintenance in vivo. 
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3.2.5 F5 TetZap70OFF T cells do not survive upon adoptive transfer  
The loss of peripheral CD8 T cells in F5 TetZap70OFF mice, in addition to the 
block in T cell development are likely to make F5 TetZap70OFF mice and 
chimeras progressively more lymphopaenic the longer they are off dox. Since 
competition for limiting survival factors, like IL-7, is an important mechanism by 
which the peripheral T cell pool is maintained at a constant size (reviewed in 
Freitas and Rocha, 2000) we predicted that the survival of F5 TetZap70OFF T 
cells might be altered in these lymphopaenic conditions. To characterise the 
survival of F5 TetZap70OFF T cells in lymphoreplete conditions, we transferred 
(Ly5.2) F5 TetZap70OFF and Ly5.1 F5 Rag1-/- T cells into Ly5.1 Ly5.2 F5 Rag1-/- 
hosts and assessed their relative survival 1, 7 and 14 days after transfer (Figure 
3.5A and B). The ratio of donor Ly5.1+ to Ly5.2+ CD8 T cells dropped 
dramatically in the LN of Ly5.1 Ly5.2 F5 Rag1-/- hosts so that the overwhelming 
majority of donor T cells in Ly5.1 Ly5.2 F5 Rag1-/- hosts were Ly5.1+ F5 Rag1-/- 
T cells by day 14 (Figure 3.5A and B). These data clearly demonstrate a 
survival defect in F5 TetZap70OFF T cells compared to WT F5 Rag1-/- T cells in 
lymphoreplete conditions. 
Considering the clonal competition for spMHC in F5 Rag1-/- (Ge et al., 2004; 
Hao, 2006; Moses et al., 2003; Troy and Shen, 2003) we also wanted to 
examine the survival of F5 TetZap70 T cells after transfer into OT-I Rag1-/- hosts. 
We followed donor F5 Rag1-/- and F5 TetZap70 T cells in the blood of OT-I 
Rag1-/- mice by expression of Vβ11 by donor CD8 T cells and Vα2 by 
endogenous CD8 T cells. Interestingly, despite reduced clonal competition, both 
F5 Rag1-/- and F5 TetZap70 T cells disappeared rapidly in OT-I Rag1-/- hosts, 
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although F5 TetZap70 T cells disappeared more rapidly than F5 Rag1-/- T cells 
(Figure 3.5C). It is thought that OT-I TCR transgenic T cells have higher affinity 
for spMHC than F5 TCR transgenic T cells (Ge et al., 2004; Sinclair et al., 2011), 
reflected in the difference in CD5 expression between F5 Rag1-/- and OT-I 
Rag1-/- T cells (Figure 3.5D and E). Meanwhile, the level of IL-7Rα expression 
on OT-I Rag1-/- T cells is also higher than on F5 Rag1-/- and F5 TetZap70 T 
cells (Figure 3.5D and E). F5 Rag1-/- and F5 TetZap70 T cells are likely 
outcompeted by OT-I Rag1-/- T cells for IL-7 survival signals. Clearly, F5 
TetZap70OFF T cells have a survival defect compared to F5 Rag1-/- T cells but 
our data also confirm the non-redundant role of IL-7 signals for naïve CD8 T cell 
survival. 
3.2.6 F5 TetZap70ON thymocytes are outcompeted in mixed F5 Rag1-/- F5 
TetZap70 chimeras 
To identify specific blocks in F5 TetZap70 development and survival throughout 
development, we generated competitive mixed BM chimeras, reconstituted with 
a mix of F5 Rag1-/- and F5 TetZap70 BM. Sub-lethally irradiated B6 Rag1-/- 
hosts were reconstituted with a 1:10 mix of Ly5.1 F5 Rag1-/- and (Ly5.2) F5 
TetZap70 BM and then left for 6 weeks on dox before we assessed the 
representation of the two sets of donor BM at various stages of T cell 
development (Figure 3.6). Despite reconstituting mice with 1:10 ratio of F5 
Rag1-/- and F5 TetZap70 BM, 77% of CD5lo TCRlo DP1 were Ly5.1- (Figure 3.6B 
and C). The ratio of Ly5.1- to Ly5.1+ cells dropped further in the DP3 population 
where only 40% of cells were Ly5.1- (Figure 3.6B and C). The representation of 
F5 TetZap70 cells dropped even more as cells became CD8 single positive 
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thymocytes and downregulated their HSA expression (Figure 3.6B and C). 
Ly5.1- F5 TetZap70 cells were barely detectable in the periphery of these mixed 
BM chimeras (Figure 3.6B and C). Analysis of RTE markers by flow cytometry 
revealed that, Ly5.1- F5 TetZap70ON T cells in mixed BM chimeras expressed 
lower IL-7Rα and higher HSA than to F5 Rag1-/- T cells in the same host (Figure 
3.6D) suggesting that peripheral Ly5.1- F5 TetZap70 were largely RTEs.  
3.2.7 Periphery of F5 TetZap70ON is enriched for RTEs 
In mixed F5 Rag1-/- F5 TetZap70ON BM chimeras the majority of peripheral 
Ly5.1- F5 TetZap70 T cells were phenotypically similar to RTEs suggesting that 
F5 TetZap70 RTEs failed to integrate into the mature naïve T cell pool. To 
assess whether F5 TetZap70 RTEs similarly failed to integrate into the mature 
naïve T cell pool in absence of competing F5 Rag1-/- we assessed HSA, Qa2 
and CD45RB expression on CD8 T cells in F5 TetZap70ON chimeras (Figure 
3.7). HSA is downregulated on thymocytes as they leave the thymus, whereas 
Qa2 and CD45RB are upregulated (Boursalian et al., 2004; Kelly and Scollay, 
1990; Lee et al., 2001). CD8 T cells from F5 TetZap70ON chimeras expressed 
lower Qa2 and CD45RB and higher HSA than F5 Rag1-/- T cells (Figure 3.7A) 
suggesting that, compared to F5 Rag1-/- mice, the peripheral T cell 
compartment of F5 TetZap70ON chimeras, is enriched for immature RTEs. 
To quantify and compare the enrichment of RTEs in F5 Rag1-/- and F5 
TetZap70ON chimeras we defined HSAhi, HSAint and HSAlo CD8 T cell 
populations. This analysis revealed a specific enrichment of HSAint CD8 T cells 
in the LN of F5 TetZap70ON chimeras (Figure 3.7B). Similar analysis of Qa2 
expression showed that Qa2int CD8 T cells were enriched in the LN of F5 
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TetZap70ON compared to F5 Rag1-/- chimeras (Figure 3.7B). Together, these 
data show that the peripheral compartment of F5 TetZap70ON chimeras is 
enriched for less mature HSAint Qa2int T cells compared to F5 Rag1-/-.  
3.2.8 In vivo homing of F5 TetZap70OFF T cells to LN and spleen 
Considering the evidence that many important survival signals for naïve T cells 
are provided in SLOs (Dai and Lakkis, 2001; Dummer et al., 2001; Link et al., 
2007) and that Zap70 might be involved in the transduction of T cell migration 
signals independent of TCR signalling (Evans et al., 2011) we wanted to assess 
whether homing of F5 TetZap70OFF T cells was normal. To do this we co-
transferred a mix of Ly5.1 F5 Rag1-/- and (Ly5.2) F5 TetZap70OFF T cells into a 
Ly5.1 L5.2 F5 Rag1-/- mouse and analysed the presence of Ly5.1+ or Ly5.2+ 
donor cells in the blood, LNs and spleen of recipients by flow cytometry after 60 
and 150 minutes (Figure 3.8). Both Ly5.1+ F5 Rag1-/- and Ly5.2+ F5 
TetZap70OFF T cells were readily detectable in the blood and spleen of Ly5.1 
Ly5.2 F5 Rag1-/- recipients 60 min after transfer (Figure 3.10B, C and D). 150 
min after transfer, we detected both Ly5.1+ F5 Rag1-/- and Ly5.2+ F5 
TetZap70OFF T cells in the LN of recipients (Figure 3.10B). We detected no 
significant difference in the number of donor Ly5.1+ and Ly5.2+ CD8 T cells in 
the LN or spleen of recipients either 60 or 150 min after transfer (3.9D). 
Furthermore, the ratio of F5 Rag1-/- to F5 TetZap70OFF donor cells at 150 min 
was 0.94±0.30 in the LN and 1.49±0.17 in the spleen (Figure 3.10C) suggesting 
that F5 TetZap70OFF T cells homed to SLOs as efficiently as F5 Rag1-/- cells.   
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3.2.9 F5 TetZap70OFF T cells survive but do not proliferate in vivo 
Next, we examined the ability of F5 TetZap70OFF T cells to transduce IL-7 
survival signals in vivo. We did this by transferring (Ly5.2) F5 TetZap70 and 
Ly5.1 F5 Rag1-/- cells into B6 Rag1-/- mice. B6 Rag1-/- mice lack any B or T cells 
(Mombaerts et al., 1992) and as a consequence there should be little 
competition for T cell survival factors in these mice. F5 Rag1-/- T cells proliferate 
after transfer into lymphopaenic hosts (Buentke et al., 2006; Ge et al., 2004; 
Hogan et al., 2013; Saini et al., 2009; Seddon and Zamoyska, 2002b; Yates et 
al., 2008) and in order to differentiate between proliferation and survival of F5 
TetZap70OFF and F5 Rag1-/- donor cells we labelled cells with CTV (Lyons, 
2000). As previously described, F5 Rag1-/- T cells proliferated in B6 Rag1-/- 
recipients as determined by their dilution of CTV (Figure 3.9A). None of the 
donor F5 TetZap70OFF T cells proliferated, however (Figure 3.9A) reflecting the 
importance of intact TCR signalling for homeostatic proliferation (Seddon et al., 
2000). Interestingly, Ly5.1- F5 TetZap70OFF T cells remained readily detectable 
in the LN of B6 Rag1-/- recipients up to 14 days after transfer (Figure 3.9B). 
Analysing precursor populations normalised for proliferation revealed little 
difference in survival between F5 Rag1-/- and F5 TetZap70OFF T cells (Figure 
3.9C). Consistent with the idea that reduced competition for IL-7 survival signals 
in B6 Rag1-/- would lead to F5 Rag1-/- and F5 TetZap70OFF T cells receiving 
more IL-7 signals in B6 Rag1-/- we detected an increase in IL-7Rα expression 7 
days after transfer (Figure 3.9E). Together these data suggest that, in 
lymphopaenic conditions, when IL-7 is non-limiting, F5 TetZap70OFF T cells are 
able to persist as well as F5 Rag-/- cells. 
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To test whether the survival defect of naïve F5 TetZap70OFF T cells was IL-7-
dependent we co-transferred Ly5.1 F5 Rag1-/- and (Ly5.2) F5 TetZap70 T cells 
into IL-7-/- Rag1-/- mice to assess the relative importance for naïve F5 Rag1-/- T 
cells of losing both the IL-7Rα and the TCR survival signal (Figure 3.9D). 
Interestingly, analysis of the ratio of Ly5.1+ to Ly5.1- F5 Rag1-/- T cells revealed 
that Ly5.1- F5 TetZap70OFF T cells disappeared more rapidly than Ly5.1+ F5 
Rag1-/- T cells (Figure 3.9D). Consistent with transferred T cells not receiving 
any IL-7 signals in IL-7-/- Rag1-/-, IL-7Rα expression on F5 Rag1-/- and F5 
TetZap70OFF T cells was increased 3 days after transfer (Figure 3.9F). 
Collectively, these data demonstrate that Zap70-deficiency causes a survival 
defect in naïve F5 Rag1-/- T cells that impairs their survival even more than IL-7-
deficiency alone does. 
3.2.10 Bmf expression is upregulated in F5 TetZap70OFF T cells 
Naïve T cells require spMHC TCR interactions for their survival (Labrecque et 
al., 2001; Polic et al., 2001; Seddon and Zamoyska, 2002a; Seddon et al., 2000; 
Takeda et al., 1996; Tanchot et al., 1997; Viret et al., 1999; Wang et al., 2001; 
Witherden et al., 2000) but the downstream targets of this TCR survival signal 
have not been characterised. We used F5 TetZap70OFF T cells to investigate 
TCR gene regulation in F5 Rag1-/- T cells by RNA-sequencing. We compared 
gene expression patterns in FACS-purified CD8+ TCR+ T cells from F5 Rag1-/- 
and F5 TetZap70OFF chimeras. First, we characterised Zap70 and Cd5 mRNA 
levels, since protein levels of Zap70 and CD5 were reduced in F5 TetZap70OFF 
T cells compared to F5    Rag1-/- T cells (Figure 3.1-4). Indeed, Zap70 and Cd5 
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mRNA levels were reduced in F5 TetZap70OFF T cells compared to F5 Rag1-/- T 
cells (Figure 3.10A).  
Next, we characterised mRNA expression of Bcl-2 family members. Bcl-2, Mcl-1 
and Bax have been proposed to be downstream targets of IL-7 signalling. 
Furthermore, the ratio of pro- and anti-apoptotic members of the Bcl-2 family 
members is thought to be critical in the regulation of lymphocyte survival and 
death (reviewed in Opferman and Korsmeyer, 2003; Wojciechowski et al., 2007). 
Interestingly, both Bcl2 and Bcl2l1 mRNA expression were slightly increased in 
F5 TetZap70OFF T cells compared to F5 Rag1-/- T cells (Figure 3.10B). 
Expression of most Bcl-2 family members, including Bcl2 and Bcl2l1 did not 
differ more than 2-fold between F5 TetZap70OFF T cells and F5 Rag1-/- T cells 
(Figure 3.10B). Interestingly, Bmf mRNA expression was increased 14-fold in 
F5 TetZap70OFF T cells compared to F5 Rag1-/- T cells (Figure 3.10B). 
Collectively, these data show that Zap70 and Cd5 mRNA levels correlate with 
Zap70 and CD5 protein levels in F5 Rag1-/- and F5 TetZap70OFF T cells. These 
data also reveal a putative downstream target for TCR survival signals in Bmf, 
which is upregulated in F5 TetZap70OFF T cells compared to F5 Rag1-/- T cells. 
3.3 Discussion 
Naïve CD8 T cells require signals via the TCR for their survival (Labrecque et 
al., 2001; Polic et al., 2001; Seddon and Zamoyska, 2002a; Seddon et al., 2000; 
Takeda et al., 1996; Tanchot et al., 1997; Viret et al., 1999; Wang et al., 2001; 
Witherden et al., 2000) but the exact nature and downstream targets of this 
survival signal remain unclear. In this chapter, we sought to characterise the 
role of Zap70 in naïve T cell survival. Since Zap70-/- lack any peripheral T cells 
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due to a block in T cell development (Negishi et al., 1995) we used a transgenic 
mouse model where Zap70 expression was conditional upon dox-feeding. Dox-
inducible expression of Zap70 in the thymus of F5 TetZap70 mice overcomes 
the block in T cell development seen in Zap70-deficient mice and leads to the 
generation of mature naïve F5 Rag1-/- T cells in which Zap70 expression can be 
ablated by dox-withdrawal. Despite conditional expression of Zap70 at levels 
comparable to F5 Rag1-/-, constitutively dox-fed F5 TetZap70 mice and 
chimeras had fewer developing CD8 SP thymocytes and reduced peripheral 
CD8 T cells compared to F5 Rag1-/-. The defect in F5 TetZap70 T cell 
development was more obvious in mixed F5 Rag1-/- F5 TetZap70 BM chimeras, 
where F5 TetZap70 thymocytes were almost completely outcompeted by 
developing F5 Rag1-/- thymocytes by the time they left the thymus. Also, F5 
TetZap70ON T cells in the LN and spleen of mixed chimeras were almost all 
immature RTEs. Interestingly, peripheral F5 TetZap70 T cells in intact F5 
TetZap70ON chimeras were also consistently enriched for RTEs. We showed 
that Zap70 was required for naïve T cell survival both in intact F5 TetZap70 
mice and chimeras as well as after transfer into F5 Rag1-/- mice. Ablation of 
Zap70 in F5 TetZap70 T cells, correlated with a reduction in surface CD5 
expression, which was already reduced on F5 TetZap70 compared to F5 Rag1-/- 
T cells. IL-7R signalling was intact in F5 TetZap70OFF T cells, which survived in 
conditions where IL-7 was non-limiting. The survival defect of F5 TetZap70OFF T 
cells was also not secondary to a defect in IL-7R signalling since in absence of 
IL-7, F5 TetZap70OFF T cells still died more rapidly than Zap70-sufficient cells. 
Finally, mRNA of the pro-apoptotic Bmf was upregulated in F5 TetZap70OFF T 
cells making it a putative target for a Zap70 dependent TCR survival signal.  
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Impaired development of T cells in absence of endogenous regulation of Zap70 
expression in polyclonal TetZap70 mice has been previously described (Saini et 
al., 2010). In WT C57Bl/6 mice, Zap70 abundance and expression is 
progressively upregulated as thymocytes mature and undergo positive selection. 
Failure of Zap70 upregulation in transgenic TetZap70 mice leads to a specific 
defect in CD8 T cell development (Saini et al., 2010). The defect in CD8 T cell 
development in F5 TetZap70 mice (Figure 3.1C and F) is consistent with the 
loss of endogenous upregulation of Zap70 in DP thymocytes. In fact, Zap70 
abundance in F5 TetZap70 DP thymocytes first remains constant and then 
drops in the most mature DP thymocytes and CD8 SP thymocytes (Figure 3.1E). 
We generated mixed F5 Rag1-/- F5 TetZap70 BM chimeras to compare the 
selection efficiency and survival of F5 Rag1-/- and F5 TetZap70ON thymocytes at 
various developmental stages. Analysing the representation of Ly5.1- F5 
TetZap70 thymocytes revealed that developing Ly5.1- F5 TetZap70 T cells were 
outcompeted by F5 Rag1-/- thymocytes throughout development. The proportion 
of Ly5.1- F5 TetZap70 thymocytes dropped in the DP3, CD8 SP HSAlo and 
peripheral CD8 T cells, in particular (Figure 3.6B and C). These data fit with a 
model in which the developmental upregulation of Zap70 in DP2 and DP3 
thymocytes and CD8 SP thymocytes is necessary for the efficient generation of 
CD8 SP thymocytes (Saini et al., 2010). We cannot exclude that, at least in the 
periphery of F5 TetZap70ON mice and chimeras, a defect in proliferation 
contributes to the observed lymphopaenia (Figure 3.2B) since F5 TetZap70ON T 
cells fail to proliferate after transfer into lymphopaenic hosts (data not shown) 
and are therefore unlikely to do so in more lymphoreplete F5 TetZap70ON mice 
and chimeras. 
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Like Zap70, CD5 and TCR expression are upregulated during and after positive 
selection and this developmental upregulation requires Zap70 (Negishi et al., 
1995; Otsu et al., 2002). CD5 expression is further modulated by TCR signalling 
in the thymus and periphery and is thought to correlate with TCR avidity for 
spMHC (Azzam et al., 1998; 2001; Smith et al., 2013; Wong et al., 2001). 
Interestingly, F5 TetZap70 DP thymocytes did not upregulate CD5 to the same 
degree as F5 Rag1-/- DP thymocytes (Figure 3.1C and D). Furthermore, while 
surface CD5 expression is downregulated as thymocytes become DP3 
thymocytes, F5 TetZap70ON DP2 and DP3 thymocytes expressed similar levels 
of CD5 (Figure 3.1C). Finally, naïve F5 TetZap70 T cells also expressed lower 
surface CD5 than did F5 Rag1-/- T cells. The reduction in CD5 expression on DP 
thymocytes and on peripheral T cells correlated with the reduction in Zap70 
abundance on DP3 thymocytes and peripheral F5 TetZap70 T cells suggesting 
Zap70 might transduce the TCR signals that modulate CD5 expression during 
positive selection and in peripheral T cells. The modulation of CD5 expression 
by TCR signalling in the thymus as well as the periphery is known to require Lck, 
which is upstream of Zap70 in the TCR signalling cascade and so a role for 
Zap70 is likely. 
Despite the partial block in CD8 T cell development and the low Zap70 
abundance and CD5 expression by F5 TetZap70ON T cells, dox-inducible Zap70 
expression in F5 TetZap70ON mice was able to restore T cell development to 
allow the generation of F5 TetZap70ON T cells (Figure 3.1 and 2). These CD8 T 
cells were then used to investigate the role of Zap70 in naïve T cell survival. 
Naïve T cells in intact F5 TetZap70OFF mice and chimeras disappeared with a 
half-life of 9.4±3.4 days (Figure 3.4A and C). We also showed an overall 
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reduction in the frequency and number of naïve T cells in F5 TetZap70OFF mice 
(Figure 3.4B and D). It could be argued that the observed drop in naïve F5 
TetZap70OFF T cells was the result of loss of thymic input into the peripheral 
pool of naïve T cells in F5 TetZap70 mice lacking any Zap70 expression. 
However, naïve F5 Rag1-/- T cells persisted for much longer than F5 
TetZap70OFF T cells after transfer into F5 Rag1-/- hosts (Figure 3.5A and B). 
This experiment allowed us to compare directly the survival of a cohort of 
Zap70-deficient and Zap70-sufficient F5 Rag1-/- T cells in lymphoreplete 
conditions and in absence of any thymic input. The disappearance of F5 
TetZap70OFF T cells in F5 Rag1-/- hosts confirmed that Zap70 was required for 
the maintenance of naïve F5 Rag1-/- T cells. The persistence of naïve F5 Rag1-/- 
T cells after transfer is consistent with the view that naïve T cells have a 
relatively long lifespan of ~90 days (Seddon and Zamoyska, 2002a). The 
relatively long lifespan further supports the idea that the 9.4-day average half-
life of F5 TetZap70OFF T cells is the result of impaired naïve T cell survival and 
not merely the consequence of the loss of thymic input. Interestingly, the 9.4-
day half-life of naïve T cells in absence of Zap70 is shorter than previous 
estimates of naïve CD8 T cell lifespan in absence of TCR signalling – 16 (Polic 
et al., 2001) and 19 (Labrecque et al., 2001) days following TCR ablation and 
18 days following Lck and Fyn ablation (Seddon and Zamoyska, 2002a). This 
variability is probably due to the different experimental systems used in these 
studies but might also mean that Zap70 transduces naïve T cell survival signals 
independent of MHC, TCR and Src family kinases.   
Since both Zap70, and Src family kinases, Lck and Fyn upstream of Zap70, can 
be activated independently of TCR activation (Adunyah et al., 1997; Brenner et 
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al., 1996; Evans et al., 2011; Hatakeyama et al., 1991; Kobayashi et al., 1993; 
Minami et al., 1993; Parravicini et al., 2002; Raab et al., 1995; Schmedt et al., 
1998; Taher et al., 1996; Wary et al., 1998) it is possible that the effect of 
Zap70-deficiency on naïve T cell survival is TCR-independent. Interestingly, we 
consistently detected less CD5 on F5 TetZap70ON and F5 TetZap70OFF T cells 
than on F5 Rag1-/- T cells (Figure 3.2D). CD5 expression on naïve T cells 
correlates with TCR affinity for spMHC (Azzam et al., 1998; Smith et al., 2001) 
and requires TCR expression (Polic et al., 2001), spMHC-contact (Saini et al., 
2009; Sinclair et al., 2011; Smith et al., 2001) and Lck- and Fyn-expression 
(Seddon and Zamoyska, 2002a). The reduced CD5 on F5 TetZap70ON and F5 
TetZap70OFF T cells, therefore, reflect reduced homeostatic TCR signalling.  
Furthermore, T cell CD5 expression in Lck- and Fyn-deficient mice correlates 
with survival (Seddon and Zamoyska, 2002a), as it does in our study. Finally, 
CD5 expression on naïve T cells was also found to correlate with the degree of 
CD3ζ–chain phosphorylation (Smith et al., 2001). Basal CD3ζ–chain 
phosphorylation is MHC-dependent in vitro (Smith et al., 2001) and in vivo 
(Dorfman et al., 2000; Witherden et al., 2000), it correlates with expression of 
Lck and Fyn (Seddon and Zamoyska, 2002a) and naïve T cell survival (Seddon 
and Zamoyska, 2002a; Witherden et al., 2000). There is also evidence that, like 
surface CD5 expression, basal CD3ζ–chain phosphorylation correlates with 
TCR avidity for spMHC suggesting the phosphorylation of CD3ζ arises from 
TCR interactions with spMHC (Dorfman et al., 2000). Interestingly, in this 
(Dorfman et al., 2000) and another study (Clarke and Rudensky, 2000), naïve 
CD4 T cell survival was unaffected after transfer into an Aβ-/- MHCII-deficient 
host and the partial phosphorylation of CD3ζ was proposed to be a mechanism 
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to increase sensitivity to TCR signalling rather than play a role in the 
transduction of a TCR survival signal (Stefanova et al., 2003). Subsequently, it 
was shown, however, that Aβ-/- mice are not truly MHCII-deficient (Martin et al., 
2003) and hybrid AαEβ MHCII in Aβ-/- mice might be able to promote T cell 
turnover or survival. CD4 T cell survival was indeed impaired after transfer into 
mice that lack the α and β chains of both I-A and I-E MHCII alleles (Madsen et 
al., 1999; Martin, 2006). Overall, our data show that Zap70 is crucial for naïve T 
cell survival and they suggest that the effect of Zap70-deficiency on naïve F5 T 
cell survival is TCR-dependent and MHCI-dependent. 
Although our data suggest that naïve F5 TetZap70OFF T cells home normally to 
peripheral lymphoid organs (Figure 3.10), there is evidence that Zap70 
regulates β1-integrin expression (Epler et al., 2000; Goda et al., 2004) and 
plays an important role in regulating T cell adhesion and migration by regulating 
LFA1 expression TCR independently (Evans et al., 2011). In one study (Evans 
et al., 2011), inhibition or siRNA-mediated knockdown of Zap70 and Lck in vitro,  
impaired T cell motility and migration on ICAM1. Interestingly, another study 
could only find a role for Lck in mediating LFA1-dependent T cell-B cell 
conjugates (Morgan et al., 2001). More recent work revealed that the kinase 
function of Zap70 was dispensable for adhesion to ICAM1 in vitro but that its 
adaptor function was not (Au-Yeung et al., 2010). The regulation of LFA1 and 
β1-integrin expression are clearly important for naïve T cell homing and 
migration to SLOs and therefore for naïve T cell survival (Dai and Lakkis, 2001; 
Dummer et al., 2001; Link et al., 2011) as well as for T cell-APC interactions 
and, consequently, for T cell activation and expansion (reviewed in Dustin and 
de Fougerolles, 2001). One criticism of many of the studies investigating the 
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role of Zap70 and Src family kinases in the regulation of integrin expression and 
activity is the fact that they are all largely carried out in vitro. F5 TetZap70OFF T 
cells might be used to study the role of Zap70 in T cell adhesion, homing and 
migration in vivo. 
The data in this chapter also suggest a potential role for Zap70 in regulating 
integration of RTE into the mature naïve T cell pool. We showed that in mixed 
F5 Rag1-/- and F5 TetZap70 BM chimeras, F5 TetZap70ON T cells were being 
outcompeted during positive selection but most especially after thymic egress, 
as they become mature naïve T cells (Figure 3.6B and 6). Peripheral Ly5.1- F5 
TetZap70ON T cells in these mixed BM chimeras were RTEs as defined by their 
low IL-7Rα and high HSA expression. One explanation for these data is that the 
poor survival of mature naïve F5 TetZap70ON T cells relative to F5 Rag1-/- T 
cells in the periphery leads to the outcompetition of F5 TetZap70ON T cells by 
F5 Rag1-/- T cells. Furthermore, naïve F5 TetZap70ON T cells fail to 
homeostatically proliferate in lymphopaenic hosts (data not shown) and this 
proliferative defect is likely to contribute to the outcompetition of F5 TetZap70ON 
by F5 Rag1-/- naïve T cells in the periphery of mixed BM chimeras. This data 
also suggests that the maintenance of RTEs is less dependent on Zap70 than 
the survival of naive F5 Rag1-/- T cells. Surprisingly, we also found that the 
peripheral compartment of host F5 TetZap70ON chimeras was enriched for 
RTEs (Figure 3.7). F5 TetZap70ON mice and chimeras consistently had a higher 
proportion of HSAint and Qa2int T cells and expressed lower CD45RB (Figure 
3.7A and B). These data, again, support the idea that the maintenance of naïve 
T cells is Zap70-dependent, whereas the maintenance of RTEs is less so. 
Using mice that express GFP under control of the Rag2 promotor, cells that 
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recently expressed Rag2 in the thymus were tracked and characterised as they 
entered the periphery as GFPhi and GFPlo RTEs (Boursalian et al., 2004; and 
reviewed in Fink and Hendricks, 2011). Interestingly, a more recent study 
revealed that the accumulation of RTEs in the periphery as well as the survival 
of RTEs was impaired in Egr1-/- mice in a TCR-dependent way suggesting that 
Egr1 might be important for thymic egress and RTE survival (Schnell and Kersh, 
2005). Interestingly, another study (Houston et al., 2011) showed that RTE 
integration into the mature naïve T cell pool can be enhanced by transgenic 
expression of IL-7Rα or Bcl-2. RTEs express reduced IL-7Rα and might be less 
able to compete for IL-7 survival signals in the periphery (Boursalian et al., 
2004). In conclusion, it seems likely that the survival of RTE and mature naïve T 
cell survival are not equally dependent on Zap70-and TCR-mediated signals 
and that WT Zap70-abundance is important for RTE integration into the mature 
naïve T cell pool. 
Despite impaired survival in lymphoreplete conditions, we found that F5 
TetZap70OFF T cells survived but did not proliferate, after transfer into 
lymphopaenic B6 Rag1-/- mice (Figure 3.9A, B and D). There is reduced 
competition for survival factors like IL-7 in absence of other T cells in B6 Rag1-/- 
mice (Mombaerts et al., 1992) and consistent with this, we showed that 
transferred F5 Rag1-/- and F5 TetZap70OFF T cells had downregulated their IL-
7Rα expression indicative of having received IL-7 signals (Park et al., 2004a). 
This is entirely consistent with the view that naïve T cell survival in 
lymphopaenic mice can be MHC- and thus probably TCR-independent (Martin, 
2006; Martin et al., 2003). In fact, the decay of CD8 T cell frequencies in the 
blood of F5 TetZap70 mice taken off dox appeared to slow as they became 
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increasingly lymphopaenic (Figure 3.4) and this might be the result of increased 
IL-7 signalling and thus survival in F5 TetZap70OFF mice and chimeras. F5 
TetZap70OFF T cells failed to proliferate, however, in B6 Rag1-/- mice, which fits 
with homeostatic TCR signalling being indispensable for LIP (Seddon et al., 
2000; Takeda et al., 1996; Tanchot et al., 1997; Viret et al., 1999). We also 
transferred F5 Rag1-/- and F5 TetZap70OFF T cells into IL-7-/- Rag1-/- to further 
elucidate the interplay between IL-7 and TCR survival signals. Both transferred 
F5 Rag1-/- and F5 TetZap70OFF T cells died rapidly after transfer into IL-7-
deficient hosts but the survival of F5 TetZap70OFF T cells was still impaired 
compared to F5 Rag1-/- T cells. Firstly, the impaired survival of F5 TetZap70OFF 
T cells in absence of IL-7 confirms the non-redundant role of IL-7 signals in 
naïve T cell survival in vivo (Schluns et al., 2000; Seddon and Zamoyska, 
2002b). Secondly, the impaired survival of F5 TetZap70OFF T cells relative to F5 
Rag1-/- T cells, despite all cells being deprived of IL-7 survival signals, also 
suggests that the Zap70-dependent survival signal is largely IL-7-independent. 
Finally, gene expression analysis of F5 Rag1-/- and F5 TetZap70OFF T cells 
revealed a potential target for Zap70-mediated TCR survival signals in 
peripheral T cells. We found that F5 TetZap70OFF T cells had increased Bmf 
mRNA, a pro-apoptotic BH3-only member of the Bcl-2 family of apoptotic 
regulators (Figure 3.10B). The physiological role of Bmf is much less well 
characterised than the role of its closest relative Bim (reviewed in Piñon et al., 
2008) which is known to play an important role in the regulation of T cell 
homeostasis (Wojciechowski et al., 2007). The recent characterisation of Bmf-/- 
mice and comparison with Bim-/- mice revealed that Bmf has a largely redundant 
role in embryonic development (Hubner et al., 2009; Labi et al., 2008), although 
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T cell development was not studied in Bmf-/- mice in any great detail. Bmf-/- mice 
have significantly increased CD8 T cells (Labi et al., 2008) and Bmf-deficiency 
improves CD8 T cell viability in vitro (Hubner et al., 2009). Interestingly, a recent 
study in melanoma cells (Shao and Aplin, 2012), revealed that Bmf apoptotic 
activity in vitro is reduced following phosphorylation by Erk2 downstream of 
MEK while phosphorylation of Bmf by Jnk enhances Bmf apoptotic activity in 
vitro (Hubner et al., 2009; Lei and Davis, 2003). Little else is known about the 
regulation of Bmf expression and function in vivo. Since Bmf mRNA levels were 
dramatically upregulated in F5 TetZap70OFF T cells, we propose that TCR 
signalling might regulate Bmf expression in vivo and thus naïve T cell survival. 
We will confirm whether Bmf is indeed a target for TCR survival signals by 
investigating whether Bmf-deficiency can rescue the survival of naïve F5 
TetZap70OFF T cells.  
 
 
 
 
 
 
 
 
 
 
 138 
Figure 3.1 Reconstitution of T cell development in F5 TetZap70 mice 
following transgene induction 
Thymocytes from F5 Rag1-/- (grey fill) and F5 TetZap70unind mice (red) and 
constitutively dox-fed F5 TetZap70ON mice and BM chimeras (F5 TetZap70ON) 
(blue) were counted and analysed by flow cytometry. BM chimeras were made 
by reconstituting sub-lethally irradiated B6 Rag1-/- mice with F5 TetZap70 BM. 
(A) Histograms show hCD2 expression and Zap70 abundance on live 
thymocytes. (B) Dot plot shows hCD2 expression against Zap70 abundance on 
F5 TetZap70ON live thymocytes. (C) Dot plots show CD4 against CD8 
expression on live, hCD2+ or hCD2-thymocytes and CD5 against TCR 
expression on CD4+ CD8+ DP thymocytes from intact F5 Rag1-/- and F5 
TetZap70unind mice and F5 TetZap70ON chimeras. (D) Histograms show TCR 
and CD5 expression on CD4+ CD8+ DP thymocytes. (E) Histograms show 
Zap70 abundance on hCD2- (grey fill), DP1 (red), DP2 (blue) and DP3 (green) 
thymocytes. (F) Box and whisker plot shows the hCD2+ CD5hi TCRhi CD8+ SP 
thymocyte number in intact (n=14) and host chimera (n=2) F5 Rag-/- mice and 
intact (n=13) and host chimera (n=14) F5 TetZap70ON mice; **** p≤0.0001 and 
ns p>0.05 (one-way analysis of variance followed by Bonferroni correction for 
multiple comparisons). Data are representative of ≥three independent 
experiments. 
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Figure 3.2 Reconstitution of the peripheral T cell compartment in F5 
TetZap70 mice following transgene induction 
LN and spleen lymphocytes from C57Bl/6 (black), F5 Rag1-/- (grey fill) and F5 
TetZap70unind mice and F5 TetZap70ON (blue) mice and BM chimeras were 
counted and analysed by flow cytometry. Lymhocytes from F5 TetZap70OFF 
chimeras taken off dox ≥5 days previously were used as Zap70-deficient 
controls (red) in (C) and (D). BM chimeras were made by reconstituting sub-
lethally irradiated B6 Rag1-/- mice with F5 TetZap70 BM.    (A) Dot plots show 
CD8 against TCR expression on live LN and spleen lymphocytes. (B) Box and 
whisker plot shows the pooled number of LN and spleen CD8+ TCR+ CD5hi 
TCRhi lymphocytes in F5 Rag-/- mice (n=14) and chimeras (n=2), F5 
TetZap70unind mice (n=7) and F5 TetZap70ON mice (n=11) and chimeras (n=14); 
*** p≤0.001, * p≤0.05 and ns p>0.05 (one-way analysis of variance followed by 
Bonferroni correction for multiple comparisons). (C) Histograms show hCD2 
expression and Zap70 abundance on CD8+ TCR+ CD5hi TCRhi Lymphocytes 
(LN). (D) Histograms show TCR and CD5 expression on CD8+ TCR+ CD5hi 
TCRhi Lymphocytes (LN). Data are representative of ≥three independent 
experiments. 
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Figure 3.3 Kinetics of transgene ablation following dox-withdrawal 
Thymocytes and Lymphocytes (LN) from F5 Rag1-/- mice (black), F5 
TetZap70ON chimeras (blue) and F5 TetZap70 chimeras taken off dox (F5 
TetZap70OFF) for 1-5 days (d1-d5), as indicated, were analysed by flow 
cytometry. BM chimeras were made by reconstituting sub-lethally irradiated B6 
Rag1-/- mice with F5 TetZap70 BM. F5 TetZap70OFF mice taken off dox ≥7 days 
previously were used as Zap70-deficient controls (red). (A) Histograms show 
hCD2 expression and Zap70 abundance on live thymocytes. (B) Histograms 
show hCD2 expression and Zap70 abundance on CD8+ TCR+ CD5hi TCRhi 
lymphocytes. 
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Figure 3.4 F5 TetZap70 fail to persist in the absence of Zap70 induction 
Intact F5 TetZap70ON mice and chimeras were taken off dox and the frequency 
and number of CD8+ TCR+ CD5hi TCRhi lymphocytes in the blood and LN of F5 
Rag1-/- (grey), F5 TetZap70ON (blue) and F5 TetZap70 taken off dox (F5 
TetZap70OFF) (red) was assessed by flow cytometry. BM chimeras were made 
by reconstituting sub-lethally irradiated B6 Rag1-/- mice with F5 TetZap70 BM. 
Line graphs show the frequency of CD8+ TCR+ CD5hi TCRhi lymphocytes in 
blood of intact mice (A) and BM chimeras (C) as a  percentage of the frequency 
at d0; **** p≤0.0001, *** p≤0.001, ** p≤0.01 and * p≤0.05 F5 TetZap70OFF 
compared to F5 TetZap70ON (two-way analysis of variance followed by 
Bonferroni correction for multiple comparisons). Each time-point represents ≥3 
replicate mice. Box and whiskers plots show the frequency or number of LN 
CD8+ TCR+ CD5hi TCRhi lymphocytes in intact mice (n≥5) (B) and BM chimeras 
(n≥3) (D); **** p≤0.0001 (one-way analysis of variance followed by Bonferroni 
correction for multiple comparisons). Data are representative of ≥three 
independent experiments. 
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Figure 3.5 F5 TetZap70OFF do not survive upon adoptive transfer  
Ly5.1 F5 Rag1-/- and F5 TetZap70OFF (Ly5.2) lymphocytes (LN) were 
transferred intravenously into Ly5.1 Ly5.2 F5 Rag1-/- placed on dox or OT-I 
Rag1-/- mice that were placed on or off dox. F5 TetZap70OFF lymphocytes were 
isolated from the LNs of F5 TetZap70 chimeras taken off dox ≥5 days 
previously. BM chimeras were made by reconstituting sub-lethally irradiated B6 
Rag1-/- mice with F5 TetZap70 BM. Host and donor LN or blood lymphocytes 
were analysed by flow cytometry 1-14 days after transfer (d1-d14). (A) Dot plots 
show Ly5.1 against Ly5.2 expression on donor CD8+ TCR+ CD5hi TCRhi 
Lymphocytes (LN) in Ly5.1 Ly5.2 F5 Rag1-/- host LNs. (B) Line graph shows the 
ratio of donor Ly5.2+ to Ly5.1+ CD8+ TCR+ CD5hi TCRhi lymphocytes in Ly5.1 
Ly5.2 F5 Rag1-/- host LNs. Each time-points represents ≥2 replicate mice.      
(C) Line graph shows the frequency of transferred Vβ11+ CD8+ TCR+ CD5hi 
TCRhi F5 Rag1-/- (grey) and F5 TetZap70 lymphocytes in the blood of OT-I 
Rag1-/- hosts on (blue) and off (red) dox. Each time-point represents ≥3 
replicate mice. Histograms show CD5 and IL-7Rα expression on endogenous 
OT-I Rag1-/- and transferred F5 Rag1-/- (grey) lymphocytes (D) and transferred 
F5 Rag1-/- and F5 TetZap70 lymphocytes (E) 7 days after transfer into OT-I 
Rag1-/- hosts that were on (red) or off (blue) dox. Intact F5 Rag1-/- (grey fill) 
lymphocyte CD5 and IL-7Rα expression are also shown as controls. Data are 
representative of ≥two independent experiments. 
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Figure 3.6 F5 TetZap70ON thymocytes are outcompeted in mixed F5 Rag1-/- 
F5 TetZap70 chimeras 
Mixed F5 Rag1-/- F5 TetZap70 BM chimeras were made by reconstituting sub-
lethally irradiated B6 Rag1-/- with a 1:10 ratio of T cell depleted Ly5.1 F5 Rag1-/- 
and F5 TetZap70 BM. Representation of Ly5.1+ F5 Rag1-/- and Ly5.2+ F5 
TetZap70 cells in the thymus and LN of mixed BM chimeras was analysed by 
flow cytometry. (A) Dot plots show CD4+ CD8+ DP and CD8+ SP gating of total 
thymocytes, DP1, DP2 and DP3 gating of DP thymocytes, HSAhi and HSAlo 
gating of CD8+ SP thymocytes and CD8+ CD5+ gating of lymphocytes (LN).    
(B) Representation of Ly5.1+ F5 Rag1-/- and Ly5.2+ F5 TetZap70 cells in DP1, 
DP2, DP3, HSAhi and HSAlo CD8+ SP thymocytes and in CD8+ CD5+ 
lymphocytes (LN) of mixed BM chimeras. (C) Bar chart shows the average 
representation of Ly5.1+ F5 Rag1-/- and Ly5.2+ F5 TetZap70 cells in DP1, DP2, 
DP3, HSAhi and HSAlo CD8+ SP thymocytes and in CD8+ CD5+ lymphocytes 
(LN) of mixed BM chimeras. Each bar represents ≥6 replicate mice; **** 
p≤0.0001 and *** p≤0.001 compared to DP1 (one-way analysis of variance 
followed by Bonferroni correction for multiple comparisons). Histograms show 
C57Bl/6 (black), Ly5.1+ F5 Rag1-/- (grey fill) and Ly5.2+ F5 TetZap70 (blue) 
lymphocyte (LN) CD5 (D), IL-7Rα and HSA (E) expression. Data are 
representative of ≥three independent experiments. 
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Figure 3.7 Periphery of F5 TetZap70ON is enriched for recent thymic 
emigrants 
F5 Rag1-/- (grey fill) and F5 TetZap70ON (blue) thymocyte and lymphocyte (LN) 
RTE marker expression was analysed by flow cytometry. (A) Histograms show 
CD8+ CD5+ lymphocyte (LN) HSA, Qa2 and CD45RB expression. (B) Dot plots 
show CD8 and CD5 expression on live lymphocytes from LNs. Histograms 
show F5 Rag1-/- and F5 TetZap70ON CD4+ CD8+ DP thymocyte (grey fill) and 
CD8+ CD5+ lymphocyte (LN) (black) HSA and Qa2 expression. Data are 
representative of ≥three independent experiments. 
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Figure 3.8 In vivo homing of F5 TetZap70OFF T cells to LN and spleen 
Ly5.1 F5 Rag1-/- and F5 TetZap70OFF (Ly5.2) Lymphocytes (LN) were 
transferred intravenously into Ly5.1 Ly5.2 F5 Rag1-/- hosts. F5 TetZap70OFF 
lymphocytes were isolated from the LNs of F5 TetZap70 chimeras taken off dox 
≥5 days previously. BM chimeras were made by reconstituting sub-lethally 
irradiated B6 Rag1-/- mice with F5 TetZap70 BM. Host and donor LN or blood 
lymphocytes were analysed by flow cytometry 60 and 150min after transfer (d1-
d14). (A) Dot plots show CD8 against TCR expression on live Lymphocytes 
(LN) and Ly5.2 against TCR expression on CD8+ TCR+ Lymphocytes (LN) 
before transfer. (B) Dot plots show Ly5.2 against Ly5.1 expression on CD8+ 
TCR+ blood, LN and spleen lymphocytes 60 and 150min after transfer. (C) Plots 
show the ratio of donor Ly5.2+ to Ly5.1+ CD8+ TCR+ lymphocytes in Ly5.1 Ly5.2 
F5 Rag1-/- host LN and spleen at 60 and 150min. (D) Plots show donor Ly5.2+ 
(grey) and Ly5.1+ (red) CD8+ TCR+ lymphocyte numbers in Ly5.1 Ly5.2 F5 
Rag1-/- host LN and spleen at 60 and 150min. Each time-points represents ≥4 
replicate mice. 
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Figure 3.9 F5 TetZap70OFF T cells survive but do not proliferate in vivo 
CTV-labelled Ly5.1 F5 Rag1-/- and F5 TetZap70OFF (Ly5.2) Lymphocytes (LN) 
were transferred intravenously into B6 Rag1-/- or IL-7-/- Rag1-/- hosts. F5 
TetZap70OFF lymphocytes were isolated from the LNs of F5 TetZap70 chimeras 
taken off dox ≥5 days previously. BM chimeras were made by reconstituting 
sub-lethally irradiated B6 Rag1-/- mice with F5 TetZap70 BM. Host and donor 
LN or spleen lymphocytes were analysed by flow cytometry 1-14 days after 
transfer (d1-d14). (A) Histograms show CTV-dilution by donor Ly5.1+ F5 Rag1-/- 
(grey) and Ly5.2+ F5 TetZap70OFF (red) CD8+ TCR+ lymphocyte in B6 Rag1-/- 
LN. (B) Dot plots show Ly5.1 expression against CTV dilution on donor CD8+ 
TCR+ lymphocytes in B6 Rag1-/- LN. (C) Line graph shows the ratio of donor 
Ly5.2+ to Ly5.1+ CD8+ TCR+ lymphocytes in B6 Rag1-/- LNs. Each time-point 
represents ≥2 replicate mice. (D) Line graph shows the ratio of donor Ly5.2+ to 
Ly5.1+ CD8+ TCR+ lymphocytes in IL-7-/- Rag1-/- LNs. Each time-point 
represents ≥2 replicate mice. Histograms show IL-7Rα expression on donor 
Ly5.1+ F5 Rag1-/- (grey fill) and Ly5.2+ F5 TetZap70OFF (red) CD8+ TCR+ 
Lymphocytes (LN) 7 days after transfer into B6 Rag1-/- hosts (E) and 3 days 
after transfer into IL-7-/- Rag1-/- hosts (F). Pre-transfer (grey fill) IL-7Rα 
expression is also shown as a control. Data are representative of ≥two 
independent experiments. 
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Figure 3.10 Bmf expression is upregulated in F5 TetZap70OFF T cells 
mRNA was isolated from FACS-purified CD8+ TCR+ F5 Rag1-/- (grey) and F5 
TetZap70OFF lymphocytes (LN) (red). F5 TetZap70OFF lymphocytes were 
isolated from the LNs of F5 TetZap70 chimeras taken off dox ≥5 days 
previously. BM chimeras were made by reconstituting sub-lethally irradiated B6 
Rag1-/- mice with F5 TetZap70 BM. Total mRNA was sequenced by an Illumina 
Genome Analyser IIx. Bar charts show expression of Hprt, Zap70 and Cd5 (A) 
and of indicated apoptotic regulators (B). Data are mean±S.D. nRPKM from 
duplicates. 
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Chapter 4 The role of Zap70 in naïve T cell 
survival in vitro 
4.1 Introduction 
The survival of naïve CD8 T cells in vivo depends on MHC-dependent TCR 
signalling (Labrecque et al., 2001; Polic et al., 2001; Seddon and Zamoyska, 
2002a; Tanchot et al., 1997) and also requires Zap70, as we show in Chapter 3. 
Very little is known, though, about the downstream targets (discussed in section 
3.3) or the potential source of this TCR survival signal.  
In contrast, the downstream targets of IL-7 survival signals, although not fully 
characterised, have been extensively studied (introduced and discussed in 
section 3.1 and 3.3). IL-7 production occurs mainly in the stroma of the thymus, 
lymphoid organs, skin, intestine as well as the liver at a constitutive rate such 
that the amount of IL-7 available is mostly regulated by consumption by 
lymphocytes (Fry and Mackall, 2005).  In a recent study the importance of IL-7 
produced by non-haematopoietic stromal cells in the LN was investigated (Link 
et al., 2007). Consistent with previous studies (Cinalli et al., 2005), the study 
showed firstly, that blocking access to SLOs leads to a drop in the total number 
of peripheral naïve CD4 and CD8 T cells suggesting access to SLOs is 
important for naïve T cell survival (Link et al., 2007). Secondly, treating mice 
with an IL-7Rα-neutralising antibody has a similar effect on naïve T cell 
numbers as preventing access to SLOs does. Finally, isolated LN gp38+ CD31- 
CD35- FRCs both expressed and produced IL-7 and were able to promote CD4 
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and CD8 T cell survival in vitro in an IL-7- and CCL19-dependent manner. 
Interestingly, access to SLOs has also been shown to be important for 
homeostatic proliferation of naïve T cells (Dai and Lakkis, 2001; Dummer et al., 
2001) which, like naïve T cell survival, requires both IL-7 (Schluns et al., 2000; 
Tan et al., 2001) and TCR signals (Seddon et al., 2000; Takeda et al., 1996; 
Tanchot et al., 1997; Viret et al., 1999). 
The source of spMHC for TCR-dependent survival signals is still unknown. 
Ablation of I-Aβ expression in MHCII+ dendritic cells revealed that CD4 T cell 
survival depends on MHCII+ DCs (Bröcker, 1997). Furthermore, DCs and T cells 
can form synapses in the absence of antigen and these antigen-independent 
interactions induce T cell Ca2+ responses as well as tyrosine phosphorylation at 
the T cell-DC interface (Revy et al., 2001). DCs isolated by plastic adherence 
have been shown to enhance T cell viability if co-cultured with either naïve CD4 
or CD8 T cell survival in vitro and this effect was shown to be specific to isolated 
DCs since co-culturing T cells with B cells had no effect on T cell viability 
(Feuillet et al., 2005; Revy et al., 2001). The survival signal provided by DCs to 
CD4 T cells in vitro was shown to be IL-7-independent but was impaired, 
although not completely abolished, if DCs did not express any MHCII molecules 
(Feuillet et al., 2005). Interestingly, basal CD3ζ-phosphorylation was also 
maintained by co-culture of WT DCs and T cells but disappeared if DCs did not 
express MHCII (Feuillet et al., 2005). Finally, and perhaps most importantly, the 
survival signal provided by DCs also required Src family kinases raising the 
possibility that the DCs were providing a spMHC-induced TCR-dependent 
survival signal transduced by Src family kinases and possibly Zap70. There is 
also evidence that suggests that DCs do not provide naïve T cells with survival 
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signals, since at least in vitro FACS-purified DCs co-cultured with T cells at a 1 
to 40 DC to T cell ratio had no effect on T cell viability (Link et al., 2007). 
In this chapter we sought to characterise the IL-7 and TCR signalling 
requirements for T cell survival in more detail in vitro. We wanted to assess 
whether the Zap70-dependent TCR survival signal acts via IL-7. We also hope 
to investigate the source and downstream targets of a TCR survival signals in 
an in vitro model of TCR- and Zap70-dependent naïve T cell survival. 
4.2 Results 
4.2.1 sing in F5 TetZap70 mice 
Given the evidence that TCR and IL-7R signalling are cross-regulated (Kimura 
et al., 2012; Park et al., 2007) we wanted to investigate whether F5 
TetZap70OFF CD8 T cells also had a defect in IL-7R signalling in vivo which 
contributed to the survival defect seen in naïve CD8 T cells in F5 TetZap70OFF 
mice. Interestingly, IL-7Rα surface expression on both F5 TetZap70ON and F5 
TetZap70OFF T cells was reduced to a similar extent compared to F5 Rag1-/- T 
cells (Figure 4.1A). There was also no difference in surface CD8α expression 
between F5 Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T cells (Figure 4.1A). 
Since surface IL-7Rα expression is regulated by IL-7 availability in vivo (Park et 
al., 2004a) we wanted to examine the IL-7Rα expression of F5 TetZap70 and 
F5 Rag1-/- in the absence of this repressive signal in vitro. We did this by 
culturing F5 Rag1-/- and F5 TetZap70ON cells in vitro without IL-7 and then 
analysed IL-7Rα expression after 24h (Figure 4.1B). Despite low IL-7Rα 
expression ex vivo, F5 TetZap70OFF T cells upregulated their IL-7Rα expression 
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to a greater extent than F5 Rag1-/- T cells (Figure 4.1B). Interestingly, though, 
there was no change in F5 Rag1-/- CD8α expression after overnight culture 
without IL-7 (Figure 4.1B). Together, these data show that, the lower IL-7Rα 
expression on F5 TetZap70 T cells ex vivo is not cell-intrinsic but likely due to 
IL-7 availibilty in vivo. 
Since Bcl-2 expression is reduced in absence of IL-7 signalling in vivo (Schluns 
et al., 2000; Vivien et al., 2001) and transgenic Bcl-2 is able to rescue 
thymopoïesis in IL-7Rα-deficient mice (Akashi et al., 1997; Maraskovsky et al., 
1997) we assessed Bcl-2 abundance in F5 TetZap70 T cells to assess their 
ability to transduce IL-7 signals. We looked initially at Bcl-2 abundance in 
thymocytes from F5 Rag1-/- and F5 TetZap70ON mice. Bcl-2 is upregulated on 
thymocytes following positive selection (Akashi et al., 1997; Freeden-Jeffry et 
al., 1995; 1997; Linette et al., 1994). We found that Bcl-2 abundance was higher 
in CD8 SP thymocytes than in DP thymocytes from F5 Rag1-/- and F5 
TetZap70ON mice (Figure 4.1C). Although it is less clear what the role of IL-7 is 
in maintaining Bcl-2 in naïve T cells (Pearson et al., 2011; Rathmell et al., 2001; 
Schluns et al., 2000; Vivien et al., 2001) Bcl-2 abundance was consistently 
greater in F5 TetZap70 T cells than in F5 Rag1-/- T cells (Figure 4.1D). The IL-7-
induced upregulation of Bcl-2 in vitro, as previously described (Akashi et al., 
1997; Armant et al., 1995; Freeden-Jeffry et al., 1997; Graninger et al., 2000; 
Karawajew et al., 2000; Vella et al., 1997), was also comparable in F5 Rag1-/- 
and F5 TetZap70 T cells (Figure 4.1E). These data show that despite reduced 
IL-7Rα expression, F5 TetZap70 T cells are able to transduce IL-7 signals in 
vitro. 
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4.2.2 Zap70-deficiency does not affect the IL-7-induced survival of naïve 
CD8 T cells at saturating concentrations of IL-7 
Given the important role IL-7 signals play in mediating naïve T cell survival 
(Pearson et al., 2011; Saini et al., 2009; Schluns et al., 2000) and the variable 
surface expression of IL-7Rα on F5 TetZap70 T cells we wanted to investigate 
the IL-7-induced survival of F5 TetZap70ON and F5 TetZap70OFF T cells. To do 
this, we isolated F5   Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T cells and 
cultured these T cells with or without saturating concentrations of IL-7 in vitro 
(Figure 4.2). We assessed survival ex vivo and at 24, 48 and 72h by staining 
cells with recombinant annexin-V which binds to phosphatidylserine when it is 
externalised on the outer layer of the plasma membrane of cells undergoing 
apoptosis (Brumatti et al., 2008). There were no significant differences in 
lymphocyte viability between F5 Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T 
cells ex vivo (Figure 4.2A). In order to compare the survival of F5 Rag1-/-, F5 
TetZap70ON and F5 TetZap70OFF T cells directly, we normalised the frequency 
of live cells at each time-point to the starting frequency of live cells. In absence 
of IL-7, most T cells died after 72h in vitro (Figure 4.2B and C). In four 
independent experiments, the viability of F5 TetZap70OFF T cells in absence of 
IL-7 was reduced compared to F5 Rag1-/- and F5 TetZap70ON T cells. 
Interestingly, the viability of F5 Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T 
cells cultured with IL-7 was very similar at all time-points tested (Figure 4.2B 
and C). Collectively, these data show that IL-7-induced survival of T cells is 
unaffected by Zap70-deficiency but that F5 TetZap70OFF were more prone to 
apoptosis. 
 163 
To investigate the effect of Zap70-deficiency on IL-7 sensitivity in vitro, we co-
cultured Ly5.1 F5 Rag1-/- cells isolated from LN with F5 TetZap70ON (Ly5.2) or 
F5 TetZap70OFF (Ly5.2) T cells and with a titration of IL-7 (Figure 4.2D). We 
normalised the viability of T cells at 72h to the 0h viability of T cells as well as to 
the viability of F5 Rag1-/- T cells in the same well. Interestingly, the viability of F5 
TetZap70ON T cells and Ly5.1 F5 Rag1-/- T cells was similar at all IL-7 
concentrations tested (Figure 4.2D). The viability of F5 TetZap70OFF T cells, 
was very similar to the viability of F5 Rag1-/- T cells at IL-7 concentrations 
greater than 1.25ng/mL but at lower IL-7 concentrations F5 TetZap70OFF T cell 
viability was reduced compare to co-cultured F5 Rag1-/- T cells (Figure 4.2D). 
Together, these data show that F5 TetZap70OFF T cells respond less well to IL-7 
survival signals at low, non-saturating concentrations of IL-7. 
4.2.3 B6 Rag1-/- splenocytes enriched for CD11c+ cells promote Zap70-
dependent T cell survival 
We also wanted to set up an in vitro survival assay to investigate TCR survival 
signalling. Since CD11c+ MHCI+ DCs enriched by plastic adherence improve 
CD4 and CD8 T cell viability in vitro (Feuillet et al., 2005; Revy et al., 2001) we 
first tested whether DCs could improve the viability of CD8 T cells in vitro. To do 
this we enriched B6 Rag1-/- splenocytes for CD11c+ cells (Figure 4.3A). To 
ensure that all the non-T cells originated from the B6 Rag1-/- CD11c+ enriched 
fraction we FACS-purified CD8+ TCR+ T cells from F5 Rag1-/-, F5 TetZap70ON 
and F5 TetZap70OFF LN (Figure 4.3B). We assessed the viability of T cells 
cultured in the presence or absence of CD11c+ enriched B6 Rag1-/- splenocytes 
at a 1 to 10 ratio at 24, 48 and 72h by annexin-V staining. Addition of CD11c+ 
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enriched splenocytes consistently enhanced T cell viability at all time-points 
tested (Figure 4.3C and D). FACS-purified T cells cultured alone, died very 
rapidly (Figure 4.3D). Interestingly, the viability of T cells cultured with CD11c+ 
enriched splenocytes correlated with their level of Zap70 abundance as 
assessed by flow cytometry (Figure 3.2). The viability of F5 Rag1-/- T cells was 
greatest, while F5 TetZap70OFF T cells responded least to CD11c+ enriched 
splenocytes in vitro (Figure 4.3C and D). Taken together, these results show 
that CD11c+ enriched splenocytes can improve T cell viability in a Zap70-
dependent manner.  
4.2.4 FACS-purified cDCs and pDCs alone do not promote substantial 
naïve T cell survival in vitro 
It has been shown that both purified DCs and stromal cells can promote T cell 
survival in vitro (Feuillet et al., 2005; Link et al., 2011). Therefore, we wanted to 
identify which fraction of the CD11c+ enriched B6 Rag1-/- splenocytes was 
responsible for the Zap70-dependent survival signal in vitro (Figure 4.4). To do 
this, we first characterised CD11c+ enriched B6 Rag1-/- splenocytes in more 
detail by flow cytometry. Conventional DCs (cDCs), which express the highest 
levels of CD11c and MHCII, represented 14.3±6.5% of all CD11c+ enriched B6 
Rag1-/- splenocytes on average (Figure 4.4B). Within the MHCII+ fraction we 
also detected a substantial population of plasmacytoid dendritic cells (pDCs), 
which express lower CD11c than cDCs and additionally express the pDC-
marker mouse plasmacytoid dendritic cell antigen 1 (mPDCA1) (Barchet et al., 
2005; Krug et al., 2004). Furthermore, there was a substantial MHCII- fraction, 
which contained both CD45+ haematopoietic cells and CD45- non-
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haematopoietic cells (Figure 4.4D). We went on to FACS-purify MHCII- cells, 
cDCs and pDCs from CD11c+ enriched B6 Rag1-/- splenocytes and tested each 
subset for its ability to promote F5 Rag1-/- T cell survival in vitro (Figure 4.4E 
and G). To account for the different abundance of MHCII- cells, cDCs and pDCs 
in the CD11c+ enriched B6 Rag1-/- spleen, we added the equivalent number of 
FACS-purified cells present in 1x106 CD11c+ enriched B6 Rag1-/- spleen. We 
also tested whether WT T cells or B cells were able to promote naïve T cell 
survival in vitro and so C57Bl/6 CD4+ TCR+ T cells and B220+ CD19+ B cells 
were also purified (Figure 4.4F and G). T cell viability was assessed at 48h and 
compared to the viability of T cells cultured with unfractionated CD11c+ enriched 
splenocytes. Interestingly, purified cDCs and pDCs alone were poor at 
promoting the survival of F5 Rag1-/- T cells (Figure 4.4G). FACS-purified 
C57Bl/6 CD4 T or B cells were also unable to replicate the survival promoted by 
CD11c+ enriched spleen although the viability of T cells cultured with B cells 
was consistently better than the viability of T cells cultured with CD4 T cells 
(Figure 4.4G). Interestingly, only the viability of F5 Rag1-/- T cells cultured with 
MHCII- cells was similar to the viability of T cells cultured with CD11c+ enriched 
DCs (Figure 4.4G). Collectively, these data show that only MHCII- cells, not 
cDCs or pDCs, were able to account for the survival promoted by unfractionated 
CD11c+ enriched splenocytes.  
4.2.5 The survival signal provided by CD11c+ splenocytes is β2m- and IL-
7-independent 
We next wanted to ask whether the survival signals provided by CD11c+ 
enriched splenocytes were dependent on intact spMHC or IL-7. To do this, we 
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enriched CD11c+ splenocytes from β2m-/- Rag1-/- (β2m-deficient hereon), which 
lack MHCI surface expression (Koller et al., 1990; Zijlstra et al., 2010) and IL-7-/- 
Rag1-/- (IL-7-deficient hereon) (Freeden-Jeffry et al., 1995) mice (Figure 4.5A). 
We tested the ability of CD11c+ enriched β2m- and IL-7-deficient splenocytes to 
promote the survival of naïve F5 Rag1-/- T cells in vitro (Figure 4.5B and C). 
Interestingly, the viability of T cells cultured with CD11c+ enriched β2m- and IL-
7-deficient splenocytes was indistinguishable from the viability of T cells 
cultured with CD11c+ enriched splenocytes from B6 Rag1-/- mice (Figure 4.5B 
and C). Collectively, these data show that the T cell survival signal provided by 
CD11c+ enriched splenocytes is β2m- and IL-7-independent. 
To investigate any cooperation between IL-7 survival signals and the survival 
signal provided by CD11c+ enriched B6 Rag1-/- splenocytes we cultured F5 
Rag1-/- T cells with titrations of IL-7 and of CD11c+ enriched splenocytes (Figure 
4.5D). In absence of IL-7 and at a saturating concentration of IL-7, the viability 
of T cells at 48h correlated with the added number of CD11c+ enriched 
splenocytes. At intermediate concentrations of IL-7, however, addition of DCs 
had no additive effect on T cell survival (Figure 4.5D). These data show that the 
survival signal provided by CD11c+ enriched splenocytes in vitro is dose-
dependent and that IL-7 and CD11c+ enriched splenocytes signals are not 
additive. 
4.2.6 The T cell survival signal provided by CD11c+ splenocytes is 
impaired by MEK inhibition 
Finally, we wanted to use this system of IL-7 independent, Zap70-dependent in 
vitro T cell survival to investigate putative downstream signalling pathways of a 
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Zap70-dependent T cell survival signal. We co-cultured F5 Rag1-/- T cells and 
B6 Rag1-/- splenocytes enriched for CD11c+ cells with specific inhibitors for 
MEK, mTOR and PI3K and then assessed T cell viability at 48h. Interestingly, 
both inhibition of mTOR, by rapamycin and PI3K, by LY294002, respectively, 
lead to a modest reduction of the T cell survival at 48h induced by CD11c+ 
enriched splenocytes (Figure 4.6B). Addition of the MEK1/2 inhibitor UO126, 
meanwhile, completely abrogated the T cell survival signal provided by CD11c+ 
enriched splenocytes, such that there was no significant difference between the 
viability of FACS-purified T cells alone and T cells cultured with CD11c+ 
enriched splenocytes and UO126 (Figure 4.6B). Together, these data show that 
the survival signal provided by CD11c+ enriched splenocytes in vitro depends 
on intact PI3K/Akt and intact mTOR signalling but mostly on intact MAPK/ERK 
signalling. 
4.3 Discussion 
Having characterised the effect of Zap70-deficiency on T cell survival in vivo 
using dox-inducible expression of Zap70 in F5 TetZap70 mice and chimeras in 
Chapter 3, we next investigated the survival of F5 TetZap70OFF T cells in more 
detail in vitro. We show that Zap70-deficiency did not affect IL-7-induced Bcl-2 
upregulation or survival, despite F5 TetZap70 T cells expressing reduced IL-
7Rα ex vivo. At lower concentrations of IL-7 F5 TetZap70OFF T cells did show 
reduced survival compared to F5 TetZap70ON and F5 Rag1-/-. Interestingly, the 
reduced Zap70 abundance in F5 TetZap70ON T cell had no effect on IL-7-
induced survival in vitro at any IL-7 concentration tested. Furthermore, we show 
that Zap70-deficiency did affect the survival induced by CD11c+ enriched 
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splenocytes in vitro. F5 TetZap70OFF T cells consistently responded less than 
F5 TetZap70ON T cells, which in turn responded less than F5 Rag1-/- T cells 
suggesting that Zap70-abundance was directly affecting T cell survival signal 
provided by CD11c+ enriched splenocytes. Surprisingly, FACS-purifying DC and 
non-DC subsets from CD11c+ enriched splenocytes revealed that neither cDCs 
nor pDCs alone were able to replicate the survival induced by CD11c+ enriched 
splenocytes. We also show that the survival signals from CD11c+ enriched 
splenocytes were largely, β2m- and IL-7-independent. Finally, we show that the 
survival signals from CD11c+ enriched splenocytes were only partially 
dependent on PI3K/Akt signalling but almost entirely on MAPK/ERK signalling 
since the survival induced by CD11c+ enriched splenocytes was almost 
completely abolished in the presence of MEK-inhibitor UO126. 
Surface IL-7Rα expression on F5 TetZap70ON and F5 TetZap70OFF T cells was 
reduced compared to F5 Rag1-/- T cells ex vivo but, interestingly, F5 
TetZap70ON and F5 TetZap70OFF T cells upregulated their surface IL-7Rα 
expression to a greater extent than F5 Rag1-/- T cells in absence of IL-7 (Figure 
4.1A and B). These data are consistent with the view that Il7ra transcription and 
IL-7Rα surface expression is inhibited by IL-7 signalling (Park et al., 2004a), in 
contrast to other γc-chain cytokine receptors whose expression is upregulated 
by cytokine signalling (Depper et al., 1985). We also characterised the 
intracellular abundance of anti-apoptotic regulator Bcl-2, which has been 
proposed to be a target for IL-7 survival signals in thymocytes and peripheral T 
cells. We did not detect a defect in Bcl-2 abundance between F5 Rag1-/- and F5 
TetZap70ON thymocytes or naïve T cells (Figure 4.1C and D). In fact, in contrast 
to IL-7Rα expression, F5 TetZap70ON and F5 TetZap70OFF T cells consistently 
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had higher Bcl-2 abundance (Figure 4.1D) and Bcl2 expression (Figure 3.10) 
than F5 Rag1-/- T cells and this might reflect the preferential survival of cells with 
more anti-apoptotic Bcl-2. 
There is evidence that TCR and IL-7 signalling are cross-regulated in naïve 
CD8 T cells (Park et al., 2007) such that TCR signalling limits IL-7 signalling, 
while IL-7 signalling enhances surface CD8α expression and thus TCR 
signalling (Park et al., 2007). In an extension of this model, it was recently 
shown that homeostatic TCR signalling is, in fact, essential to interrupt IL-7 
signalling and thus to prevent ‘cytokine-induced T cell death’ (Kimura et al., 
2012). In contrast, there is also evidence for an opposite relationship between 
TCR and IL-7 signalling, since TCR signalling has been shown to enhance IL-7 
sensitivity in vitro and in vivo by promoting localisation of the γc to lipid rafts 
(Cho et al., 2010). In another study (Takada and Jameson, 2009), IL-7Rα and 
CD5 expression were downregulated while CD8α expression was upregulated 
in absence of spMHC interactions. Meanwhile, Lck-ablation has no effect on IL-
7Rα-expression in vivo (Seddon and Zamoyska, 2003) and more recent work 
found no evidence of peripheral modulation of IL-7Rα expression by TCR 
signalling (Sinclair et al., 2011). Instead, TCR signalling strength during positive 
selection of T cells in the thymus determines IL-7Rα expression on peripheral 
naïve T cells (Sinclair et al., 2011). It is clear that the potential cross-regulation 
of TCR and IL-7R signaling is complex and so is the cross-regulation of CD8α 
and IL-7Rα expression.  
The low IL-7Rα expression on F5 TetZap70 T cells could be consistent with the 
‘co-receptor tuning model’ (Park et al., 2007), where weak TCR signalling in 
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CD8 T cells with low or no Zap70 would lead to enhanced IL-7 signalling and 
thus reduced IL-7Rα expression (Park et al., 2004a). Cell-intrinsic surface IL-
7Rα expression on F5 TetZap70 T cells, however, was increased compared to 
F5 Rag1-/- T cells (Figure 4.1B), which is inconsistent with the ‘co-receptor 
tuning model’ (Park et al., 2007). We also observed no differences in surface 
CD8α expression between F5 TetZap70 or F5 Rag1-/- T cells ex vivo or after 
overnight culture in absence of IL-7 (Figure 4.1A and B). Furthermore, in vitro 
IL-7-induced Bcl-2 upregulation was comparable in F5 TetZap70 and F5 Rag1-/- 
T cells. Finally, IL-7-induced survival of F5 Rag1-/-, F5 TetZap70ON or F5 
TetZap70OFF T cells at saturating IL-7 concentrations in vitro was comparable 
(Figure 4.2A, B and C) suggesting that IL-7 signalling is largely intact in F5 
TetZap70 T cells. Zap70-deficiency, meanwhile, impaired IL-7-induced survival 
in vitro at low concentrations of IL-7 (Figure 4.2D), while the ‘co-receptor tuning 
model’ predicts enhanced IL-7-sensitivity of F5 TetZap70OFF CD8 T cells (Park 
et al., 2007). Our data suggest that TCR signalling might have a minor role in 
the regulation of T cell sensitivity to IL-7 at low concentrations. The variable 
surface expression of IL-7Rα on F5 TetZap70 T cells is, in fact, likely the result 
of the relative lymphopaenia of F5 TetZap70 chimeras rather than reduced 
Zap70-abundance.  
Splenocytes enriched for DCs are able to provide both survival (Feuillet et al., 
2005; Revy et al., 2001) and proliferation (Ge et al., 2002) signals for naïve T 
cells in vitro and so we tested the ability of DCs to promote the survival of naïve 
F5 Rag1-/- and F5 TetZap70ON T cells (Figure 4.3). Interestingly, naïve T cell 
death in vitro in absence of any growth factors was consistently greater if T cells 
had been FACS-purified than if other LN cells were present (Figure 4.2). This 
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suggests that non-T cells contributed to T cell viability in vitro. CD11c+ enriched 
splenocytes, meanwhile, were able to promote the in vitro survival of F5 Rag1-/-, 
F5 TetZap70ON as well as F5 TetZap70OFF T cells but to different degrees 
(Figure 4.3C, D and E). In fact, the ability of CD11c+ enriched splenocytes to 
induce T cell survival correlated with naïve T cell Zap70 abundance as 
assessed by flow cytometry (Figure 3.2). This is consistent with a previous 
study where DC-induced survival of CD4 T cells in vitro was abolished by 
addition of PP2, an inhibitor of Src family kinases, upstream of Zap70 in the 
TCR signalling cascade (Feuillet et al., 2005). In the same study, CD4 T cell 
phosphorylation of CD3ζ, a correlate of homeostatic TCR signalling (Dorfman et 
al., 2000; Seddon and Zamoyska, 2002a; Smith et al., 2001; Witherden et al., 
2000), was maintained if CD4 T cells were co-cultured with WT DCs but not if 
co-cultured with MHC-deficient DCs (Feuillet et al., 2005). Taken together, our 
data confirms that splenocytes enriched for CD11c+ cells can provide naïve 
CD8 T cells with a survival signal in vitro and suggests that this survival signal is 
in part Zap70- and thus TCR-dependent. 
We found, however, that the survival signal provided by CD11c+ enriched 
splenocytes did not require splenocytes to express β2m, since the viability of T 
cells cultured with either β2m-deficient and B6 Rag1-/- CD11c+ enriched 
splenocytes was similar (Figure 4.5B, C and D). Our data are consistent with an 
earlier study, which shows that both the formation of antigen-independent DC-T 
cell synapses and DC-induced CD4 and CD8 T cell survival in vitro is MHC-
independent (Revy et al., 2001). A more recent study showed that DC-induced 
survival of CD4 T cells in vitro was unaffected by deficiency of I-Aβ and β2m, 
but that DCs lacking expression of all MHCII chains (Madsen et al., 1999; 
 172 
Martin, 2006) were less able to provide CD4 T cells with a survival signal in vitro. 
This raises the possibility that DCs expressing hybrid non-classical AαEβ MHCII 
might be able to promote CD4 T cell survival in vitro (Feuillet et al., 2005; Revy 
et al., 2001) as well as in vivo (Martin, 2006; Martin et al., 2003). Furthermore, 
there is evidence that β2m-deficient mice still express H-2Db (Allen et al., 1986) 
enough to mediate the deletion of H2-Db restricted HY TCR transgenic T cells in 
male mice. Therefore we cannot exclude that β2m-deficient CD11c+ enriched 
splenocytes are providing naïve CD8 T cells with an MHCI-dependent survival 
signal. Intriguingly, however, even completely MHCII-deficient DCs are able to 
promote some survival of CD4 T cells in vitro (Feuillet et al., 2005) suggesting 
that at least some of the survival signal provided by DCs is MHC-independent. 
Like DC MHC-deficiency, T cell Zap70-deficiency only partially impaired the 
survival signal provided by CD11c+ enriched splenocytes suggesting that some 
of the survival signals provided by CD11c+ enriched splenocytes is Zap70-
independent (Figure 4.3E). There is evidence that MHC-independent DC 
survival signals, at least to CD4 T cells in vitro, can be mediated by CD28/B7 
interactions as well LFA1/ICAM1 (Feuillet et al., 2005). It remains to be 
examined how the Zap70-independent survival signal provided by CD11c+ 
enriched splenocytes to T cells in vitro is mediated. 
We characterized the B6 Rag1-/- CD11c+ enriched splenocytes in more detail 
and as well as mPDCA1- CD11c+ MHCII+ cDCs and mPDCA1+ CD11cint 
MHCIIint pDCs, a large frequency of the CD11c+ enriched splenocytes were 
MHCII- (Figure 4.4D). Interestingly, only the FACS-purified MHCII- subset was 
able to promote F5 Rag1-/- survival in vitro and F5 Rag1-/- T cell co-culture with 
either cDCs or pDCs did not improve F5 Rag1-/- T cell viability compared to 
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culturing F5 Rag1-/- T cells alone (Figure 4.4G). F5 Rag1-/- T cell survival 
promoted by CD11c+ enriched splenocytes correlated with the frequency of 
CD11c+ cells after enrichment, but not with the frequency of CD11c+ MHCII+ 
cDCs after enrichment, suggesting that the cell population providing F5 Rag1-/- 
T cells with a survival signal is CD11c+ but not a CD11c+ MHCII+ cDC. These 
data contradict previous data suggesting DCs can promote T cell survival in 
vitro (Feuillet et al., 2005; Revy et al., 2001) and provide an MHC-dependent 
survival signal to CD4 T cells in vivo (Bröcker, 1997). In the studies that support 
a role for DCs promoting T cell survival in vitro, DCs were isolated by repeated 
rounds of plastic adherence and were co-cultured with T cells at a 1 to 1 ratio 
(Feuillet et al., 2005; Revy et al., 2001). It is conceivable that a non-DC 
population contributed to the survival of T cells in these studies. Furthermore, 
culturing F5 Rag1-/- T cells with more FACS-purified cDCs or alternatively with 
bone marrow derived DCs might improve F5 Rag1-/- T cell viability in vitro.  
Consistent with DCs not being the source of a T cell survival signal provided by 
CD11c+ enriched splenocytes, a recent study also found that FACS-purified 
CD45+ CD11c+ CD11blo DCs were unable to improve the viability of co-cultured 
T cells at a 40 to 1 T cell to DC ratio (Link et al., 2007). A stromal CD45- gp38+ 
cell population, however, was shown to promote T cell survival in vitro at the 
same 40 to 1 ratio (Link et al., 2007) and stromal splenocytes present after 
CD11c+ enrichment might thus contribute to F5 Rag1-/- T cell survival in vitro. It 
seems unlikely, however, that stromal cells alone are responsible for the 
survival signal provided by CD11c+ enriched splenocytes for two reasons. 
Firstly, the survival signal provided by CD11c+ enriched splenocytes correlated 
with the frequency of CD11c+ cells after enrichment yet the frequency of CD45- 
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cells dropped after CD11c+ enrichment (Figure 4.4D). Secondly, the survival 
signal provided by FRC is inhibited by addition of IL-7Rα neutralising antibodies 
(Link et al., 2007), whereas the survival signal provided by CD11c+ enriched 
splenocytes was IL-7-independent. In fact, IL-7-/- Rag1-/- CD11c+ enriched 
splenocytes provided F5 Rag1-/- T cells with a better survival signal than B6 
Rag1-/- CD11c+ enriched splenocytes and addition of non-saturating 
concentrations of IL-7 reduced the survival signal provided by B6 Rag1-/- 
CD11c+ enriched splenocytes (Figure 4.5E). These data suggest a more 
complex relationship between the survival signals provided by IL-7 and CD11c+ 
enriched splenocytes.  
Neither FACS-purified cDCs, pDCs or MHCII- cells were able to promote F5 
Rag1-/- T cell survival alone but, interestingly, the survival signal they did 
provide correlated was dose-dependent (Figure 4.5D). This raised the 
possibility that the improving F5 Rag1-/- T cell viability in vitro was not a feature 
of CD11c+ enriched splenocytes alone, but that contact with any cell might 
enhance F5 Rag1-/- T cell survival in vitro. Co-culturing F5 Rag1-/- T cells with 
either FACS-purified C57Bl/6 B or CD4 T cells did not improve F5 Rag1-/- T cell 
viability in vitro to the same degree as CD11c+ enriched splenocytes (Figure 
4.4G). Interestingly, culturing F5 Rag1-/- T cells with FACS-purified B cells did 
consistently improve in vitro F5 Rag1-/- T cell viability compared to the viability of 
F5 Rag1-/- T cells cultured alone (Figure 4.4G). This observation is consistent 
with other work that finds a minimal role for B cells promoting T cell survival in 
vitro (Link et al., 2007; Revy et al., 2001). It seems likely therefore, that one or 
multiple specific cell subsets enriched in the CD11c+ enriched spleen promote 
F5 Rag1-/- T cell survival in vitro, although which cell population or combination 
 175 
of cell populations mediate this survival signal is still unclear. The importance of 
cell contact and soluble factors for survival signals from CD11c+ enriched 
splenocytes, also requires further investigation. 
Finally, we were able to demonstrate a role for PI3K and mTOR signalling, as 
well as a role for and MEK signalling, in the T cell survival signal provided by 
CD11c+ enriched splenocytes (Figure 4.6A and B). The regulation of both 
glucose and amino acid metabolism by PI3K, and its target Akt, and mTOR 
signalling have been implicated in IL-7-induced T cell growth (Pearson et al., 
2012; Rathmell et al., 2001; Wofford et al., 2008) and T cell survival (Barata et 
al., 2004; Kelly et al., 2002; Wofford et al., 2008). The exact role of glucose 
metabolism for IL-7-induced T cell survival in vitro and in vivo remains 
controversial since glucose has recently been shown to be dispensable for IL-7-
induced survival in vitro (Pearson et al., 2012) and glucose uptake of IL-7Rα-
deficient T cells appears normal (Jacobs et al., 2010). Regardless of their role in 
IL-7-mediated T cell survival, PI3K and Akt signalling have been implicated in 
multiple cellular survival processes (Datta et al., 1999). The modest reduction of 
viable F5 Rag1-/- T cells in the presence of either rapamycin or LY294002 
(Figure 4.6A and B) suggests that both PI3K and mTOR signalling are important 
for the T cell survival signal from CD11c+ enriched splenocytes in vitro. 
Inhibition of MEK signalling, meanwhile, completely abolished the enhanced 
survival of F5 Rag1-/- T cells co-cultured with CD11c+ enriched splenocytes 
(Figure 4.6A and B) and this finding was of particular interest for several 
reasons.  
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Firstly, Erk activation by MEK is a downstream target of TCR signalling 
(reviewed in Brownlie and Zamoyska, 2013). Intriguingly, TCR signalling to Erk 
via Ras and MAPK in thymocytes has been shown to be particularly sensitive to 
TCR signalling strength. Even small differences in positive selection affinity are 
transduced to differences in Zap70 phosphorylation ultimately leading to either 
positive selection and survival or negative selection and cell death (Daniels et 
al., 2006). Secondly, constitutive activation of MAPK signalling has been 
implicated in the development and progression of many cancers where 
signalling to Erk via Raf and MEK has been shown to prevent apoptosis and 
promote cell growth while inhibition of MEK can induce apoptosis and inhibit 
growth (reviewed in Platanias, 2003). Finally, and perhaps most intriguingly, 
MEK inhibition in melanoma cells in vitro results in enhanced transcription of 
pro-apoptotic Bmf (Shao and Aplin, 2010; VanBrocklin et al., 2009), which we 
show is downstream of Zap70 signalling in F5 Rag1-/- T cells in vivo (Figure 
3.10). The MEK dependence of the survival signal from TCR via Zap70 is 
interesting since MEK and Erk have been shown to regulate Bmf transcription 
(Shao and Aplin, 2010) and Bmf activity (Shao and Aplin, 2012). How MEK-
inhibition will affect the in vitro survival of Zap70- or Bmf-deficient F5 Rag1-/- T 
cells co-cultured with CD11c+ enriched splenocytes remains to be investigated. 
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Figure 4.1 Intact IL-7R signalling in F5 TetZap70 mice 
F5 Rag1-/- (grey fill), F5 TetZap70ON (blue) and F5 TetZap70OFF (red) LN 
lymphocyte IL-7Rα and CD8 expression and intracellular Bcl-2 abundance were 
analysed by flow cytometry. F5 TetZap70OFF lymphocytes were isolated from 
the LNs of F5 TetZap70 chimeras taken off dox ≥5 days previously. Bone 
marrow chimeras were made by reconstituting sub-lethally irradiated B6 Rag1-/- 
mice with F5 TetZap70 bone marrow. (A) Histograms show ex vivo IL-7Rα and 
CD8 expression on F5 Rag1-/- (grey fill), F5 TetZap70ON (blue) and F5 
TetZap70OFF (red) CD8+ TCR+ CD5hi TCRhi Lymphocytes (LN). (B) Histograms 
show IL-7Rα and CD8 expression on F5 Rag1-/- (black), F5 TetZap70ON (blue) 
and F5 TetZap70OFF (red) CD8+ TCR+ CD5hi TCRhi Lymphocytes (LN) after 24h 
in vitro in absence of IL-7; 0h F5 Rag1-/- (grey fill) IL-7Rα and CD8 expression 
are also shown as controls. (C) Histograms show intracellular Bcl-2 abundance 
in F5 Rag1-/- and F5 TetZap70ON DP1 (dark grey fill) and CD8+ SP thymocytes 
(black); thymocyte PE-conjugated IgG monoclonal isotype staining (light grey 
fill) is also shown as a control. (D) Histogram shows intracellular Bcl-2 
abundance in CD8+ TCR+ CD5hi TCRhi Lymphocytes (LN); LN lymphocyte PE-
conjugated IgG monoclonal isotype staining (light grey fill) is also shown as a 
control. (E) Histograms show intracellular  Bcl-2 abundance in F5 Rag1-/-, F5 
TetZap70ON and F5 TetZap70OFF CD8+ TCR+ CD5hi TCRhi Lymphocytes (LN) 
cultured with 10ng/mL IL-7 (solid) or medium alone (dark grey fill) with 10ng/mL 
IL-7. Data are representative of ≥three independent experiments. 
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Figure 4.2 Zap70-deficiency does not affect the IL-7-induced survival of 
naïve CD8 T cells at saturating concentrations of IL-7 
F5 Rag1-/- (grey), F5 TetZap70ON (blue) and F5 TetZap70OFF (red) lymphocytes 
(LN) were cultured at 1x106 cells/well with 10ng/mL IL-7 (+IL-7, filled squares) 
or medium alone (-IL-7, empty squares) for 24, 48 or 72 hours (h), as indicated, 
after which they were counted and analysed by flow cytometry. F5 TetZap70OFF 
lymphocytes were isolated from the LNs of F5 TetZap70 chimeras taken off dox 
≥5 days previously. Bone marrow chimeras were made by reconstituting sub-
lethally irradiated B6 Rag1-/- mice with F5 TetZap70 bone marrow. Dot plots 
show annexin-V staining against forward scatter (FS) of cultured CD8+ TCR+ 
lymphocytes at 0 (A) and 72 (B) hours. (C) Line graphs show the frequency of 
live annexin-V- CD8+ TCR+ lymphocytes (LN) at 0, 24, 48 and 72 hours (h) as a 
percentage of the frequency at 0 hours. Each time-point represents ≥2 replicate 
wells (technical). (D) Line graph shows the frequency of live annexin-V- CD8+ 
TCR+ F5 TetZap70ON (Ly5.2) or F5 TetZap70OFF (Ly5.2) lymphocytes (LN) at 48 
hours as a percentage of the frequency at 0 hours. Data are also expressed as 
a percentage of the frequency of live annexin-V- CD8+ TCR+ Ly5.1 F5 Rag1-/- 
lymphocytes in the same well at 48 hours. Each time-point represents ≥2 
replicate wells (technical). Data are representative of ≥three independent 
experiments. 
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Figure 4.3 B6 Rag1-/- splenocytes enriched for CD11c+ cells promote 
Zap70-dependent T cell survival 
FACS-purified CD8+ TCR+ F5 Rag1-/- (grey), F5 TetZap70ON (blue) and F5 
TetZap70OFF (red) lymphocytes (LN) were cultured at 1x105 cells/well with 1x106 
CD11c+ enriched B6 Rag1-/- splenocytes (+CD11c+, filled squares) or medium 
alone (-CD11c+, empty squares) for 24, 48 or 72 hours (h), as indicated, after 
which they were counted and analysed by flow cytometry. F5 TetZap70OFF 
lymphocytes were isolated from the LNs of F5 TetZap70 chimeras taken off dox 
≥5 days previously. Bone marrow chimeras were made by reconstituting sub-
lethally irradiated B6 Rag1-/- mice with F5 TetZap70 bone marrow. (A) Dot plots 
show MHCII and CD11c expression and histograms show CD11c expression on 
total live splenocytes pre- and post-CD11c+-enrichment. (B) Dot plots show 
CD8 and TCR expression on FACS-purified CD8+ TCR+ lymphocytes (LN). (C) 
Dot plots show annexin-V staining against forward scatter (FS) of cultured CD8+ 
TCR+ lymphocytes at 0 and 72 hours. (D) Line graphs show the frequency of 
live annexin-V- CD8+ TCR+ lymphocytes (LN) at 0, 24, 48 and 72 hours (h) as a 
percentage of the frequency at 0 hours. Each time-point represents ≥2 replicate 
wells (technical). Data are representative of ≥three independent experiments. 
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Figure 4.4 FACS-purified cDCs and pDCs alone are unable to promote 
substantial naïve T cell survival in vitro  
FACS-purified CD8+ TCR+ F5 Rag1-/- were cultured at 1x105 cells/well with 
1x106 CD11c+ enriched B6 Rag1-/- splenocytes, FACS-purified DC subsets, 
CD4 (LN) or B (spleen) lymphocytes or medium alone, as indicated, for 48 
hours (h) after which they were counted and analysed by flow cytometry. 
Histogram shows CD11c expression (A) and dot plots show MHCII and CD11c 
expression (B) on total live splenocytes pre- and post-CD11c+-enrichment. (C) 
Dot plot shows MHCII and CD19/TCR (Lin) expression on total live splenocytes 
post-CD11c+-enrichment. (D) Dot plot shows mPDCA1 and CD11c expression 
and histogram shows CD45 expression on MHCII+ and MHCII- live CD11c+ 
splenocytes pre- and post-enrichment. Dot plots show MCHII and CD19/TCR 
(Lin) expression and, mPDCA1 and CD11c expression on FACS-purified MHCII-, 
cDC and pDC subsets (E) and CD4 and TCR expression and, B220 and CD19 
expression on FACS-purified CD4 and B lymphocytes (F). (G) Bar chart shows 
the frequency of live annexin-V- CD8+ TCR+ F5 Rag1-/- lymphocytes (LN) after 
48 hours of culture with medium alone (white), MHCII- (1), cDCs (2), pDCs (3), 
CD4 T (4) or B (5) lymphocytes as a percentage of the frequency at 0 hours and 
as a percentage of the frequency of live annexin-V- CD8+ TCR+ F5 Rag1-/- 
lymphocytes after 48 hours cultured with 1x106 CD11c+ enriched B6 Rag1-/- 
splenocytes. Each time-point represents ≥2 replicate wells (technical). Data are 
representative of ≥two independent experiments. 
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Figure 4.5 The T cell survival signal provided by CD11c+ splenocytes is 
β2m- and IL-7-independent 
FACS-purified CD8+ TCR+ F5 Rag1-/- were cultured at 1x105 cells/well with 
1x106 CD11c+ enriched B6 Rag1-/-, b2m-/- Rag1-/- or IL-7-/- Rag1-/- splenocytes 
with IL-7 and medium alone, as indicated, for 48 hours (h) after which they were 
counted and analysed by flow cytometry. (A) Dot plot shows CD8 and TCR 
expression on FACS-purified CD8+ TCR+ lymphocytes (LN). (B) Dot plots show 
MHCII and CD11c on total live splenocytes post-CD11c+-enrichment. (C) Dot 
plots show annexin-V staining against forward scatter (FS) of cultured CD8+ 
TCR+ lymphocytes (LN) at 48 hours. (D) Bar chart shows the frequency of live 
annexin-V- CD8+ TCR+ F5 Rag1-/- lymphocytes (LN) after 48 hours of culture 
with 10ng/mL IL-7 (black), medium alone (white), 1x106 CD11c+ enriched B6 
Rag1-/- (1), b2m-/- Rag1-/- (2) or IL-7-/- Rag1-/- (3) splenocytes. Each bar 
represents ≥4 replicate wells (biological); ns p>0.05 (one-way analysis of 
variance followed by Bonferroni correction for multiple comparisons). (E) Line 
graph shows the frequency of live annexin-V- CD8+ TCR+ F5 Rag1-/- 
lymphocytes (LN) after 48 hours of culture with 0.25x106, 0.5x106 or 1x106 
CD11c+ enriched B6 Rag1-/- lymphocytes and 10ng/mL, 2ng/mL, 0.4ng/mL, 
0.08ng/mL, 0.016ng/mL or medium alone as a percentage of the frequency at 0 
hours. Data are representative of ≥three independent experiments. 
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Figure 4.6 The T cell survival signal provided by CD11c+ splenocytes is 
impaired by MEK inhibition 
FACS-purified CD8+ TCR+ F5 Rag1-/- were cultured at 1x105 cells/well with 
10ng/mL IL-7 (black), medium alone (white) or 1x106 CD11c+ enriched B6 
Rag1-/- splenocytes alone (dark grey) or with DMSO, UO126, rapamycin or 
LY294002 (grey), as indicated. (A) Dot plots show annexin-V staining against 
forward scatter (FS) of cultured CD8+ TCR+ lymphocytes (LN) at 48 hours. (B) 
Bar chart shows the frequency of live annexin-V- CD8+ TCR+ F5 Rag1-/- 
lymphocytes (LN) after 48 hours. Each bar represents ≥3 replicate wells 
(biological); *** p≤0.001, ** p≤0.01, * p≤0.05 and ns p>0.05 (one-way analysis 
of variance followed by Bonferroni correction for multiple comparisons). Data 
are representative of ≥two independent experiments. 
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Chapter 5 The importance of two Zap70 
domains for the transduction of TCR 
survival signals 
5.1 Introduction 
We characterised the importance of Zap70-mediated TCR signals for naïve F5 
T cell survival in Chapter 3 and Chapter 4. In this chapter we will investigate 
how mutations in Zap70 leading either to the loss of Zap70 adaptor function or 
impaired recruitment of Zap70 to the TCR signalling complex, affect the 
transduction of TCR survival signals in naïve F5 T cells. Zap70, like its family 
member Syk, consists of a C-terminal kinase domain and two tandem N-
terminal SH2 domains, which bind phosphorylated ITAMs of CD3 chains 
associated with the TCR complex (Figure 1.5 and introduced in section 1.3.2) 
(reviewed in Au-Yeung et al., 2009). Three tyrosine residues located in the 
interdomain B in between the two SH2 domains of Zap70, Y292, Y315 and 
Y319, are known sites of phosphorylation and interact with downstream 
signalling targets of Zap70. Interestingly, as well as mediating the adaptor 
function of Zap70, Y315 and Y319 have also been implicated in regulating the 
auto-inhibitory conformation of Zap70, thus regulating its activity (Brdicka et al., 
2005). 
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Mutation of Y315 and Y319 to alanine and a missense mutation in the C-
terminal SH2 domain of Zap70 in YYAA and SKG mice, respectively, both result 
in hypomorphic TCR signalling (Hsu et al., 2009; Sakaguchi et al., 2003). The 
mutation in the SH2 domain of Zap70 leads to defective recruitment and 
association of Zap70 with CD3ζ ITAMs following TCR activation (Sakaguchi et 
al., 2003). Consistent with this TCR stimulation of T cells from SKG mice in vitro 
results in impaired Ca2+ mobilisation and impaired phosphorylation of LAT and 
PLCγ (Sakaguchi et al., 2003). The YYAA mutation is thought to specifically 
disrupt Zap70 adaptor function without stabilising the autoinhibitory 
conformation regulated by Y315 and Y319 (Hsu et al., 2009). Similar to T cells 
from SKG mice, T cells from YYAA mice show impaired Erk phosphorylation 
and Ca2+ mobilisation following TCR stimulation, although the defects in TCR 
signalling are more severe in T cells from SKG than from YYAA mice (Hsu et al., 
2009). Although Zap70+/- mice apparently have no impairment in TCR signalling 
or T cell development, it is important to bear in mind the reduced T cell 
abundance of Zap70Yyya and Zap70Skg in YYAA and SKG mice (Hsu et al., 
2009). 
Despite the more severe TCR signalling defect in SKG mice, T cell numbers in 
SKG and YYAA mice are similar (Hsu et al., 2009). Positive and negative 
selection is impaired in both SKG and YYAA mice resulting in the selection of 
autoreactive T cells which would be eliminated during negative selection in WT 
mice (Hsu et al., 2009; Sakaguchi et al., 2003). Consistent with a shift in the T 
cell repertoire and reduced numbers of Treg, both strains develop serum 
rheumatoid factor following zymosan challenge but only SKG mice develop 
rheumatoid arthritis (Hsu et al., 2009; Sakaguchi et al., 2003). Interestingly, the 
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in vitro suppressive activity of CD4 Treg from SKG mice is normal (Hsu et al., 
2009) but CD4 Treg from YYAA mice are much less able to suppress the 
proliferation of naïve T cells in vitro (Hsu et al., 2009). Differences in Treg 
function between SKG and YYAA mice thus fail to explain why only SKG mice 
develop rheumatoid arthritis. Instead, it has been proposed that the difference in 
TCR signalling defects as a result of the SKG and YYAA mutation in Zap70 lead 
to differences in the T cell repertoire so that only SKG mice develop rheumatoid 
arthritis following zymosan challenge (Hsu et al., 2009). 
In this chapter we sought to investigate whether two hypomorphic Zap70 alleles 
might be able to transduce TCR survival signals in naïve F5 T cells. To do this 
we crossed F5 TetZap70 mice with YYAA and SKG mice resulting in mice, 
which expressed WT Zap70 under transgenic control and mutant Zap70YYAA or 
Zap70SKG under endogenous control. We anticipated that this would allow the 
development of F5 T cells expressing WT and mutant Zap70 in dox-fed mice 
after which we hope to assess the effect of Zap70YYAA or Zap70SKG on naïve F5 
T cell survival following dox-withdrawal. 
5.2 Results 
5.2.1 F5 T cell development is blocked in F5 TetZap70unind Zap70Yyaa/- and 
F5 TetZap70unind Zap70Skg/- chimeras 
To investigate whether two Zap70 mutants, Zap70YYAA and Zap70SKG, were able 
to transduce a Zap70-dependent TCR survival signal we crossed F5 TetZap70 
mice with polyclonal C57Bl/6 mice expressing Zap70Yyaa (Hsu et al., 2009) or 
Zap70Skg (Sakaguchi et al., 2003). These mice express dox-inducible and T-cell 
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specific Zap70 and hCD2 (Zap70Tre rtTA.ChuCD2), are Rag1-deficient and 
express the F5 TCR.  In addition, these mice express mutant Zap70Yyaa or 
Zap70Skg under endogenous control on one allele while the second allele is a 
null allele (F5 TetZap70 Zap70Yyaa/- or F5 TetZap70 Zap70Skg/-, respectively, 
hereon). We anticipated that transgenic expression of Zap70WT in constitutively 
dox-fed mice would allow normal F5 T cell development while dox-withdrawal 
would lead to expression of only Zap70Yyaa or Zap70Skg. As with F5 TetZap70 
mice, we generated host bone marrow chimeras using F5 TetZap70 YYAA 
bone marrow in sub-lethally irradiated B6 Rag1-/- mice, which were left to 
reconstitute for a minimum of 6 weeks. 
In view of the defect in TCR signalling and resulting impaired T cell 
development in polyclonal YYAA and SKG we wanted to characterise the 
thymic development of F5 T cells in constitutively dox-fed and uninduced F5 
TetZap70 Zap70Yyaa/- and F5 TetZap70 Zap70Skg/- chimeras and mice (F5 
TetZap70ON Zap70Yyaa/-, F5 TetZap70ON Zap70Skg/-, F5 TetZap70unind Zap70Yyaa/- 
and F5 TetZap70unind Zap70Skg/-, respectively, hereon) (Figure 5.1). Since F5 
TetZap70unind Zap70Yyaa/- and F5 TetZap70unind Zap70Skg/- mice express only one 
allele of Zap70 under endogenous control and only one allele of F5 TCR,  we 
used F5+/- Rag1-/- Zap70+/- chimeras as controls in addition to F5 Rag1-/- mice 
and chimeras (Figure 5.1A). We detected no gross differences in T cell 
development in F5+/- Rag1-/- Zap70+/- and F5 Rag1-/- chimeras by flow cytometry, 
other than a small reduction in the number of CD8 SP thymocytes developing in 
F5+/- Rag1-/- Zap70+/- chimeras compared to F5 Rag1-/- chimeras (Figure 5.1A, 
D and E). Similar to Zap70-/- mice (Negishi et al., 1995), F5 T cell development 
was blocked at the DP stage in F5 TetZap70unind Zap70Yyaa/- and F5 
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TetZap70unind Zap70Skg/- mice (Figure 5.1A). The block in F5 T cell development 
in F5 TetZap70unind Zap70Yyaa/- and F5 TetZap70unind Zap70Skg/- mice was 
overcome by constitutive dox-feeding, and F5 TetZap70ON Zap70Yyaa/- and F5 
TetZap70ON Zap70Skg/- chimeras had readily detectable CD8 SP thymocyte 
populations (Figure 5.1A). Interestingly, we consistently detected fewer CD8 SP 
in F5 TetZap70ON Zap70Yyaa/- than in F5 TetZap70ON chimeras, whereas the 
frequency and number of CD8 SP thymocytes in F5 TetZap70ON Zap70Skg/- and 
F5 TetZap70ON chimeras was similar (Figure 5.1D and E). Collectively, these 
data show that neither Zap70Yyaa nor Zap70Skg can mediate the development of 
F5 T cells but that dox-feeding rescues T cell development in F5 TetZap70ON 
Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- chimeras. 
We looked at the block in T cell development in F5 TetZap70unind Zap70Yyaa/- 
and F5 TetZap70unind Zap70Skg/- mice in some more detail by looking at CD5 and 
TCR expression within the DP subset by flow cytometry (Figure 5.1B). DP 
thymocytes can subdivided into 3 phenotypically and developmentally distinct 
DP subsets based on their CD5 and TCR expression (described in Chapter 3) 
and in both F5 TetZap70unind Zap70Yyaa/- and F5 TetZap70unind Zap70Skg/- mice 
were blocked at the CD5lo TCRlo DP1 stage (Figure 5.1B). Thymocytes in 
Zap70+/- mice (Negishi et al., 1995) and F5 TetZap70unind mice (Figure 3.1D and 
Figure 5.1B) are also blocked at the DP1 stage. Interestingly, while blocked 
DP1 thymocytes in F5 TetZap70unind and F5 TetZap70unind Zap70Skg/- mice 
express heterogeneous levels of CD5, all blocked DP1 thymocytes in F5 
TetZap70unind Zap70Yyaa/- mice had upregulated their CD5 expression (Figure 
5.1B). Taken together, these data show firstly, that CD5 expression is 
modulated at the DP1 stage of T cell development and secondly, that the two 
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Zap70 mutants, Zap70YYAA and Zap70SKG have different effects on this 
modulation. 
Finally, we also characterised transgene expression in F5 TetZap70 Zap70Yyaa/- 
and F5 TetZap70 Zap70Skg/- chimeras. In view of the difficulty of distinguishing 
between mutant and WT Zap70 we focussed mainly on transgenic hCD2 
expression. Both thymocytes from F5 TetZap70ON Zap70Yyaa/- and F5 
TetZap70ON Zap70Skg/- chimeras expressed hCD2 upon dox-feeding (Figure 
5.1C) although the overall abundance of Zap70 was reduced in thymocytes 
from F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- chimeras 
compared to thymocytes from F5 TetZap70ON chimeras (Figure 5.1C). The 
frequency of hCD2+ thymocytes was comparable in F5 TetZap70ON, F5 
TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/-. Collectively, these data 
suggest that transgene expression reduced in F5 TetZap70ON Zap70Yyaa/- and 
F5 TetZap70ON Zap70Skg/- chimeras consistent F5 TetZap70ON Zap70Yyaa/- and 
F5 TetZap70ON Zap70Skg/- chimeras expressing only one inducible allele of 
Zap70Wt. 
5.2.2 Peripheral reconstitution of constitutively dox-fed F5 TetZap70 
Zap70Yyaa/- and F5 TetZap70 Zap70Skg/- chimeras 
Next we wanted to characterise the peripheral reconstitution of F5 TetZap70ON 
Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- chimeras compared to F5 
TetZap70ON, F5 Rag1-/- and F5+/- Rag1-/- Zap70+/- chimeras (Figure 5.2). Despite 
the reduction in CD8 SP thymocytes in F5+/- Rag1-/- Zap70+/- chimeras 
compared to F5 Rag1-/- chimeras, F5 Rag1-/- and F5+/- Rag1-/- Zap70+/- chimeras 
had a similar frequency and number of peripheral CD8 T cells in the LN and 
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spleen (Figure 5.2A, B and C). We could not detect any peripheral CD8 T cells 
in F5 TetZap70unind, F5 TetZap70unind Zap70Yyaa/- and F5 TetZap70unind 
Zap70Skg/- mice (Figure 5.2A) consistent with the observed block in T cell 
development in these mice (Figure 5.1A). Peripheral CD8 T cells were readily 
detectable by flow cytometry in the LN of F5 TetZap70ON Zap70Yyaa/- and F5 
TetZap70ON Zap70Skg/- chimeras (Figure 5.2A). In addition to fewer CD8 SP 
thymocytes, F5 TetZap70ON Zap70Yyaa/- chimeras also consistently had a 
reduced frequency and number of peripheral CD8 T cells in the LN and spleen. 
These data show that dox-feeding allows the peripheral reconstitution of F5 
TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- chimeras but that 
Zap70YYAA exerts a dominant negative effect on T cell homeostasis in F5 
TetZap70ON Zap70Yyaa/- chimeras.  
Since surface CD5 expression on peripheral CD8 T cells is modulated by 
homeostatic TCR signalling (Saini et al., 2009; Smith et al., 2001) and 
Zap70YYAA and Zap70SKG mediate reduced TCR signalling in polyclonal T cells 
we analysed CD5 expression on peripheral CD8 T cells from F5 TetZap70ON, 
F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- chimeras by flow 
cytometry (Figure 5.2D). CD8 T cells from F5+/- Rag1-/- Zap70+/- chimeras 
consistently expressed less CD5 than CD8 T cells from F5 Rag1-/- chimeras 
suggesting heterozygous Zap70 expression is sufficient for a reduction in T cell 
homeostatic TCR signalling (Figure 5.2D). Meanwhile CD8 T cells from F5 
TetZap70ON, F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- 
chimeras all had the same low surface CD5 expression suggesting that CD8 T 
cells in these three mouse strains receive similar reduced homeostatic TCR 
signals. 
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5.2.3 Regulation of Zap70 abundance in F5 TetZap70 Zap70Yyaa/- and F5 
TetZap70 Zap70Skg/- chimeras 
In view of the expression defects of both Zap70Yyaa and Zap70Skg in polyclonal 
mice we wanted to characterise Zap70 abundance in F5 TetZap70 Zap70Yyaa/- 
and F5 TetZap70 Zap70Skg/- chimeras taken off dox at least 5 days previously 
(F5 TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/-, respectively, 
hereon). Zap70 abundance in thymocytes from F5 TetZap70OFF Zap70Yyaa/- and 
F5 TetZap70OFF Zap70Skg/- chimeras was similar and higher than in thymocytes 
from F5 TetZap70OFF chimeras but lower than in thymocytes from F5+/- Rag1-/- 
Zap70+/- chimeras (Figure 5.3A). Interestingly, Zap70 abundance in CD8 T cells 
from F5+/- Rag1-/- Zap70+/- and F5 TetZap70OFF Zap70Yyaa/- chimeras was similar, 
whereas Zap70 abundance in CD8 T cells from F5 TetZap70OFF and F5 
TetZap70OFF Zap70Skg/- chimeras was much lower. We also compared Zap70 
abundance in CD8 T cells from F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70OFF 
Zap70Yyaa/- chimeras and from F5 TetZap70ON Zap70Skg/- and F5 TetZap70OFF 
Zap70Skg/- chimeras (Figure 5.3B). CD8 T cell Zap70 abundance was very 
similar regardless of dox-feeding suggesting the majority of Zap70 in peripheral 
CD8 T cells comes from the endogenous Zap70 locus (Figure 5.3B). Together, 
these data show that Zap70 abundance is more severely affected in F5 
TetZap70 Zap70Skg/- chimeras than in F5 TetZap70 Zap70Yyaa/- chimeras. 
5.2.4 Zap70YYAA and Zap70SKG cannot substitute for Zap70WT to promote 
Zap70-dependent survival of F5 T cells in F5 TetZap70 chimeras 
Finally we wanted to assess the survival of CD8 T cells in F5 TetZap70 
Zap70Yyaa/- and F5 TetZap70 Zap70Skg/- chimeras following dox-withdrawal to 
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investigate whether either Zap70YYAA or Zap70SKG can substitute for Zap70WT 
and promote the survival of naïve F5 T cells. We took a cohort of F5 
TetZap70ON, F5 TetZap70 Zap70Yyaa/- and F5 TetZap70 Zap70Skg/- chimeras off 
dox (F5 TetZap70OFF Zap70Yyaa/- and F5 OFF Zap70Skg/-, respectively, hereon) 
and followed the peripheral frequency of CD8 T cells in the blood of these mice 
(Figure 5.4). To account for the different frequencies of CD8 T cells in the blood 
of F5 Rag1-/-, F5+/- Zap70-/-, F5 TetZap70, F5 TetZap70 Zap70Yyaa/- and F5 
TetZap70 Zap70Skg/- chimeras at d0, we normalised the frequency of blood F5 T 
cells at each time-point to the starting frequency at d0. Interestingly, in both F5 
TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/- chimeras, F5 T cells 
were not maintained (Figure 5.4A and B). The drop in CD8 T cells in F5 
TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/- chimeras compared to 
F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- chimeras could not 
be explained by a reduction in Zap70 since the frequency of peripheral blood F5 
T cells was maintained in F5+/- Rag1-/- Zap70+/- chimeras (Figure 3.5A). CD8 T 
cells had an average half-life of 21.1±1.3 days in TetZap70OFF Zap70Yyaa/- 
chimeras and 18.2 days in F5 TetZap70OFF Zap70Skg/- chimeras. After 48 days 
the LN and spleen of F5 TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF 
Zap70Skg/- chimeras consistently had fewer CD8 T cells than the LN and spleen 
of F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- chimeras (Figure 
5.3C and D). Taken together, these data show that neither Zap70YYAA nor 
Zap70SKG is able to substitute for Zap70WT in the transduction of a Zap70-
dependent TCR survival signal in naïve CD8 T cells. 
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5.3 Discussion 
In this chapter we show that neither Zap70YYAA nor Zap70SKG are able to 
substitute for Zap70WT during F5 T cell positive selection or to mediate a TCR 
survival signal in peripheral naïve F5 T cells. We show that T cell development 
is blocked at the CD5lo TCRlo DP1 stage in F5 TetZap70unind Zap70Yyaa/- and F5 
TetZap70unind Zap70Skg/- mice and that heterozygous dox-inducible expression of 
Zap70Wt rescues T cell development and reconstitutes the peripheral T cell 
compartment in F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- 
chimeras. Interestingly, blocked DP1 thymocytes F5 TetZap70unind Zap70Yyaa/- 
mice expressed higher CD5 than blocked DP1 thymocytes F5 TetZap70unind and 
F5 TetZap70unind Zap70Skg/- mice. F5 TetZap70ON Zap70Yyaa/- consistently had 
fewer CD8 SP thymocytes and peripheral CD8 T cells than F5 TetZap70ON 
Zap70Skg/- and F5 TetZap70ON chimeras, suggesting Zap70YYAA has a dominant 
negative effect on TCR signal transduction by Zap70WT. Consistent with data 
from polyclonal YYAA and SKG mice, Zap70 abundance was lower in 
thymocytes and peripheral CD8 T cells from F5 TetZap70unind Zap70Skg/- than 
from F5 TetZap70unind Zap70Yyaa/- mice. CD5 expression was equally reduced 
on peripheral CD8 T cells from F5 TetZap70ON, F5 TetZap70ON Zap70Yyaa/- and 
F5 TetZap70ON Zap70Skg/- chimeras.  
In Chapter 3 we characterised the development and survival of CD8 T cells in 
F5 TetZap70ON and F5 TetZap70OFF chimeras and showed that CD8 T cell 
development and survival required dox-inducible Zap70Wt expression. Like in F5 
TetZap70unind and F5 TetZap70OFF chimeras, T cell development was blocked at 
the DP1 stage in F5 TetZap70unind Zap70Yyaa/- and F5 TetZap70unind Zap70Skg/- 
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chimeras. Interestingly, blocked DP1 thymocytes in F5 TetZap70unind Zap70Yyaa/- 
had all upregulated their CD5 expression in contrast to blocked DP1 thymocytes 
in F5 TetZap70unind and F5 TetZap70unind Zap70Skg/- chimeras (Figure 5.1B). 
Meanwhile, Zap70 abundance was similar in DP1 thymocytes from F5 
TetZap70unind Zap70Yyaa/- and F5 TetZap70unind Zap70Skg/- chimeras (Figure 
5.3A). These data suggested that, in addition to being modulated on thymocytes 
during positive selection (Azzam et al., 1998; Tarakhovsky et al., 1995), CD5 
expression is regulated on thymocytes at the DP1 stage before positive 
selection. Furthermore, this regulation of CD5 expression appeared to be 
mediated by Zap70 and was preserved in absence of Zap70 adaptor function in 
thymocytes from F5 TetZap70unind Zap70Yyaa/- chimeras. CD5 expression on DP 
thymocytes in polyclonal YYAA mice, is also higher than on DP thymocytes in 
SKG mice (Hsu et al., 2009). This and our data are consistent with the SKG 
mutation in Zap70 leading to a more severe impairment of Zap70 and TCR 
signalling. Interestingly, in the periphery CD5 expression on CD8 T cells from 
F5 TetZap70ON, F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70ON Zap70Skg/- 
chimeras was similar,  suggesting that one allele of dox-inducible Zap70Wt is 
sufficient to transduce homeostatic TCR signals. 
In this chapter we also show that Zap70YYAA exerts a dominant negative effect 
on T cell development and homeostasis in F5 TetZap70ON Zap70Yyaa/- chimeras. 
F5 TetZap70ON Zap70Yyaa/- chimeras consistently had fewer CD8 SP thymocytes 
and fewer peripheral CD8 T cells than F5 TetZap70ON chimeras (Figure 5.1D 
and E and Figure 5.2D). F5 TetZap70ON Zap70Skg/- and F5 TetZap70ON 
chimeras, on the other hand had a similar frequency and number of CD8 SP 
thymocytes and peripheral CD8 T cells suggesting that Zap70YYAA, specifically, 
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exerts a dominant negative effect on T cell development and peripheral 
homeostasis in F5 TetZap70ON Zap70Yyaa/- chimeras. F5+/- Rag1-/- Zap70+/- 
chimeras had fewer CD8 SP thymocytes than F5 Rag1-/- chimeras but had a 
similar number of peripheral CD8 T cells (Figure 5.1D and E and Figure 5.2D). 
Reduced Zap70 abundance alone, does not account for the defect in T cell 
development in F5 TetZap70ON Zap70Yyaa/- chimeras since Zap70 abundance is 
similar in F5 TetZap70ON Zap70Yyaa/- and F5+/- Rag1-/- Zap70+/- thymocytes is 
similar (Figure 5.3A). The TCR-mediated upregulation of Zap70YYAA during 
positive selection might be impaired in F5 TetZap70ON Zap70Yyaa/- chimeras. 
This seems unlikely, since peripheral CD8 T cells in F5 TetZap70ON Zap70Yyaa/- 
and F5+/- Rag1-/- Zap70+/- chimeras have similar Zap70 abundance (Figure 
5.3A) suggesting transgenic Zap70Wt can transduce the TCR signals that 
mediate the developmental upregulation of Zap70Yyaa. Instead, it seems likely 
that Zap70YYAA interferes with Zap70WT signalling in F5 TetZap70ON Zap70Yyaa/- 
chimeras.  
We generated F5 TetZap70 Zap70Yyaa/- and F5 TetZap70 Zap70Skg/- mice to 
investigate the effects of loss of Zap70 adaptor function and attenuated Zap70 
signalling on naïve CD8 T cell survival in vivo. We show that neither Zap70YYAA 
nor Zap70SKG was sufficient for the transduction of TCR survival signals in naïve 
CD8 T cells. Furthermore, in absence of transgenic Zap70WT expression, CD8 T 
cells are not maintained in F5 TetZap70OFF, F5 TetZap70OFF Zap70Yyaa/- or F5 
TetZap70OFF Zap70Skg/- chimeras (Figure 5.4A and B). Reduced Zap70 
abundance in F5+/- Rag1-/- Zap70+/- chimeras had no effect on CD8 T cell half-
life for 48 days (Figure 5.4A). Since Zap70 abundance in CD8 T cells from F5 
TetZap70OFF Zap70Yyaa/- and F5+/- Rag1-/- Zap70+/- chimeras was similar, 
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reduced Zap70-abundance does not account for the impaired maintenance of 
blood CD8 T cells in F5 TetZap70OFF Zap70Yyaa/-. Zap70 abundance in CD8 T 
cells from F5 TetZap70OFF Zap70Skg/- and F5 TetZap70OFF chimeras was 
comparable and so attenuated Zap70 signalling as well as reduced Zap70 
abundance probably contributed to the impaired maintenance of blood CD8 T 
cells in F5 TetZap70OFF Zap70Skg/- chimeras. In polyclonal mice the SKG 
mutation leads to a more severe defect in TCR signalling than the YYAA 
mutation (Hsu et al., 2009) and consistent with this the half-life of CD8 T cells 
was shorter in  F5 TetZap70OFF Zap70Skg/- chimeras than in F5 TetZap70OFF 
Zap70Yyaa/- chimeras. Importantly, F5 TetZap70ON Zap70Yyaa/- chimeras are 
relatively lymphopaenic compared to F5 TetZap70ON Zap70Skg/- chimeras and 
F5 TetZap70ON and it will be essential to characterise the maintenance CD8 T 
cells from F5 TetZap70OFF, F5 TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF 
Zap70Skg/- chimeras following transfer into F5 Rag1-/- mice.  
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Figure 5.1 F5 T cell development is blocked in F5 TetZap70unind Zap70Yyaa/- 
and F5 TetZap70unind Zap70Skg/- chimeras  
Thymocytes from F5 Rag1-/-, F5+/- Rag1-/- Zap70+/-, F5 TetZap70unind (red, solid), 
F5 TetZap70unind Zap70Yyaa/- (red, dotted) and F5 TetZap70unind Zap70Skg/- (red, 
thin) mice and constitutively dox-fed F5 TetZap70ON (blue, solid), F5 
TetZap70ON Zap70Yyaa/- (blue, dotted) and F5 TetZap70ON Zap70Skg/- (blue, thin) 
bone marrow chimeras were counted and analysed by flow cytometry. Bone 
marrow chimeras were made by reconstituting sub-lethally irradiated B6 Rag1-/- 
mice with F5 TetZap70 bone marrow. (A) Dot plots show CD4 against CD8 
expression on live or hCD2+ thymocytes. (B) Dot plots show CD5 against TCR 
expression on CD4+ CD8+ DP thymocytes and histogram shows CD5 
expression on CD4+ CD8+ DP thymocytes. (C) Histograms show hCD2 
expression on total live thymocytes. Box and whisker plots show the frequency 
(D) and number (E) of hCD2+ CD5hi TCRhi CD8+ SP thymocytes F5 Rag-/- (n=2), 
F5+/- Rag1-/- Zap70+/- (n=7), F5 TetZap70ON (n=13), F5 TetZap70ON Zap70Yyaa/- 
(n=13) and F5 TetZap70ON Zap70Skg/- (n=5) chimeras; *p≤0.05 and ns p>0.05 
(one-way analysis of variance followed by Bonferroni correction for multiple 
comparisons). Data are representative of ≥two independent experiments.CC) 
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Figure 5.2 Peripheral reconstitution of constitutively dox-fed F5 TetZap70 
Zap70Yyaa/- and F5 TetZap70 Zap70Skg/- chimeras 
Lymphocytes (LN) from F5 Rag1-/-, F5+/- Rag1-/- Zap70+/-, F5 TetZap70unind (red, 
solid), F5 TetZap70unind Zap70Yyaa/- (red, dotted) and F5 TetZap70unind Zap70Skg/- 
(red, thin) mice and constitutively dox-fed F5 TetZap70ON (blue, solid), F5 
TetZap70ON Zap70Yyaa/- (blue, dotted) and F5 TetZap70ON Zap70Skg/- (blue, thin) 
bone marrow chimeras were counted and analysed by flow cytometry. Bone 
marrow chimeras were made by reconstituting sub-lethally irradiated B6 Rag1-/- 
mice with F5 TetZap70 bone marrow. (A) Dot plots show CD8 against TCR 
expression on live lymphocytes (LN). Box and whisker plots show the frequency 
(B) and number (C) of CD8+ TCR+ CD5hi TCRhi lymphocytes in F5 Rag-/- (n=2), 
F5+/- Rag1-/- Zap70+/- (n=7), F5 TetZap70ON (n=13), F5 TetZap70ON Zap70Yyaa/- 
(n=18) and F5 TetZap70ON Zap70Skg/- (n=5); **** p≤0.0001 and ns p>0.05 (one-
way analysis of variance followed by Bonferroni correction for multiple 
comparisons). (D) Histograms show CD5 expression on CD8+ TCR+ CD5hi 
TCRhi lymphocytes (LN). Data are representative of ≥two independent 
experiments. 
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Figure 5.3 Regulation of Zap70 abundance in F5 TetZap70 Zap70Yyaa/- and 
F5 TetZap70 Zap70Skg/- chimeras 
Thymocytes and lymphocytes (LN) from F5 Rag1-/-, F5+/- Rag1-/- Zap70+/-, F5 
TetZap70OFF (red, solid), F5 TetZap70OFF Zap70Yyaa/- (red, dotted) and F5 
TetZap70OFF Zap70Skg/- (red, thin) mice and constitutively dox-fed F5 
TetZap70ON (blue, solid), F5 TetZap70ON Zap70Yyaa/- (blue, dotted) and F5 
TetZap70ON Zap70Skg/- (blue, thin) bone marrow chimeras were counted and 
analysed by flow cytometry. Bone marrow chimeras were made by 
reconstituting sub-lethally irradiated B6 Rag1-/- mice with F5 TetZap70 bone 
marrow. (A) Histograms show Zap70 abundance in total thymocytes and in 
CD8+ TCR+ CD5hi TCRhi lymphocytes (LN). (B) Histograms show Zap70 
abundance in CD8+ TCR+ CD5hi TCRhi lymphocytes (LN). With the exception of 
the left panel of (A) and (B), data are representative of ≥three independent 
experiments. 
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Figure 5.4 Zap70YYAA and Zap70SKG cannot substitute for Zap70WT to 
promote Zap70-dependent survival of F5 T cells in F5 TetZap70 chimeras 
A cohort of constitutively dox-fed F5 TetZap70ON, F5 TetZap70ON Zap70Yyaa/- 
and F5 TetZap70ON Zap70Skg/- bone marrow chimeras were taken off dox and 
the frequency and number of CD8+ TCR+ CD5hi TCRhi lymphocytes in the blood, 
LN and spleen of F5 Rag1-/- (grey), F5+/- Rag1-/- Zap70+/- (grey), F5 TetZap70ON 
(blue, solid), F5 TetZap70ON Zap70Yyaa/- (blue, dotted), F5 TetZap70ON 
Zap70Skg/- (blue, dotted), F5 TetZap70OFF (red, solid), F5 TetZap70OFF 
Zap70Yyaa/- (red, dotted), F5 TetZap70OFF Zap70Skg/- (red, dotted)  was assessed 
by flow cytometry. Bone marrow chimeras were made by reconstituting sub-
lethally irradiated B6 Rag1-/- mice with F5 TetZap70 bone marrow. (A) and (B) 
Line graphs show the frequency of CD8+ TCR+ CD5hi TCRhi blood lymphocytes 
as a percentage of the frequency at d0; **** p≤0.0001, ** p≤0.01 and * p≤0.05 
F5 TetZap70OFF compared to F5 TetZap70ON, F5 TetZap70OFF Zap70Skg/-  
compared to F5 TetZap70ON Zap70Skg/- or F5 TetZap70OFF Zap70Yyaa/-  
compared to F5 TetZap70ON Zap70Yyaa/- (two-way analysis of variance followed 
by Bonferroni correction for multiple comparisons). Each time-point represents 
≥2 replicate mice. Box and whiskers plots show the frequency (C) and number 
(D) of LN CD8+ TCR+ CD5hi TCRhi lymphocytes in bone marrow chimeras (n≥2); 
*** p≤0.001 and ** p≤0.01 (one-way analysis of variance followed by Bonferroni 
correction for multiple comparisons). With the exception of (B) data are 
representative of ≥two independent experiments. 
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Chapter 6 The role of TCR signalling during 
a cognate immune response 
6.1  Introduction 
Naïve CD8 T cells are activated in SLOs by activated DCs presenting the 
correct pMHC ligand. Efficient T cell sampling of pMHC on DCs is mediated by 
transient T cell DC interactions (Gunzer et al., 2000) which become more stable 
following T cell recognition of a specific pMHC (Dustin and Springer, 1989; 
Shimizu et al., 1990; van Kooyk et al., 1989). Subsequent CD8 T cell activation, 
proliferation and differentiation into effector and memory cells requires CD28 co-
stimulation (reviewed in Acuto and Michel, 2003), cytokine signals, CD4 T cell 
help (reviewed in Mescher et al., 2006) in addition to antigen stimulation (Zehn 
et al., 2012).  
Following T cell activation, antigen-specific CD8 T cells expand for ~7-8 days, 
undergoing as many as 15-20 divisions (Butz and Bevan, 1998; Murali-Krishna 
et al., 1998; and reviewed in Williams and Bevan, 2007). After T cell expansion 
up to 90-95% antigen-specific T cells undergo apoptosis. The remaining T cells 
become long-lived memory cells (Kaech et al., 2002; and reviewed in Williams 
and Bevan, 2007). In addition to many other factors, the strength and duration 
of the initial TCR stimulus impact on T cell expansion and T cell differentiation 
during an immune response. A recent study investigated the impact of TCR 
signal strength on T cell expansion and differentiation using an OT-I TCR 
transgenic model (Zehn et al., 2009). Interestingly, in this model the initial T cell 
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expansion and differentiation response provoked by low and high-affinity TCR 
ligands is similar (Zehn et al., 2009). Stronger TCR signals ultimately promote 
more sustained proliferation explaining the accumulation of mainly high-affinity 
antigen-specific T cells during a polyclonal immune response (Zehn et al., 2009). 
Interestingly, in this study (Zehn et al., 2009), even TCR stimulation mediated 
by low affinity ligands promoted  the differentiation of CD8 T cells into effector 
and memory T cells.  
Meanwhile, the impact of the duration of pMHC and TCR interactions has been 
studied extensively in vitro and in vivo (reviewed Williams et al., 2007 and in 
Masopust et al., 2004)). It seems that CD8 T cells only need very brief 
encounters with antigen after which the CD8 T cell enters a program of 
differentiation and expansion in vitro (Kaech and Ahmed, 2001; van Stipdonk et 
al., 2001; 2003). Even the onset of T cell contraction and differentiation into 
memory cells after the antigen is cleared, might be programmed very early on 
during an immune response (Badovinac et al., 2002; Kaech and Ahmed, 2001). 
Consistent with this, in vivo imaging of T cell DC interactions reveals that initial 
T cell and DC interactions in the LN are brief (Mempel et al., 2004). Once 
activated, T cell motility decreases and more stable T cell-DC conjugates form. 
Finally, proliferating T cells resume their brief encounters with DCs (Mempel et 
al., 2004). Recent in vivo experiments, however, show that removal of antigen 
does affect the degree of clonal expansion but that the functionality of 
generated effector cells does not depend on the duration of antigen exposure 
(Prlic et al., 2006).  
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In this chapter, we sought to examine both the strength and duration of TCR 
signals required to induce F5 T cell activation, expansion and differentiation in 
vivo. To do this, we challenged F5 Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF 
T cells with live influenza in Ly5.1 C57Bl/6 hosts and assessed T cell activation 
and expansion 7 days after challenge. We also assessed the effect of two 
Zap70 mutants to transduce antigen-specific T cell activation signals and 
promote F5 T cell expansion. Finally, we assessed the temporal requirements 
of Zap70 and thus TCR signaling in vivo by withdrawing dox at various stages 
of the immune response from C57Bl/6 hosts who received F5 TetZap70ON T 
cells.  
6.2  Results 
6.2.1 F5 TetZap70ON T cells expand in response to cognate antigen in B6 
Rag1-/- mice in vivo 
Naïve CD8 T cells from F5 TetZap70ON chimeras had low Zap70 abundance 
and low surface CD5 expression (Figure 3.2) consistent with receiving weak 
homeostatic TCR signals. We wanted to test whether CD8 T cells from F5 
TetZap70ON chimeras, while less responsive to homeostatic TCR signalling, 
could respond to cognate antigen in vivo. We did this by challenging CD8 T 
cells from F5 TetZap70ON chimeras with A/NT/60/68 influenza virus after 
transfer into B6 Rag1-/- hosts. We assessed CD8 T cell expansion and 
differentiation 7 days after transfer (Figure 6.1). Interestingly, we found that T 
cells from F5 TetZap70ON chimeras were able to proliferate when challenged 
with influenza in dox-fed B6 Rag1-/- mice (Figure 6.1A and B). The number of 
expanded F5 TetZap70ON T cells in dox-fed hosts was 10-fold lower than the 
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number of expanded F5 Rag1-/- T cells 7 days after challenge (Figure 6.1B). We 
observed no significant expansion of F5 TetZap70ON T cells in B6 Rag1-/- hosts 
that were not fed dox (Figure 6.1A and B). Both F5 Rag1-/- and F5 TetZap70 T 
cells showed induction of the T cell activation marker CD44 (Budd et al., 1987) 
7 days after challenge (Figure 6.1C). Interestingly, activated F5 TetZap70 and 
F5 Rag1-/- T cells had also upregulated surface expression of CD5 (Figure 6.1D). 
In fact, F5 TetZap70 CD5 expression 7 days after challenge exceeded CD5 
expression of naïve F5 Rag1-/- T cells. Taken together these data show that 
CD8 T cells from F5 TetZap70ON chimeras can proliferate and become 
activated in vivo despite evidence for low homeostatic TCR signalling in naïve 
CD8 T cells from F5 TetZap70ON chimeras. 
6.2.2 F5 TetZap70ON T cells expand in response to cognate antigen in 
C57Bl/6 mice in vivo 
We next wanted investigate whether F5 TetZap70 would be able to respond to 
cognate antigen in a more physiological context. To do this we transferred F5 
Rag1-/- and F5 TetZap70 T cells into lymphoreplete Ly5.1 C57Bl/6 hosts, 
challenged these mice with influenza and then analysed the expansion of 
Ly5.2+ F5, F5 TetZap70ON and Zap70 deficient F5 T cells after 7 days of 
transfer (Figure 6.2). As we observed in B6 Rag1-/- hosts, CD8 T cells from F5 
TetZap70ON chimeras proliferated in Ly5.1 C57Bl/6 hosts (Figure 6.2A and B). 
Again CD8 T cells from F5 TetZap70ON chimeras did not proliferate to the same 
extent as CD8 T cells from F5 Rag1-/- mice (Figure 6.2B and C). CD8 T cell 
proliferation required Zap70 expression, as CD8 T cells from of F5 TetZap70OFF 
chimeras did not expand to the same extent as CD8 T cells from F5 
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TetZap70ON chimeras (Figure 6.2B and C). T cell expansion was also influenza 
specific and F5 Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T cells failed to 
proliferate in unchallenged Ly5.1 C57Bl/6 hosts (Figure 6.2B and C). 
Collectively, these data show that F5 TetZap70 T cell expansion is dependent 
on the presence of both antigen and Zap70.  
We also characterised the expression of CD44 and IL-7Rα on challenged F5 
Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T cells. Activated T cells 
upregulate their expression of CD44 (Budd et al., 1987) while the re-expression 
of IL-7Rα during an immune response is thought to be important for the 
development of long-lived memory T cells (Buentke et al., 2006; Huster et al., 
2004; Kaech et al., 2003). F5 Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T 
cells had all upregulated CD44 7 days after being challenged (Figure 6.2D). 
This CD44 induction did not occur in animals that were not challenged (Figure 
6.2D). IL-7Rα expression was also upregulated on influenza-challenged F5 
Rag1-/-, F5 TetZap70ON and F5 TetZap70OFF T cells as well as on endogenous 
Ly5.1+ CD8 T cells (Figure 6.2 E). Taken together these data show that F5 
Rag1-/- and F5 TetZap70ON but not F5 Tet Zap70OFF T cells become activated 
and expand if challenged with cognate antigen in lymphoreplete hosts in vivo. 
6.2.3 Neither Zap70Yyaa or Zap70Skg can substitute for Zap70Wt in F5 
TetZap70 cognate response 
We also wanted to investigate whether mutant Zap70YYAA or Zap70SKG could 
substitute for Zap70WT in response to cognate antigen. Both Zap70 mutants 
have been shown to mediate weaker TCR signalling (Hsu et al., 2009; 
Sakaguchi et al., 2003) and neither is able to substitute for Zap70WT in the 
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transduction of the TCR survival signal in naïve T cells (Chapter 5). To study 
this, we challenged CD8 T cells from F5 TetZap70ON Zap70Yyaa/-, F5 
TetZap70ON Zap70Skg/-, F5 TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF 
Zap70Skg/- chimeras with influenza in Ly5.1 C57Bl/6 hosts. We used F5 Rag1-/- 
and F5 TetZap70ON T cells as controls and analysed hosts 7 days after 
challenge (Figure 6.3). Influenza-challenged F5 Rag1-/- and F5 TetZap70ON T 
cells proliferated when in Ly5.1 C57Bl/6 (Figure 6.3B). CD8 T cells from F5 
TetZap70ON Zap70Yyaa/-, F5 TetZap70ON Zap70Skg/-, F5 TetZap70OFF Zap70Yyaa/- 
and F5 TetZap70OFF Zap70Skg/- chimeras however, did not expand to the same 
extent as F5 TetZap70ON or F5 Rag1-/- T cells (Figure 6.3C and D). These data 
show that neither of the two Zap70 mutants can substitute for Zap70WT 
signalling during T cell expansion. It also suggests that heterozygous 
expression of transgenic Zap70WT in F5 TetZap70ON Zap70Yyaa/- and F5 
TetZap70ON Zap70Skg/- chimeras is insufficient to mediate antigen-induced 
proliferation. 
To investigate whether CD8 T cells from F5 TetZap70OFF Zap70Yyaa/- and F5 
TetZap70OFF Zap70Skg/- chimeras underwent any proliferation following an 
influenza challenge we labelled CD8 T cells with CTV prior to transfer (Figure 
6.3E). Interestingly, F5 Rag1-/-, F5 TetZap70ON, F5 TetZap70OFF Zap70Yyaa/- and 
F5 TetZap70OFF Zap70Skg/- T cells had all diluted out their CTV by day 7 despite 
differences in expansions (Figure 6.3E and G). CD8 T cells from F5 
TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/- chimeras also showed 
evidence of activation and had upregulated CD44 (Figure 3.6F). Collectively, 
these data show that, CD8 T cells from F5 TetZap70OFF Zap70Yyaa/- and F5 
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TetZap70OFF Zap70Skg/- chimeras do not expand as much as F5 TetZap70ON T 
cells but do show evidence of activation and significant cell division. 
6.2.4 TCR signalling is required until 96-144 hours after influenza 
challenge for optimal CD8 T cell expansion  
Finally, we also wanted to investigate the temporal requirements for TCR 
signalling during the activation and expansion of CD8 T cells challenged with 
influenza in vivo. It has been proposed that commitment of CD8 T cells to 
proliferate and differentiate into effector cells might require only a brief 
encounter with antigen and that expansion after this initial contact can occur 
without further antigenic stimulation (Kaech and Ahmed, 2001; van Stipdonk et 
al., 2001). To investigate the temporal requirements of TCR signalling 
throughout this response, we used F5 TetZap70 mice where Zap70 expression 
and thus TCR signalling could be controlled by dox-feeding. As before, we 
transferred F5 TetZap70 T cells into Ly5.1 C57Bl/6 hosts and challenged these 
hosts with influenza. We then took cohorts of C57Bl/6 mice off dox-
supplemented food throughout the 7-day time-course to characterise how long 
F5 TetZap70ON T cells required Zap70 expression and intact TCR signalling in 
order to expand maximally (Figure 6.4). It takes approximately 48-72 hours for 
Zap70 abundance to drop in F5 TetZap70 T cells following dox-withdrawal, as 
determined by intracellular flow cytometry staining (Figure 3.3). F5 TetZap70ON 
T cells transferred into hosts not fed dox, failed to expand to the same degree 
as F5 Rag1-/- and F5 TetZap70ON T cells in dox-fed hosts (Figure 6.4A and B). 
Interestingly, F5 TetZap70ON T cells transferred into Ly5.1 C57Bl/6 hosts that 
were fed dox for 1 day did not expand substantially either (Figure 6.4A, B and 
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E). In hosts taken off dox 2 days after cell transfer and challenge we observed a 
range of responses. In some hosts, F5 TetZap70 T cells expanded, while we 
observed little expansion in other hosts (Figure 6.4A, B and E). Overall, the 
influenza-induced F5 T cell expansion in hosts that were fed dox for less than 2 
days never matched the expansion of F5 TetZap70ON T cells in hosts fed dox 
for 3 or more days (Figure 6.3E). Collectively, these data show that Zap70 
expression was required until 96-144 hours after the initial IV administration of 
influenza, for maximal expansion of F5 TetZap70 T cells.  
6.3  Discussion 
In this chapter we investigated the temporal requirements of TCR signalling 
during a cognate immune challenge using F5 T cells from mice in which 
conditional Zap70 expression could be controlled by dox-feeding. We show that, 
despite much lower Zap70 abundance in F5 TetZap70ON T cells compared to 
F5 Rag1-/- T cells, F5 TetZap70ON T cells could become activated and expand 
when challenged with live influenza, both in lymphopaenic B6 Rag1-/- and in 
lymphoreplete Ly5.1 C57Bl/6 hosts. This expansion was dependent on 
continued Zap70 expression since F5 TetZap70ON T cells transferred into dox-
free B6 Rag1-/- and Ly5.1 C57Bl/6 hosts did not expand. We confirmed that 
expansion of F5 Rag1-/- and F5 TetZap70ON T cells was antigen-dependent, as 
F5 T cells transferred into unchallenged hosts did not expand. Interestingly, the 
recovery of F5 TetZap70OFF T cells from influenza-challenged Ly5.1 C57Bl/6 
hosts was consistently greater than the recovery from unchallenged hosts. 
Furthermore, F5 TetZap70OFF T cells also upregulated CD44, a sign of 
activation. We show that CD5 expression on influenza-challenged F5 
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TetZap70ON T cells is upregulated so that the CD5 on activated and expanded 
F5 TetZap70ON T cells was as high as on activated F5 Rag1-/- T cells. Influenza-
challenged F5 TetZap70ON T cells also upregulated surface IL-7Rα expression. 
Neither heterozygous expression of Zap70Yyaa or Zap70Skg was able to mediate 
F5 T cell expansion in response to a challenge with influenza. Finally, we 
transferred F5 TetZap70ON T cells into Ly5.1 C57Bl/6 hosts that we challenged 
with influenza and then took off dox to test the temporal requirements for TCR 
signalling during T cell activation and expansion. Interestingly, unless animals 
remained on dox for 2 or more days after the challenge with influenza, F5 T cell 
expansion was submaximal. In other words, F5 T cells appeared to require 
intact Zap70 signalling until 96-144 hours after the challenge with influenza in 
order to respond and expand maximally. 
In view of the low Zap70 abundance in naïve F5 TetZap70ON T cells (Figure 
3.2C), as well as their low surface CD5 expression (Figure 3.2D) and failure to 
proliferate in lymphopaenic B6 Rag1-/- hosts placed on dox (data not shown) we 
were surprised to find that F5 TetZap70ON T cells were activated, expanded and 
adopted an activated phenotype following challenge with live influenza both in 
lymphopaenic and lymphoreplete hosts in vivo (Figure 6.1 and 6.2). The role of 
TCR signalling strength in promoting T cell activation and proliferation has been 
studied extensively using H2-Kb-restricted OT-I TCR transgenic CD8 T cells 
(Clarke et al., 2000), since so many ligands with varying binding affinity for the 
OT-I TCR exist (reviewed in Zehn et al., 2012). By generating recombinant L. 
monocytogenes strains that express Ova containing various altered peptide 
ligands, the role of TCR-ligand avidity in T cell activation and expansion has 
been studied in vivo. In this study revealed that even L. monocytogenes 
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expressing Ova containing altered peptide ligands that mediated very weak 
TCR-peptide interactions were able to promote T cell activation and clonal 
expansion in vivo (Zehn et al., 2009). While the initial T cell responses were 
very similar regardless of whether OT-I T cells had been strongly or weakly 
stimulated, strongly stimulated OT-I T cells proliferated longer and contracted 
later than more weakly stimulated OT-I T cells ultimately leading to greater OT-I 
T cell numbers accumulating in response to higher-affinity antigen (Zehn et al., 
2009). Although we did not characterise the kinetics of F5 TetZap70ON 
expansion, we consistently detected fewer F5 TetZap70ON T cells than F5 
Rag1-/- T cells 7 days after challenge (Figure 6.1B and 6.2C and D), which could 
fit with F5 TetZap70ON T cells receiving a weaker TCR signal than F5 Rag1-/- T 
cells as a result of reduced Zap70 abundance in F5 TetZap70ON compared to 
F5 Rag1-/- T cells. Indeed, both Lck and Zap70 are indispensable for T cell 
activation and proliferation (Au-Yeung et al., 2010; Tewari et al., 2006), although 
the importance of Zap70 abundance has not been specifically assessed. 
Interestingly, T cell development and TCR signalling are largely normal in 
polyclonal Zap70+/- (Hsu et al., 2009) and F5 Rag1-/- Zap70+/- (Figure 5.1, 2 and 
3). Furthermore, Erk2 activation downstream of TCR signalling has also been 
implicated in regulating the survival of differentiated CD8 T cells after viral 
infection (D'Souza et al., 2008) and we can not exclude that impaired survival 
after T cell activation affected F5 TetZap70ON expansion and accumulation. 
Data in this chapter also show that CD5 expression was upregulated on both F5 
Rag1-/- and F5 TetZap70ON T cells such that 7 days after challenged F5 Rag1-/- 
and F5 TetZap70ON T cells expressed similar CD5. So far, the regulation of CD5 
expression by spMHC TCR has largely been studied in developing thymocytes 
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and naïve T cells (Azzam et al., 1998; 2001; Smith et al., 2013; Wong et al., 
2001). This has lead to a model where productive spMHC TCR interactions in 
the thymus and periphery modulate CD5 expression (Azzam et al., 1998; Smith 
et al., 2001). In turn, CD5 modulates TCR signalling and T cell responsiveness 
(Azzam et al., 2001; Tarakhovsky et al., 1995; Wong et al., 2001). Here we 
show that activated F5 Rag1-/- and F5 TetZap70ON T cell CD5 expression is 
increased by challenge with live influenza in vivo. 
Interestingly, the effector phenotype of OT-I T cells stimulated by low- as well as 
high-affinity ligands was similar (Zehn et al., 2009). Consistent with this, both F5 
TetZap70ON and F5 Rag1-/- had upregulated the activation marker CD44 7 days 
after transfer (Figure 6.1C and 6.2E). Although, we did not specifically assess 
F5 TetZap70ON memory or effector function in our model, activated and 
expanded F5 TetZap70ON T cells all expressed high levels of IL-7Rα 7 days 
after challenge (Figure 6.2F) which is known to be important for the 
development of long-lived memory T cells in lymphoreplete hosts (Buentke et al., 
2006; Huster et al., 2004; Kaech et al., 2003). Interestingly, the frequency of 
endogenous CD44+ Ly5.1+ CD8 T cells was smaller in hosts that received F5 
Rag1-/- T cells and largest in hosts that received F5 TetZap70OFF T cells and 
thus correlated with the expansion of F5 T cells (Figure 6.2E and 6.4D). These 
data suggest that the endogenous CD8 T cell response might be greater if the 
F5 T cell expansion is suboptimal or absent. Indeed, some endogenous 
C57Bl/6 CD8 T cells responded better than OT-I T cells in response to Ova 
containing weak affinity ligands (Zehn et al., 2009). The endogenous C57Bl/6 T 
cell response to influenza remains to be examined in more detail by tetramer 
staining in the influenza challenge model described in this chapter. 
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We also assessed the ability of two hypomorphic Zap70 mutants to mediate T 
cell activation and expansion signals in response to an influenza challenge. 
Interestingly, while CD8 T cells from F5 TetZap70OFF Zap70Yyaa/- and F5 
TetZap70OFF Zap70Skg/- chimeras divided and became activated following 
influenza challenge (Figure 6.3B, C and D) their accumulation was reduced 
compared to the accumulation of influenza-challenged F5 TetZap70ON T cells 
(Figure 6.3G). Furthermore, even the addition of heterozygous dox-inducible 
Zap70 expression to mutant Zap70YYAA or Zap70SKG did not lead to a greater 
influenza-induced CD8 T cell expansion (Figure 6.3C, D and G). Interestingly, 
influenza-challenged CD8 T cells from F5 TetZap70ON Zap70Skg/- and F5 
TetZap70OFF Zap70Skg/- chimeras were consistently more readily detectable 
than CD8 T cells from F5 TetZap70ON Zap70Yyaa/- and F5 TetZap70OFF 
Zap70Yyaa/- chimeras (Figure 6.3G) despite Zap70 abundance being lower in F5 
TetZap70ON Zap70Skg/- and F5 TetZap70OFF Zap70Skg/- T cells than in F5 
TetZap70ON Zap70Yyaa/- and F5 TetZap70OFF Zap70Yyaa/- T cells (Figure 5.3). 
Furthermore, polyclonal SKG T cells both have a greater defect in TCR 
signalling and T cell proliferation than polyclonal YYAA T cells (Hsu et al., 2009). 
Although the altered TCR signalling sensitivity in F5 TetZap70 Zap70Skg/- and 
F5 TetZap70 Zap70Yyaa/- T cells remains to be examined in more detail in vitro, 
our data suggest the scaffolding function of Zap70, impaired in mutant 
Zap70YYAA, is crucial for CD8 T cell activation and expansion.  
Intriguingly, despite expanding less than F5 Rag1-/- T cells, influenza-challenged 
F5 TetZap70OFF, F5 TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/- T 
cells had all upregulated CD44 suggesting they had become activated (Figure 
6.2D and 6.3F). In fact CTV-labelled F5 TetZap70OFF Zap70Yyaa/- and F5 
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TetZap70OFF Zap70Skg/- T cells had completely diluted out CTV 7 days following 
challenge with influenza (Figure 6.3E). Furthermore, influenza-challenged F5 
TetZap70OFF T cells were consistently more readily detectable than 
unchallenged F5 TetZap70OFF T cells (Figure 6.2D). A small subset of F5 
TetZap70OFF T cells expressing sufficient Zap70 to become activated and divide 
could explain the apparent activation and improved recovery of influenza-
challenged F5 TetZap70OFF T cells. Alternatively, all F5 TetZap70OFF T cells 
underwent some minimal influenza-induced proliferation independent of Zap70 
signalling. One possibility is that influenza-challenged F5 TetZap70OFF, F5 
TetZap70OFF Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/- T cells became 
activated and proliferated as bystanders in response to cytokines and non-
antigen-specific signals (Tough et al., 1996; Tripp et al., 1995; Yang et al., 
1989) although this remains to be formally assessed in our model.  
Finally, we used the ability to ablate Zap70 expression by removing hosts from 
dox to assess the temporal requirements of TCR signalling during an immune 
response in vivo. We show that F5 TetZap70ON T cells in hosts fed dox for less 
than 2 days did not expand to the same degree as F5 TetZap70ON T cells that 
were transferred into hosts fed dox for more than 2 days (Figure 6.4E). These 
data suggest that F5 TetZap70ON T cells need intact Zap70 signalling until 96-
144 days after the influenza challenge for maximal influenza-induced CD8 T cell 
expansion in vivo. One interpretation of our data is that CD8 T cells require 
continuous Zap70 signalling for at least 96-144 hours following challenge with 
influenza to expand maximally in vivo. This contrasts with data from in vitro 
studies where activated T cells were shown to require only ~2h of antigen 
exposure to divide and become effector CD8 T cells (Kaech and Ahmed, 2001; 
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van Stipdonk et al., 2001 and reviewed in Masopust et al., 2004). Longer in vitro 
antigen exposure was required for sustained CD8 T cell differentiation and 
expansion in vivo (van Stipdonk et al., 2003). Continuous Zap70 signalling 
might not only be required for optimal CD8 T cell activation and expansion. T 
cell sensitivity to foreign antigen is also thought to depend on spMHC contact 
and intact TCR signalling (reviewed in Stefanova et al., 2003) and so intact 
Zap70 signalling might be required to maintain F5 TetZap70 CD8 T cell 
sensitivity prior activation and expansion following challenge with influenza. 
Alternatively, intact Zap70 signalling might not be required continuously 
throughout the expansion phase of F5 TetZap70ON CD8 T cells n C57Bl/6 hosts 
but only for a discrete period during the 96-144 hours after challenge with 
influenza. In fact, intact Zap70 and TCR signalling might only be required for 
briefly in vivo as has been shown in vitro (Kaech and Ahmed, 2001; van 
Stipdonk et al., 2001 and reviewed in Masopust et al., 2004) and the 96-144 
hours required for optimal T cell expansion might be the result of CD8 T cells 
migration and T cell APC interactions before Zap70 expression is required. We 
hope to investigate whether Zap70 signalling is required continuously 
throughout the expansion phase or for a brief and discrete period during the first 
96-144 hours after challenge using F5 TetZap70 CD8 T cells exposed to 
doxycyline for different periods following their initial expansion. 
Previous work has investigated the signalling requirements for T cell activation 
and expansion by studying ligand affinity and ligand exposure (reviewed Zehn 
et al., 2012). In this chapter we have used the F5 TetZap70 mice to directly 
study the duration and strength of signalling required for T cell activation and 
maximal F5 T cell expansion in response to cognate antigen. It is conceivable 
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that the temporal requirements for pMHC TCR engagement differ from the 
duration of TCR signalling necessary for maximal T cell expansion. Persistence 
of signalling downstream of the TCR beyond the exposure to antigen might 
explain why only brief contact with pMHC but much longer Zap70 signalling is 
required for T cell expansion. We propose that, as such, the expansion of F5 
TetZap70ON T cells in C57Bl/6 mice in response to flu is a good model to study 
the TCR signalling requirements during primary and memory CD8 T cell 
responses directly. 
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Figure 6.1 F5 TetZap70ON T cells expand in response to cognate antigen 
B6 Rag1-/- mice in vivo 
F5 Rag1-/- (grey fill/black) and F5 TetZap70ON lymphocytes (LN) were 
transferred intravenously into B6 Rag1-/- hosts placed on (blue) or off (red) dox 
and challenged with live influenza A/NT/60/68. Host and donor splenocytes 
were counted and analysed 7 days (d7) after challenge by flow cytometry.C (A) 
Density plots show CD8 against CD5 expression on live splenocytes 7 days 
after challenge. (B) Graph shows the number of CD8+ CD5+ splenocytes 7 days 
after challenge; *** p≤0.001 (one-way analysis of variance followed by 
Bonferroni correction for multiple comparisons). Histograms show CD44 (C) and 
CD5 (D) expression on donor CD8+ CD5+ splenocytes pre-challenge and 7 days 
after challenge. Data are representative of ≥two independent experiments. 
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Figure 6.2 F5 TetZap70ON T cells expand in response to cognate antigen 
in C57Bl/6 mice in vivo 
Ly5.2 F5 Rag1-/- (grey), F5 TetZap70ON (Ly5.2) (blue) and F5 TetZap70OFF 
(Ly5.2) (red) lymphocytes (LN) were transferred intravenously into Ly5.1 
C57Bl/B6 hosts on or off dox and challenged with live influenza A/NT/60/68 
(+flu, filled circles) or with medium (-flu, open circles). Host and donor 
splenocytes were counted and analysed 7 days (d7) after challenge by flow 
cytometry. F5 TetZap70OFF lymphocytes were isolated from the LNs of F5 
TetZap70 chimeras taken off dox ≥5 days previously. Bone marrow chimeras 
were made by reconstituting sub-lethally irradiated B6 Rag1-/- mice with F5 
TetZap70 bone marrow. (A) Density plots show Ly5.2 and CD5 expression on 
CD8+ TCR+ splenocytes 7 days after challenge.    (B) Density plot shows CD8 
against CD5 expression on Ly6.1 C57Bl/6 live splenocytes 7 days after 
challenge with live influenza A/NT/60/68. (C) Graphs show frequency and 
number of donor Ly5.2+ CD8+ CD5+ splenocytes 7 days after challenge. (D) 
Histograms show CD44 expression on host Ly5.1+ (grey fill) and donor Ly5.2+ 
CD8+ CD5+ splenocytes challenged with live influenza A/NT/60/68 (solid) or with 
medium (dotted); gate shows frequency (grey) of host Ly5.1+ CD44+ 
splenocytes. (E) Histograms show IL-7Rα expression on host Ly5.1+ (grey fill) 
and donor Ly5.2+ CD8+ CD5+ splenocytes pre-challenge (thin solid line) and 7 
days after transfer (solid line). Data are representative of ≥two independent 
experiments. 
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Figure 6.3 Neither Zap70Yyaa or Zap70Skg can substitute for Zap70Wt in F5 
TetZap70 cognate response 
CTV-labelled Ly5.2 F5 Rag1-/- (grey), F5 TetZap70ON (Ly5.2) (blue), F5 
TetZap70ON Zap70Yyaa/- (blue), F5 TetZap70ON Zap70Skg/- (blue), F5 
TetZap70OFF (red), F5 TetZap70OFF Zap70Yyaa/- (red) and F5 TetZap70OFF 
Zap70Skg/- (red) lymphocytes (LN) were transferred intravenously into Ly5.1 
C57Bl/B6 hosts on or off dox and challenged with 100 HAU live influenza 
A/NT/60/68. Host and donor splenocytes were counted and analysed 7 days 
(d7) after challenge by flow cytometry. F5 TetZap70OFF, F5 TetZap70OFF 
Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/- lymphocytes were isolated from the 
LNs of chimeras taken off dox ≥5 days previously. Bone marrow chimeras were 
made by reconstituting sub-lethally irradiated B6 Rag1-/- mice with F5 TetZap70, 
F5 TetZap70 Zap70Yyaa/- or F5 TetZap70 Zap70Skg/- bone marrow. (A) Density 
plot shows CD8 against CD5 expression on Ly6.1 C57Bl/6 live splenocytes 7 
days after challenge. (B)-(C) Density plots show Ly5.2 and CD5 expression on 
CD8+ TCR+ splenocytes 7 days after challenge. Histograms show CTV-dilution 
(E) and CD44 expression (F) on host Ly5.1+ (grey fill) and donor Ly5.2+ CD8+ 
CD5+ splenocytes pre-challenge (thin solid line) and 7 days after transfer (solid 
line); gate shows frequency (grey) of host Ly5.1+ CD44+ splenocytes. (G) Graph 
shows number of donor Ly5.2+ CD8+ CD5+ splenocytes as a percentage of the 
number of donor Ly5.2+ CD8+ CD5+ F5 Rag1-/- splenocytes 7 days after 
challenge; **** p≤0.0001 (one-way analysis of variance followed by Bonferroni 
correction for multiple comparisons).  Data are representative of ≥two 
independent experiments. 
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Figure 6.4 TCR signalling is required until 96-144 hours after influenza 
challenge for optimal CD8 T cell expansion  
Ly5.2 F5 Rag1-/- (grey) and F5 TetZap70ON (Ly5.2) (blue) lymphocytes (LN) 
were transferred intravenously into Ly5.1 C57Bl/B6 hosts and challenged with 
live influenza A/NT/60/68. Ly5.1 C57Bl/B6 hosts were taken off dox 0-4 days 
after transfer as indicated (red and pink). (A) Density plot shows CD8 against 
CD5 expression on Ly6.1 C57Bl/6 live splenocytes 7 days after challenge. (B) 
and (C) Density plots show Ly5.2 and CD5 expression on CD8+ TCR+ 
splenocytes 7 days after challenge. (D) Histograms show CD44 expression on 
host Ly5.1+ (grey fill) and donor Ly5.2+ (solid) CD8+ CD5+ splenocytes 7 dyas 
after challenge; gate shows frequency (grey) of host Ly5.1+ CD44+ splenocytes. 
(E) Graph shows the number of donor Ly5.2+ CD8+ CD5+ splenocytes as a 
percentage of the number of donor Ly5.2+ CD8+ CD5+ F5 Rag1-/- splenocytes 7 
days after challenge; **** p≤0.0001, *** p≤0.001 and ns p>0.05 (one-way 
analysis of variance followed by Bonferroni correction for multiple comparisons). 
Data are representative of ≥two independent experiments. 
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Chapter 7 Final discussion 
The aim of this thesis was to study the role of Zap70 in naïve T cell survival. 
The role of TCR signalling has been extensively studied but the source and 
downstream target of this TCR-mediated survival signal remain elusive. We 
studied naïve T cell survival in F5 TCR transgenic mice that conditionally 
express Zap70Wt, which allowed naïve T cells to develop normally. We were 
then able to ablate Zap70 expression. We characterised the survival of naïve 
CD8 T cells that lacked Zap70 both in vivo and in vitro in an attempt to identify 
the source and targets of TCR-mediated survival signals. We also studied the 
ability of two Zap70 mutants to substitute for Zap70WT during the development 
and survival of F5 TCR transgenic T cells. In the final chapter we investigated 
the temporal requirements for TCR signalling during T cell activation and 
proliferation in response to cognate antigen. We show that Zap70 expression is 
indeed required for the maintenance of CD8 T cells in vivo and that two 
previously described Zap70 mutants, Zap70YYAA and Zap70SKG were unable to 
substitute for Zap70WT in the transduction of this survival signal. In absence of 
Zap70, the pro-apoptotic Bcl-2 family member Bmf mRNA is upregulated in 
naïve CD8 T cells raising the possibility that Bmf might be a target of a Zap70-
dependent TCR survival signal. We also show that, CD8 T cells with low or no 
Zap70 fail to integrate properly into the mature naïve T cell pool, probably as a 
result of a survival defect.  We found that CD8 T cells that no longer express 
Zap70 are less sensitive to IL-7 although the survival defect of CD8 T cells in 
absence of Zap70 is IL-7-independent.  Unexpectedly, cDCs were unable to 
promote naïve T cell survival although CD11c+ enriched splenocytes improved 
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naïve T cell survival in a MEK-dependent manner. Since MEK is an important 
regulator of Bmf transcription and activity we propose that a TCR-mediated 
survival signal transduced by Zap70 regulates Bmf via MEK.  
7.1 The role Zap70 signalling in T cell homeostasis 
In order to study the survival of naïve CD8 T cells that lacked Zap70 we used 
mice that conditionally express Zap70. This allowed the development of T cells 
in which could later be made Zap70-deficient. T cell development in polyclonal 
TetZap70 mice was previously studied and revealed that the TCR-mediated 
developmental upregulation of Zap70 during positive selection was crucial for 
CD8 T cell development in particular (Saini et al., 2010). Zap70 expression is 
not upregulated in TetZap70 or F5 TetZap70 mice. In fact, Zap70 abundance 
drops as T cells mature beyond the CD8 SP stage in F5 TetZap70 mice and 
chimeras. CD8 T cell development was also impaired in F5 TetZap70ON 
chimeras, which had fewer CD8 SP thymocytes and naïve CD8 T cells than 
control F5 Rag1-/- chimeras. F5 TetZap70 thymocytes were also outcompeted 
by F5 Rag1-/- thymocytes in mixed BM chimeras at the DP3 CD5int TCRhi and 
CD8 SP HSAlo, coinciding with the impaired upregulation of Zap70 and low 
abundance of transgenic Zap70. Furthermore, peripheral F5 TetZap70 T cells in 
these mixed BM chimeras were predominantly RTEs suggesting that naïve T 
cells require WT abundance of Zap70 for their integration into the mature naïve 
T cell pool. Interestingly, we found that the peripheral CD8 T cell compartment 
in F5 TetZap70 chimeras was also enriched for RTEs consistent with the idea 
that the survival of RTE is not TCR-dependent but that integration into the naïve 
T cell pool does require intact TCR signalling. 
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In absence of continued Zap70 expression CD8 T cells failed to be maintained 
in the SLOs of F5 TetZap70 chimeras. The half-life of CD8 T cells in absence of 
Zap70 was 9.4 days. The estimated half-life of WT naïve T cells is in excess of 
90 days (Seddon and Zamoyska, 2002a) and so a half-life of 9.4 days is 
consistent with impaired survival and not just a block in T cell development in 
F5 TetZap70OFF chimeras. Previous estimates of the half-life TCR-deficient 
naïve CD8 T cells and cells lacking Lck and Fyn ranged between 16 and 19 
days (Labrecque et al., 2001; Polic et al., 2001; Seddon and Zamoyska, 2002a) 
and the shorter half-life of CD8 T cells in F5 TetZap70OFF might reflect 
differences in the survival of polyclonal and F5 TCR transgenic naïve T cells, 
which express low IL-7Rα (Sinclair et al., 2011). The half-life of HY TCR 
transgenic T cells in MHCI-deficient hosts, is even lower than the half-life of 
CD8 T cells in F5 TetZap70OFF chimeras and this variability is probably the 
result of the different experimental systems used.  
TCR-independent Zap70 signals might also contribute to naïve T cell survival. 
Zap70 activation can occur downstream of LFA1 (Evans et al., 2011) and so T 
cell migration might be impaired in absence of Zap70. CD8 T cells from F5 
Tetzap70OFF chimeras, however did not show any gross defects in homing to 
LN and spleen, which is where survival signals such as IL-7 and spMHC are 
proposed to be concentrated (Surh and Sprent, 2008). In fact, the impaired 
survival of CD8 T cells from F5 TetZap70OFF chimeras correlated with reduced 
CD5 expression. CD5 expression is modulated by homeostatic MHC-dependent 
TCR signals on naïve T cells (Smith et al., 2001) and so it seems likely that the 
impaired survival of CD8 T cells in absence of Zap70 is largely the result of 
impaired TCR signalling. 
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Consistent with previous data (Seddon and Zamoyska, 2002a) CD8 T cells from 
F5 TetZap70OFF chimeras failed to proliferate in lymphopaenic B6 Rag1-/- hosts, 
reflecting the importance of TCR signalling for homeostatic proliferation. 
Interestingly, CD8 T cells from F5 TetZap70OFF chimeras survived as well as 
CD8 T cells from F5 Rag1-/- mice after transfer into lymphopaenic hosts. Our 
data fit with other studies, which show that survival in lymphopaenic conditions 
is MHC- and TCR-independent (Martin, 2006; Martin et al., 2003) and reduced 
competition for other survival factors, including IL-7, might keep naïve T cells 
alive in T-cell-deficient hosts independently of TCR. 
Clearly, IL-7 signals are non-redundant for T cell survival and naïve CD8 T cells 
disappear rapidly after transfer into IL-7-deficient hosts. CD8 T cells from F5 
TetZap70OFF chimeras still disappeared more rapidly than CD8 T cells from F5 
Rag1-/- mice and so the survival defect of Zap70-deficient naïve CD8 T cells is 
largely IL-7-independent. It has recently been shown that TCR signals regulate 
IL-7Rα expression in the thymus (Sinclair et al., 2011) but whether IL-7Rα and 
TCR signalling are crossregulated in naïve T cells remains controversial. There 
is evidence that IL-7Rα signalling downregulates its own signalling (Park et al., 
2004a) while increasing the T cell sensitivity to spMHC by increasing Cd8a 
transcription (Park et al., 2007). Other studies have failed to show that TCR 
signalling regulates IL-7Rα signalling in naïve T cells (Seddon et al., 2003; 
Sinclair et al., 2011). Interestingly, ex vivo IL-7Rα expression on CD8 T cells 
from F5 TetZap70 chimeras was reduced compared to CD8 T cells from F5 
Rag1-/- mice but after overnight culture without IL-7, IL-7Rα expression was 
higher on CD8 T cells from F5 TetZap70 chimeras than on control F5 Rag1-/- T 
cells. The higher IL-7Rα expression on CD8 T cells from F5 TetZap70 chimeras 
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could reflect impaired IL-7 signalling and in fact we do find that CD8 T cells from 
F5 TetZap70OFF chimeras are less sensitive to low concentrations of IL-7 in vitro. 
This is inconsistent with a ‘co-receptor tuning model’ of TCR and IL-7Rα 
crosstalk (Park et al., 2007) which would argue that reduced homeostatic TCR 
signals should instead enhance IL-7Rα signalling. Moreover, we observed no 
differences in CD8 expression or IL-7-induced Bcl-2 upregulation between naïve 
T cells from F5 TetZap70 and F5 Rag1-/- chimeras and propose that the 
difference in IL-7Rα expression between CD8 T cells from F5 TetZap70 and F5 
Rag1-/- chimeras is largely the result of the relative lymphopaenia of F5 
TetZap70 chimeras. 
We also tested whether the Zap70 mutants, Zap70YYAA and Zap70SKG, were 
able to transduce this TCR-mediated survival signal. The TCR signalling and T 
cell development defects in polyclonal mice expressing these mutants were 
previously characterised (Hsu et al., 2009; Sakaguchi et al., 2003). Both 
Zap70YYAA and Zap70SKG are hypomorphic alleles of Zap70 and as a result the 
repertoire of T cells that are positively selected in polyclonal YYAA and SKG 
mice is shifted in favour of more auto-reactive T cells (Hsu et al., 2009; 
Sakaguchi et al., 2003). Neither Zap70YYAA nor Zap70SKG was able to support 
the development or the survival of F5 TCR transgenic T cells in F5 TetZap70OFF 
Zap70Yyaa/- and F5 TetZap70OFF Zap70Skg/- chimeras. The impaired survival of 
CD8 T cells in F5 TetZap70OFF Zap70Skg/- chimeras could be attributed to a 
combined effect of reduced Zap70 abundance and attenuated TCR signalling 
mediated by Zap70SKG. The abundance of Zap70YYAA in CD8 T cells from F5 
TetZap70OFF Zap70Yyaa/- and F5+/- Rag1-/- Zap70+/- chimeras was equivalent and 
so the failure of CD8 T cells to survive in F5 TetZap70OFF Zap70Yyaa/- chimeras 
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must reflect the importance of Zap70 adaptor function for the transduction of 
TCR survival signals. The tyrosine residues mutated in Zap70YYAA have been 
implicated in the recruitment of Lck and PLCγ and Ca2+ mobilisation, PLCγ 
phosphorylation and Ras and Erk activation are impaired in mice expressing 
mutations of either of these residues (Magnan et al., 2001; Williams et al., 1999). 
The inability of Zap70YYAA to transduce TCR-mediated survival signals F5 
TetZap70OFF Zap70Yyaa/- chimeras probably reflects the importance of these 
pathways for naïve T cell survival. 
7.2 The source and downstream targets of a Zap70-dependent 
survival signal for naïve F5 T cells 
Despite extensive research characterising the requirement of interactions 
between spMHC and TCR for naïve T cell survival very little is known about the 
source or the downstream targets of TCR-mediated survival signals. In Chapter 
4, we describe the Zap70-dependent survival of F5 TCR transgenic T cells 
cultured in vitro with CD11c+ enriched splenocytes. Despite evidence that cDCs 
are able to promote naïve T cell survival in vitro (Feuillet et al., 2005; Revy et al., 
2001), we were unable to replicate the survival signal provided by CD11c+ 
enriched splenocytes using FACS-purified cDCs or pDCs. In the studies that 
support a role for DCs providing CD8 T cells with a survival signal in vitro DCs 
were not FACS-purified and contamination of other cell populations might 
explain the contrast with our results. In fact, a subsequent study also failed to 
show that FACS-purified cDCs were able to promote naïve T cell survival in 
vitro (Link et al., 2007) and so another CD11c+ cell population is probably the 
source of a Zap70-dependent survival signal. So far, only the FACS-purified 
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MHCII- fraction of CD11c+ enriched splenocytes promoted the survival of F5 
Rag1-/- T cells in vitro and we are currently investigating whether a specific cell 
type or combination of cell types is the source of this Zap70-dependent survival 
signal. 
We were also able to show that the survival signal provided by CD11c+ enriched 
B6 Rag1-/- splenocytes was completely dependent on MEK. This finding is 
particularly interesting since we also show that the pro-apoptotic Bcl-2 family 
member Bmf is upregulated in F5 TetZap70 T cells in absence of Zap70. Bmf 
transcription is upregulated in melanoma cells following MEK inhibition with 
UO126 (Shao and Aplin, 2010) and MEK signalling has also been shown to 
inhibit the pro-apoptotic activity of Bmf (Shao and Aplin, 2012). MAPK signalling 
downstream of the TCR is sensitive and enables thymocytes to distinguish 
between positive and negative selection despite very small differences in TCR 
affinity for the selecting ligand (Daniels et al., 2006). Bmf-/- mice only have a 
small increase in the number of CD8 T cells (Labi et al., 2008) and Bmf is 
thought to be largely redundant during T cell development but the role of Bmf 
during T cell development and naïve T cell survival has not been studied in 
great detail. We propose that TCR signals via MEK regulate naïve T cell 
survival by inhibiting Bmf transcription and we plan to test whether Bmf-
deficiency can rescue the survival defect of CD8 T cells in F5 TetZap70OFF 
chimeras. 
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7.3 The TCR signalling requirements during antigen-induced T 
cell activation and proliferation  
The temporal requirements for TCR signalling during CD8 T cell activation and 
expansion in response to cognate antigen have previously been studied in 
terms of the requirement for antigen exposure (Kaech and Ahmed, 2001; van 
Stipdonk et al., 2001; 2003). CD8 T cells from F5 TetZap70 allow us to study 
the signalling requirements for CD8 T cell activation and expansion. We show 
that despite very low Zap70 abundance, CD8 T cells from F5 TetZap70ON 
chimeras become activated and expand substantially in response to cognate 
antigen. This is consistent with previous data showing that the strength of TCR 
stimulation has little impact on the early response to antigen and T cell 
activation but that it dictates the magnitude of the expansion (Zehn et al., 2009). 
Interestingly, CD8 T cells from F5 TetZap70 Zap70Yyaa/- and F5 TetZap70 
Zap70Skg/- chimeras failed to expand to the same extent as F5 TetZap70ON T 
cells in response to influenza regardless of whether they expressed transgenic 
Zap70Wt. Firstly, this suggests that heterozygous levels of Zap70WT are 
insufficient to promote substantial CD8 T cell expansion in response to cognate 
antigen. Secondly, neither Zap70SKG nor Zap70YYAA are able to mediate CD8 T 
cell expansion. Interestingly, CD8 T cells from F5 TetZap70 Zap70Yyaa/- and F5 
TetZap70 Zap70Skg/- chimeras did divide and showed signs of activation. 
Similarly, CD8 T cells from F5 TetZap70OFF upregulated CD44 and were more 
readily detected in hosts challenged with influenza than in unchallenged hosts. 
It remains to be investigated whether this T cell activation is Zap70-independent 
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or represents the activation and expansion of a small population of CD8 T cells 
that still express Zap70. 
CD8 T cells have been shown to require a brief exposure to antigen in order 
initiate a program of CD8 T cell activation, expansion and differentiation (Kaech 
and Ahmed, 2001; van Stipdonk et al., 2001; 2003). We show that only if Zap70 
expression was maintained for at least 96-144 hours, expansion of CD8 T cells 
in response to influenza was optima. This could reflect either a requirement for 
continuous Zap70 signalling throughout the expansion phase of F5 TetZap70 
CD8 T cells, in contrast to data from in vitro studies where only exposure to 
MHC and antigen was sufficient for initiating CD8 T cell activation and 
differentiation (Kaech and Ahmed, 2001; van Stipdonk et al., 2001 and reviewed 
in Masopust et al., 2004). Alternatively, F5 TetZap70ON CD8 T cells only 
required Zap70 expression briefly and the fact that maximal expansion only 
occurred in mice fed dox for more than 2 days reflects F5 TetZap70ON CD8 T 
cells entering the peripheral lymphoid organs and interacting with APCs until 
they encounter their antigen. The expansion of CD8 T cells in which Zap70 
expression was continued beyond 96-144 days broadly correlated with the 
duration of Zap70 induction. Similarly, antigen persistence has also been shown 
to affect the magnitude of T cell expansion rather than the functionality of the 
effector cells generated (Prlic et al., 2006). The response of CD8 T cells from F5 
TetZap70 chimeras to influenza provides a good model to study the Zap70 and 
TCR signalling requirements of primary and secondary responses to antigen. 
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7.4 Clinical perspectives 
Understanding the signalling pathways downstream of TCR that regulate the 
survival and proliferation of T cells in lymphoreplete and lymphopaenic 
conditions and in response to cognate antigen is important in the design of 
therapeutics. The restricted expression of Zap70, in T cells and NK cells (Chan 
et al., 1992) and its essential role in the transduction of TCR signals make it an 
interesting therapeutic target for immunosuppression following transplantation 
and in autoimmune disease. The two main immunosuppressants in common 
use, currently, tacrolimus and cyclosporin, have significant side effects as a 
result of their inhibition of calcineurin in the kidney (Dumont et al., 1992; 
Johnson et al., 1999; Wolf et al., 1990) which could be prevented by targeting 
Zap70 downstream of TCR engagement, specifically.  
In this thesis we have clearly demonstrated that Zap70 plays an important role 
in transducing T cell survival signals, in a MEK-dependent manner. Inhibition of 
Zap70 signalling might thus prevent the survival and proliferation of malignant T 
cells as well as normal T cells, although the specificity and potency of Zap70 
small molecule (Hirabayashi et al., 2009) and peptide (Nishikawa et al., 2000) 
inhibitors developed to date have not been tested in T cells in vivo. Interestingly, 
Zap70 is expressed in B cells in certain subtypes of B-CLL where it facilitates 
BCR signalling and enhances B cell migration (Calpe et al., 2011; Chen et al., 
2005a). Zap70 expression in B-CLL also correlates with disease progression 
and poor survival (Crespo et al., 2003; Rassenti et al., 2004) and as such has 
been proposed to be an attractive target for B-CLL treatment. Meanwhile Raf, 
MEK and Erk kinases are important regulators of cell survival and proliferation 
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in many non-malignant and malignant cells. Inhibition of this signalling cascade 
has been the subject of intensive research to design specific small molecule 
inhibitors for the treatment of cancer (Roberts and Der, 2007; Sebolt-Leopold 
and Herrera, 2004). Importantly, inhibition of MAPK signalling is toxic not only to 
malignant cells, but also to normal proliferating cells and so targeting Zap70 in T 
cells specifically might provide a more specific treatment of T cell malignancies 
alone or in combinations with other therapies. Whether specific T cell 
malignancies or T cell malignancy subtypes are sensitive to Zap70 inhibition, 
express increased Zap70 or hypermorphic mutants of Zap70, remains to be 
investigated. We hope, the important role Zap70 plays in the transduction of T 
cell survival and proliferation signals, as demonstrated in this thesis, might 
provide further incentive to develop a selective cell-permeable Zap70 kinase 
inhibitor.  
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